Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3019473	li-prot	mg/l (mg/l)	11196	15389	0.10%
3019473	li-prot	— (—)	657	744	100.00%	Distribution not available
3019473	li-prot	g/l (mg/l)	206	233	0.00%
3019473	li-prot	mg/l______ (mg/l)	135	153	0.00%
3019473	li-prot	mg/L (mg/l)	70	76	0.00%
3019473	li-prot	MG/L (mg/l)	28	30	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Alzheimer disease, including avohilmo

1137

2184

3.76

313.14

1.2

1.3

502.08

601.81

mg/l

2.89

1055

2093

Stroke, including SAH

1787

4743

2.79

310.67

1.6

1.3

663.46

559.72

mg/l

2.10

1711

4523

Use of anticholinesterases

1074

2288

3.78

308.55

1.2

1.3

485.53

605.41

mg/l

6.43

996

2189

N06DA Anticholinesterases

1074

2288

3.78

308.55

1.2

1.3

485.53

605.41

mg/l

6.43

996

2189

Anxiety disorders, excluding more controls

2249

5633

2.62

307.65

1.4

1.3

515.00

558.46

mg/l

0.96

2141

5440

Polyneuropathies and other disorders of the peripheral nervous system

980

2140

4.96

307.65

1.6

1.3

632.57

555.29

mg/l

1.56

951

2037

Episodal and paroxysmal disorders

3161

6115

2.69

307.65

1.4

482.24

544.84

mg/l

4.32

3033

5855

Other neurological diseases

3290

5764

4.71

307.65

1.6

1.2

517.73

565.47

mg/l

1.54

3172

5501

Any dementia

1330

2359

4.10

307.65

1.2

1.3

509.93

596.07

mg/l

2.74

1233

2268

Dizziness and giddiness

2232

5803

3.09

307.65

1.3

1.4

498.45

565.78

mg/l

3.80

2146

5589

Migraine

1779

4247

3.39

307.65

1.4

431.10

508.22

mg/l

4.06

1719

4070

Other symptoms and signs involving the nervous and musculoskeletal systems

2049

4440

4.97

307.65

1.4

495.55

533.04

mg/l

1.17

1953

4262

Delirium, not induced by alcohol and other psychoactive substances

540

825

7.08

307.65

1.3

581.99

622.80

mg/l

0.32

514

798

Alzheimer disease, excluding more controls

878

238

26.14

307.65

1.2

1.1

469.19

571.47

mg/l

1.91

809

224

Dementia

1489

2436

4.40

307.65

1.2

1.3

523.38

589.50

mg/l

1.68

1386

2347

Dementia, including avohilmo

1609

2779

4.16

307.65

1.2

1.3

518.31

585.91

mg/l

1.97

1498

2676

Other mental disorders due to brain damage and dysfunction and to physical disease

571

872

7.21

307.65

1.3

491.83

606.23

mg/l

5.18

547

843

Other degenerative diseases of the nervous system

2057

677

25.20

307.65

1.2

1.1

451.88

513.12

mg/l

2.71

1947

642

Convulsions, not elsewhere classified

1026

1745

6.21

307.65

1.6

1.3

489.18

515.38

mg/l

0.74

984

1672

Concussion

1353

1566

6.94

307.65

1.4

528.83

470.43

mg/l

0.65

1290

1500

STROKE

1849

4241

3.05

307.65

1.5

1.3

645.83

529.56

mg/l

2.73

1779

4062

Viral infections of the central nervous system

636

745

10.46

307.65

1.5

1.3

688.38

531.46

mg/l

7.30

613

711

Abnormal findings on diagnostic imaging of central nervous system

500

520

12.22

307.65

1.4

1.6

523.07

509.51

mg/l

0.17

483

497

Disturbances of skin sensation

1286

3298

4.18

307.65

1.2

1.3

436.70

514.96

mg/l

7.58

1233

3160

Intracranial trauma

1602

1583

7.09

307.65

1.4

546.58

469.89

mg/l

1.06

1527

1516

Symptoms and signs involving cognition, perception, emotional state and behaviour

4157

6837

4.28

307.65

1.3

1.4

499.30

556.07

mg/l

3.74

3975

6579

Meningitis

458

475

12.13

307.65

1.9

1.2

1127.50

497.28

mg/l

20.10

446

453

Other and unspecified polyneuropathies, also in other diseases

810

1814

4.81

307.65

1.3

619.39

560.98

mg/l

0.82

786

1719

Headache

3335

4513

6.10

307.65

1.4

1.2

474.10

519.48

mg/l

2.38

3204

4317

MS-disease / Multiple Sclerosis

753

710

13.56

307.65

1.1

1.3

424.11

479.63

mg/l

2.38

726

679

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

862

727

6.11

307.65

1.4

1.2

511.06

546.78

mg/l

0.74

819

697

Symptoms and signs involving the nervous and musculoskeletal systems

2883

6368

4.86

307.65

1.4

498.21

554.12

mg/l

2.27

2758

6115

Cerebrovascular diseases (FINNGEN)

1383

2247

4.59

307.65

1.6

1.2

681.51

509.31

mg/l

3.32

1324

2148

Implicit Sepsis, including avohilmo

3157

6462

3.65

307.65

1.4

1.3

504.23

544.54

mg/l

1.93

3017

6219

Alzheimer’s disease (Late onset), excluding more controls

540

186

20.14

307.65

1.2

494.47

592.82

mg/l

1.27

487

175

Viral encephalitis, not elsewhere classified/unspecified

280

169

25.15

307.65

1.6

1.4

717.80

455.32

mg/l

8.76

271

162

Disorders of optic nerve and visual pathways

649

1004

7.46

307.65

1.3

1.5

475.16

511.12

mg/l

0.48

619

959

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

285

171

25.24

307.65

1.6

1.4

714.56

456.51

mg/l

8.71

276

164

General symptoms and signs

3641

4859

3.90

307.65

1.4

1.2

543.37

541.10

mg/l

0.03

3498

4655

Infections, IBD-co-morbidities

422

273

11.34

307.65

1.7

1.4

609.88

445.83

mg/l

1.69

405

258

Malaise and fatigue

1821

3392

4.42

307.65

1.4

1.3

533.98

540.85

mg/l

0.08

1749

3248

Visual disturbances

1805

5866

3.23

307.65

1.4

516.88

523.73

mg/l

0.14

1730

5626

Inflammatory diseases of the central nervous system

891

829

13.91

307.65

1.8

1.3

908.99

502.36

mg/l

25.10

871

790

Unspecific neurodegenerative disorder

1331

2501

3.81

307.65

1.2

1.3

485.13

605.56

mg/l

7.78

1236

2407

Visual disturbances and blindness

1901

6292

3.16

307.65

1.4

523.01

529.41

mg/l

0.13

1821

6037

Condition for Implicit Sepsis (Organ dysfunction codes)

3306

6399

3.75

307.65

1.3

498.49

547.66

mg/l

2.71

3156

6164

Any dementia, excluding more controls

1309

1936

4.91

307.65

1.2

1.3

508.83

606.72

mg/l

3.05

1214

1871

Any mental disorder

2971

6022

2.53

307.65

1.4

487.36

559.59

mg/l

6.07

2816

5818

Postprocedural disorders of nervous system

678

656

12.82

307.65

1.3

1.2

381.82

495.69

mg/l

5.67

648

628

Other demyelinating diseases of the central nervous system

481

354

19.24

307.65

1.2

1.4

433.45

502.98

mg/l

1.53

470

338

Neurological diseases, wide definition

1130

454

13.15

307.65

1.6

1.5

461.72

422.34

mg/l

1.34

1078

433

Normal-pressure hydrocephalus

721

322

35.51

307.65

1.8

1.2

377.76

674.62

mg/l

8.31

715

299

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

3411

6638

3.62

307.65

1.3

493.74

538.40

mg/l

2.44

3261

6393

Cerebral cysts

433

486

10.53

307.65

1.5

1.3

441.16

529.98

mg/l

1.39

422

460

Hydrocephalus

1081

549

29.07

307.65

2.1

1.4

467.75

597.62

mg/l

3.46

1067

515

Other symptoms and signs involving cognitive functions and awareness

2695

3497

7.49

307.65

1.3

1.4

510.53

583.41

mg/l

3.41

2553

3365

Demyelinating diseases of the central nervous system

912

882

13.29

307.65

1.2

1.3

433.64

512.66

mg/l

3.46

882

841

Other encephalitis

426

247

27.25

307.65

1.7

1.3

694.79

457.99

mg/l

10.64

420

234

Implicit viral Sepsis

827

1879

4.68

307.65

1.6

1.3

538.96

537.82

mg/l

0.01

789

1790

Focal epilepsy

974

2233

4.71

307.65

1.5

1.6

544.02

523.20

mg/l

0.46

937

2135

Focal epilepsy, mode (most common among epilepsy diagnosis)

869

1945

4.83

307.65

1.5

552.80

527.61

mg/l

0.52

835

1860

Mood disorders, excluding more controls

2650

5921

2.70

307.65

1.3

505.35

560.47

mg/l

1.97

2536

5720

Focal epilepsy, strict definition

921

2050

4.86

307.65

1.5

542.14

529.42

mg/l

0.25

889

1957

Implicit bacterial Sepsis, including avohilmo

1420

3669

3.35

307.65

1.5

1.3

563.05

557.28

mg/l

0.09

1353

3517

Epilepsy

1373

2828

5.17

307.65

1.5

555.89

571.43

mg/l

0.22

1319

2703

Other headache syndromes

1451

4146

3.65

307.65

1.4

1.3

479.15

541.71

mg/l

2.05

1400

3966

Psychiatric diseases

2503

5074

2.53

307.65

1.4

511.87

563.42

mg/l

2.28

2378

4904

Organic, including symptomatic, mental disorders

2095

3212

4.88

307.65

1.2

1.3

527.24

579.30

mg/l

1.76

1971

3090

Implicit Sepsis

2765

6201

3.43

307.65

1.4

1.3

515.64

546.06

mg/l

1.12

2645

5962

Degenerative diseases of the nervous system

1268

2231

4.30

307.65

1.2

1.3

478.39

608.85

mg/l

8.01

1179

2146

Encephalitis

440

265

25.70

307.65

1.7

1.3

691.38

461.51

mg/l

10.28

434

253

Fever of other and unknown origin

1811

4138

3.94

307.65

1.7

1.2

592.57

532.10

mg/l

1.70

1755

3962

Viral infections of the central nervous system, including avohilmo

666

799

10.12

307.65

1.5

1.3

679.37

524.81

mg/l

7.75

642

764

Neurological diseases

3012

2121

7.46

307.65

1.5

1.4

485.32

512.25

mg/l

0.62

2886

2026

Viral Sepsis

831

1884

4.70

307.65

1.6

1.3

538.08

538.38

mg/l

0.00

793

1795

Implicit viral Sepsis, including avohilmo

1168

2907

4.24

307.65

1.5

1.3

532.95

529.35

mg/l

0.05

1113

2788

Cerebrovascular diseases

2334

5523

3.04

307.65

1.5

1.3

643.24

547.53

mg/l

2.49

2237

5291

Abnormalities of gait and mobility

654

1025

7.13

307.65

1.5

1.4

510.95

569.42

mg/l

0.94

631

971

Traumatic subdural haemorrhage

346

309

10.97

306.97

1.5

1.1

683.72

531.43

mg/l

0.92

329

295

Implicit bacterial Sepsis

1260

3391

3.31

306.51

1.5

1.3

566.36

562.18

mg/l

0.06

1197

3253

Pain, not elsewhere classified

863

2194

4.10

300.57

1.4

1.2

511.98

508.30

mg/l

0.04

820

2101

Mood [affective] disorders

2873

8507

2.21

299.54

1.3

496.63

553.32

mg/l

2.21

2747

8165

Mood disorders

2874

8510

2.21

298.22

1.3

496.55

553.18

mg/l

2.21

2748

8168

Bacterial Sepsis

1375

3826

3.08

294.30

1.5

1.3

603.45

559.11

mg/l

1.03

1309

3669

Alzheimer’s disease, strict definition

826

1590

4.40

293.68

1.2

1.3

471.62

615.09

mg/l

7.02

759

1523

Other antidepressants

2694

6070

2.32

293.67

1.3

496.27

557.97

mg/l

4.02

2568

5834

Depression

2711

8301

2.24

292.41

1.3

496.63

552.58

mg/l

2.02

2588

7966

Alzheimer disease

993

1931

3.84

284.33

1.2

1.3

476.45

602.50

mg/l

7.46

914

1855

Other and unspecified hydrocephalus

230

147

22.55

280.60

2.5

1.3

494.50

515.75

mg/l

0.16

225

140

Syncope and collapse

1161

3061

3.26

276.47

1.4

1.2

470.90

535.94

mg/l

3.91

1116

2926

Alzheimer’s disease (Early onset)

297

285

11.93

276.27

1.1

1.3

437.47

608.70

mg/l

4.78

285

277

Other meningitis

225

150

22.65

269.83

2.1

1.2

1032.99

446.51

mg/l

9.39

219

142

Spirochaetal infections, other/unspecified

508

933

6.14

269.39

1.2

1.4

611.55

558.91

mg/l

1.20

492

886

General examination and investigation of persons without complaint and reported diagnosis

1687

3244

2.77

263.99

1.5

1.3

525.36

574.86

mg/l

0.71

1619

3122

Depression or dysthymia

1595

3167

2.82

262.19

1.3

1.4

505.66

568.05

mg/l

2.60

1518

3065

Medical observation and evaluation for suspected diseases and conditions

1689

3244

2.73

255.85

1.4

1.3

483.83

574.86

mg/l

3.25

1624

3122

Dorsalgia

2608

6440

2.19

253.09

1.3

508.02

543.05

mg/l

0.91

2502

6167

Migraine without aura

752

1967

4.03

252.85

1.4

1.5

435.58

473.83

mg/l

0.63

730

1893

Autoimmune diseases excluding thyroid diseases

2784

7347

2.10

243.52

1.3

1.4

543.11

541.97

mg/l

0.02

2680

7033

Low back pain

2094

6285

2.30

242.78

1.3

498.12

543.19

mg/l

1.40

2001

6018

Status epilepticus

260

252

12.19

241.52

1.6

1.7

621.02

591.61

mg/l

0.14

252

241

Symptoms and signs involving the skin and subcutaneous tissue

2052

8843

2.25

240.98

1.4

463.74

544.10

mg/l

8.61

1965

8492

Autoimmune diseases related-to ILD

2341

9352

2.14

237.69

1.2

1.4

505.17

544.32

mg/l

1.14

2249

8965

Autoimmune diseases excluding thyroid diseases, strict definition

2693

7115

2.10

237.28

1.3

1.4

541.61

537.03

mg/l

0.07

2594

6806

Parkinson's disease, excluding more controls

274

248

10.54

235.77

1.4

1.1

488.43

564.52

mg/l

1.20

259

232

Papilloedema, unspecified

237

214

14.52

234.55

1.4

457.58

464.57

mg/l

0.04

229

205

Diplopia

567

1281

4.78

233.86

1.4

1.3

592.17

543.24

mg/l

0.64

545

1222

Other dorsopathies, not elsewhere classified

2588

6456

2.12

231.65

1.3

1.4

495.79

542.49

mg/l

1.69

2478

6183

Other soft tissue disorders, not elsewhere classified

2516

6869

2.13

231.55

1.4

493.08

551.91

mg/l

2.29

2422

6579

Optic neuritis

309

400

9.18

230.82

1.2

1.4

407.98

477.24

mg/l

2.32

291

382

Anxiety disorders

2455

8179

2.11

229.77

1.4

1.3

528.04

534.43

mg/l

0.07

2340

7857

Neurotic, stress-related and somatoform disorders

2435

8142

2.11

228.42

1.4

1.3

527.63

534.25

mg/l

0.07

2321

7821

Stroke, excluding SAH

1557

4539

2.55

227.59

1.5

1.3

625.31

564.63

mg/l

1.07

1489

4330

Migraine with aura

817

2429

3.51

226.18

1.3

447.54

507.89

mg/l

1.20

788

2332

ILD medications

2923

8037

2.00

224.97

1.6

1.3

525.68

533.53

mg/l

0.15

2814

7698

Aneurysms, operations, SAH

604

1472

4.37

224.83

1.8

1.2

750.15

549.41

mg/l

1.90

578

1403

Other disorders of optic [2nd] nerve and visual pathways

386

650

6.77

224.64

1.4

1.6

519.06

542.29

mg/l

0.16

370

622

Certain infectious and parasitic diseases

2399

5652

2.17

223.76

1.5

1.3

536.23

498.64

mg/l

1.46

2310

5408

ILD medications: immunosuppressive drugs

1811

7370

2.28

219.16

1.8

1.3

542.76

528.11

mg/l

0.21

1761

7063

Recurrent or chronic depression

1044

2409

3.09

216.63

1.3

459.88

555.93

mg/l

4.55

1000

2324

Bacterial infection, other or unspecified

1486

5202

2.48

212.96

1.6

1.3

627.54

534.20

mg/l

2.39

1417

4981

Parkinson's disease, strict definition, excluding more controls

245

228

10.38

210.28

1.4

1.2

488.17

575.96

mg/l

1.33

232

214

Bacterial infection, other or unspecified, including avohilmo

1603

5662

2.38

209.53

1.6

1.3

620.51

530.75

mg/l

2.50

1533

5426

Lower back pain or/and sciatica

2772

9001

1.95

206.66

1.3

510.59

545.10

mg/l

1.07

2656

8627

Nerve, nerve root and plexus disorders

2708

8438

1.96

204.35

1.3

550.81

538.89

mg/l

0.23

2602

8087

Anxiety (asthma-related co-morbidities)

1685

5742

2.29

197.56

1.3

1.4

470.45

539.64

mg/l

1.25

1605

5525

Nontraumatic intracranial haemmorrhage

607

1626

3.91

197.02

2.0

1.3

808.67

571.09

mg/l

2.36

579

1545

Viral meningitis, including avohilmo

278

383

8.61

196.94

1.4

1.3

694.56

478.06

mg/l

6.65

268

369

Pain in limb

2169

6726

2.09

196.74

1.4

500.38

543.20

mg/l

1.35

2086

6444

Sequelae of cerebrovascular disease

946

2789

2.99

195.63

1.5

1.3

645.02

564.38

mg/l

0.85

911

2660

Subjective visual disturbances

847

2819

3.15

195.35

1.3

1.4

479.35

534.17

mg/l

1.32

813

2697

Cerebral palsy and other paralytic syndromes

489

1134

4.66

195.28

1.7

1.5

584.61

549.33

mg/l

0.41

460

1083

Viral meningitis

270

364

8.84

195.08

1.4

1.3

704.12

478.53

mg/l

6.81

260

351

Disorders of thyroid, IBD co-morbidities

333

308

7.60

194.47

1.5

1.2

540.67

436.05

mg/l

1.90

318

291

Anaemias

630

1028

4.06

189.06

1.7

1.2

505.88

427.66

mg/l

2.63

600

988

Examination and observation for other reasons

1405

3226

2.51

188.14

1.4

1.3

490.24

574.83

mg/l

2.26

1364

3106

Use of donepezil

589

1511

3.88

187.49

1.2

1.3

474.34

605.64

mg/l

5.19

535

1438

Pain in joint

1389

3516

2.48

185.78

1.2

1.3

517.89

571.89

mg/l

1.02

1319

3372

Ischaemic Stroke, excluding all haemorrhages

1380

4284

2.43

184.77

1.4

1.3

593.41

571.37

mg/l

0.27

1319

4082

Guillain-Barre syndrome

168

137

16.45

177.73

1.4

1.3

848.49

441.88

mg/l

11.61

163

130

Persons encountering health services for specific procedures and health care

2696

8633

1.88

177.09

1.4

560.87

519.08

mg/l

1.28

2561

8312

All anxiety disorders

1725

6371

2.15

175.28

1.3

467.08

525.43

mg/l

1.03

1644

6129

Other special examinations and investigations of persons without complaint or reported diagnosis

1497

3244

2.38

174.42

1.4

1.3

499.98

574.86

mg/l

2.19

1412

3122

Dorsopathies

2459

6509

1.95

173.66

1.3

1.4

488.53

540.81

mg/l

2.64

2355

6236

Used for control exclusion in common control thyroid runs

2543

6779

1.92

173.56

1.3

1.4

519.95

538.78

mg/l

0.42

2449

6483

Alzheimer’s disease (Atypical or mixed), excluding more controls

195

112

13.52

172.93

1.2

1.1

496.35

618.82

mg/l

0.95

178

107

Pain (limb, back, neck, head abdominally)

1616

3606

2.29

171.54

1.5

1.3

510.93

570.28

mg/l

2.40

1547

3454

Opioids

2383

6414

1.95

170.69

1.3

506.57

517.28

mg/l

0.25

2272

6153

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

773

2591

3.05

170.61

1.3

464.57

505.85

mg/l

1.48

735

2503

Depression medications

757

1116

3.50

170.55

1.4

1.2

448.75

426.39

mg/l

0.65

714

1072

Other bacterial diseases

2322

8118

1.93

170.42

1.7

1.3

620.21

531.43

mg/l

3.15

2214

7805

Benzodiazepine use

2514

9213

1.87

169.87

1.3

493.50

549.82

mg/l

2.90

2396

8844

ILD medications: prednisolone, methylprednisolone, prednisone

2610

7894

1.87

167.39

1.4

1.3

549.01

535.52

mg/l

0.24

2504

7557

Other anxiety disorders

1349

5085

2.32

167.14

1.3

474.04

504.06

mg/l

0.32

1290

4898

Selective serotonin reuptake inhibitors

2272

6116

1.96

165.97

1.3

501.89

555.90

mg/l

2.50

2164

5880

Subarachnoid haemorrhage

391

867

4.83

164.82

2.0

1.3

854.77

566.53

mg/l

1.75

374

829

Dementia in Alzheimer disease

449

883

4.41

164.15

1.2

1.3

474.91

638.75

mg/l

6.07

408

853

Autoimmune diseases

2656

7382

1.86

163.17

1.3

1.4

520.76

541.22

mg/l

0.48

2560

7065

Speech disturbances, not elsewhere classified

383

850

4.88

161.82

1.4

1.3

548.36

566.08

mg/l

0.18

366

804

Care involving use of rehabilitation procedures

1661

7310

2.09

161.33

1.4

544.30

523.60

mg/l

0.38

1572

7043

First line medication for Crohn's disease

2675

7990

1.83

159.66

1.6

1.3

555.66

516.50

mg/l

1.02

2572

7655

Extrapyramidal and movement disorders

1038

4252

2.52

159.16

1.3

528.56

548.44

mg/l

0.24

986

4059

Intracranial injury

1532

6867

2.13

156.91

1.4

508.76

528.22

mg/l

0.32

1455

6594

Parasetamol

1716

4130

2.14

155.81

1.4

1.3

493.87

522.81

mg/l

0.87

1638

3963

Tramadol

1900

5758

2.02

155.77

1.3

563.15

527.41

mg/l

0.61

1819

5522

Alzheimer’s disease (Late onset)

583

1414

3.51

155.01

1.2

1.3

492.50

622.08

mg/l

4.59

523

1355

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

329

676

5.32

152.95

1.8

1.3

990.11

513.96

mg/l

2.18

323

640

Primary_lymphoid and hematopoietic malignant neoplasms

705

2436

3.02

152.09

2.8

1.3

647.86

558.40

mg/l

2.23

688

2315

Diseases of the eye and adnexa

1937

4886

2.02

151.84

1.5

1.4

493.79

544.38

mg/l

1.68

1852

4695

Abnormal involuntary movements

460

1224

3.98

151.66

1.5

1.3

549.80

561.99

mg/l

0.06

439

1166

Bell's palsy

446

1166

4.08

151.19

1.4

1.3

584.51

539.53

mg/l

0.83

432

1107

Migraine without aura and triptan purchases

605

1927

3.30

150.88

1.4

1.3

444.98

472.88

mg/l

0.33

587

1863

GASTRO-related operations

1848

4597

2.05

150.69

1.7

1.2

503.14

514.71

mg/l

0.23

1773

4396

Any gastric operation

1848

4597

2.05

150.69

1.7

1.2

503.14

514.71

mg/l

0.23

1773

4396

Nausea and vomiting

778

2770

2.83

149.89

1.7

1.5

580.34

531.55

mg/l

0.45

755

2644

Sciatica+with lumbago

1298

5257

2.24

149.76

1.3

535.52

552.46

mg/l

0.20

1248

5034

Substance abuse, excluding more controls

1246

4665

2.28

149.02

1.3

527.43

568.27

mg/l

1.07

1185

4508

Other intervertebral disc disorders

1898

5796

1.99

148.39

1.3

550.89

556.23

mg/l

0.07

1815

5553

Use of rivastigmine

446

1173

3.97

148.10

1.2

1.3

489.18

628.43

mg/l

3.40

419

1107

Codeine

2173

6329

1.89

142.68

1.3

517.09

518.24

mg/l

0.02

2088

6070

Bleeding

1960

7308

1.92

142.67

1.6

1.3

635.09

538.55

mg/l

2.29

1868

7017

Provisional assignment of new diseases of uncertain etiology

1389

6685

2.11

140.75

1.5

1.4

538.07

518.10

mg/l

0.32

1342

6398

Codes for special purposes

1389

6693

2.11

140.25

1.5

1.4

538.07

518.10

mg/l

0.32

1342

6406

Use of memantine

661

1795

3.06

140.21

1.2

1.3

472.55

609.35

mg/l

7.60

595

1714

Use of other anti-dementia drugs

661

1795

3.06

140.21

1.2

1.3

472.55

609.35

mg/l

7.60

595

1714

Other disorders of urethra and urinary system

1705

6052

2.00

139.97

1.4

1.3

528.90

526.50

mg/l

0.03

1630

5808

Cardiovascular diseases

1571

4035

2.11

139.23

1.5

1.4

469.71

472.47

mg/l

0.05

1513

3868

Other bacterial diseases, including avohilmo

2404

8506

1.79

138.88

1.6

1.3

627.44

511.58

mg/l

4.11

2298

8169

Covid-19 confirmed case

994

4245

2.41

138.45

1.6

1.4

574.71

529.61

mg/l

0.65

956

4049

Cardiovascular diseases (excluding rheumatic etc)

1638

4667

2.05

137.35

1.5

1.4

492.38

471.07

mg/l

0.53

1576

4466

Other reaction to severe stress, and adjustment disorders

1026

4469

2.36

136.67

1.5

1.3

517.86

499.11

mg/l

0.19

974

4303

Injuries to the head

2654

9210

1.73

135.88

1.4

533.69

533.41

mg/l

0.00

2539

8840

Bacterial meningitis

210

324

7.48

133.69

2.0

1.3

1457.22

491.41

mg/l

13.82

203

306

Paralytic strabismus

302

649

5.07

133.11

1.5

1.4

611.77

579.06

mg/l

0.23

294

617

Explicit Sepsis, including avohilmo

1038

4161

2.31

130.58

1.9

1.3

699.87

546.24

mg/l

3.15

981

3992

Liquid cancers

810

3066

2.58

129.46

2.6

1.3

639.46

539.37

mg/l

3.13

786

2912

Other disorders of fluid, electrolyte and acid-base balance

804

3020

2.58

128.80

1.5

1.3

610.91

556.28

mg/l

0.65

765

2870

Explicit Sepsis

1014

4083

2.31

127.78

1.9

1.3

693.66

543.78

mg/l

2.98

958

3917

Oral corticosteroids

2481

8504

1.74

126.98

1.4

1.3

551.47

535.64

mg/l

0.28

2369

8151

Pain in throat and chest

2006

6532

1.85

126.45

1.3

1.4

507.55

556.30

mg/l

1.40

1912

6269

Influenza and pneumonia

2495

9069

1.72

125.66

1.5

1.3

567.81

520.28

mg/l

1.38

2383

8708

Migraine with aura and triptan purchases

553

1860

3.11

125.60

1.3

1.4

437.04

473.34

mg/l

0.43

534

1796

Personality disorders, excluding more controls

663

2447

2.79

125.14

1.2

1.3

437.36

510.30

mg/l

3.35

631

2365

Any reimbursement code in KELA

1409

3409

2.11

123.61

1.5

1.2

475.72

495.75

mg/l

0.51

1352

3258

Inflammatory bowel disease treatment related agents

2650

8799

1.69

122.86

1.6

1.3

544.51

529.91

mg/l

0.27

2537

8438

Viral hepatitis, IBD co-morbidity

128

115

11.62

122.56

1.3

1.1

522.61

454.53

mg/l

0.55

122

110

Oedema, not elsewhere classified

673

2474

2.72

121.71

1.3

1.2

532.13

537.80

mg/l

0.04

650

2360

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2030

6624

1.82

121.62

1.4

1.3

595.74

520.96

mg/l

2.11

1935

6362

2030

6624

1.82

121.62

1.4

1.3

595.74

520.96

mg/l

2.11

1935

6362

Abnormalities of breathing

2072

6684

1.80

119.44

1.4

497.40

553.68

mg/l

1.98

1995

6413

Persons encountering health services for examination and investigation

1346

3244

2.11

119.16

1.4

1.3

517.31

574.86

mg/l

1.39

1284

3122

Disorders of ocular muscles, binocular movement, accommodation and refraction

1271

6303

2.05

118.73

1.5

1.4

486.47

517.96

mg/l

0.93

1210

6070

Memory loss

295

680

4.62

118.40

1.3

450.26

619.77

mg/l

8.61

271

660

Metabolic disorders

2163

7475

1.76

117.33

1.4

564.32

539.10

mg/l

0.59

2078

7163

Nonorganic sleeping disorders, excluding more controls

555

1936

2.96

117.29

1.4

419.11

523.59

mg/l

9.19

538

1874

Hypothyroidism (congenital or acquired)

580

1054

3.15

116.91

1.3

1.2

473.47

426.17

mg/l

1.65

560

1012

Unspecified dementia

279

541

4.80

116.08

1.2

610.59

651.06

mg/l

0.16

263

526

Lumbar disc prolapse

1447

5553

1.96

115.19

1.3

552.34

549.22

mg/l

0.03

1388

5322

Systemic atrophies primarily affecting the central nervous system

209

371

6.29

114.91

1.5

1.4

556.36

579.62

mg/l

0.09

202

348

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1537

7154

1.90

114.79

1.3

544.77

561.22

mg/l

0.30

1476

6855

Hypothyroidism and >3 levothyroxin purchases

575

1053

3.13

114.74

1.3

1.2

470.62

426.22

mg/l

1.49

555

1011

Hypothyroidism, levothyroxine purchases

575

1053

3.13

114.74

1.3

1.2

470.62

426.22

mg/l

1.49

555

1011

Schizophrenia or delusion, excluding more controls

706

2777

2.58

114.34

1.2

1.3

486.41

570.10

mg/l

2.60

670

2679

Non-Hodgkin lymphoma, all, including Hilmo

423

1291

3.45

113.42

1.8

1.3

730.16

557.25

mg/l

3.30

411

1217

Symptoms and signs involving speech and voice

866

3812

2.34

113.09

1.3

517.78

531.47

mg/l

0.27

833

3639

Strabismus

763

3185

2.47

112.05

1.5

511.99

507.12

mg/l

0.07

731

3047

Non-follicular lymphoma

331

877

4.03

110.38

1.9

1.3

698.56

564.82

mg/l

2.57

322

826

Soft tissue disorders

2293

6927

1.72

110.15

1.4

491.60

551.13

mg/l

3.17

2200

6636

Symptoms and signs involving the digestive system and abdomen

2193

6392

1.74

110.12

1.5

1.4

516.58

543.41

mg/l

1.03

2102

6116

Symptoms and signs involving the circulatory and respiratory systems

2276

6707

1.72

109.98

1.4

488.71

553.39

mg/l

3.10

2175

6435

Other diseases of urinary system

2209

7292

1.72

109.73

1.4

519.51

540.31

mg/l

0.67

2103

7014

Spondylopathies

1658

5314

1.87

109.47

1.4

1.3

629.12

556.86

mg/l

1.44

1594

5087

Non-invasive ventilation

618

2010

2.73

108.85

1.5

1.4

562.61

512.01

mg/l

1.19

559

1928

Persons encountering health services in other circumstances, wide

2548

7977

1.66

108.72

1.4

538.11

548.08

mg/l

0.16

2453

7632

Certain infectious and parasitic diseases, including avohilmo

1519

3972

1.94

107.60

1.4

1.3

538.20

504.33

mg/l

1.00

1457

3799

Complications of surgical and medical care, not elsewhere classified

2268

9106

1.69

107.37

1.5

1.3

567.92

528.38

mg/l

1.07

2187

8717

Dysphagia

645

2550

2.61

106.82

1.4

1.3

567.03

552.28

mg/l

0.18

619

2430

Other/unspecified dorsalgia

873

3927

2.24

104.18

1.3

537.22

546.01

mg/l

0.07

836

3770

Implicit fungal Sepsis, including avohilmo

255

581

4.69

104.05

1.4

1.3

467.43

519.64

mg/l

1.34

237

554

Other extrapyramidal and movement disorders in other diseases

659

2673

2.55

103.71

1.3

550.28

546.02

mg/l

0.03

621

2561

Hypo-osmolality and hyponatraemia

469

1584

3.05

103.66

1.4

636.60

576.64

mg/l

0.41

442

1503

Enlarged lymph nodes

377

1134

3.44

102.55

1.5

1.3

571.23

520.14

mg/l

0.37

359

1086

All pneumoniae

2321

9233

1.66

102.20

1.4

583.45

519.99

mg/l

2.01

2215

8868

Complications of medical and surgical care

1689

8688

1.78

101.49

1.6

1.3

592.02

529.17

mg/l

1.29

1618

8329

Codeine or tramadol medication

2511

8456

1.63

101.28

1.3

523.03

536.18

mg/l

0.24

2409

8096

Pneumonias (Asthma/COPD co-morbidities)

2302

9218

1.65

100.95

1.4

584.23

519.83

mg/l

2.03

2197

8852

Pneumonia, organism unspecified

2067

8513

1.69

99.18

1.5

1.4

594.84

528.56

mg/l

1.81

1971

8176

Asthma (mode)

1634

4740

1.84

98.87

1.3

521.47

539.63

mg/l

0.28

1561

4552

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

2205

9093

1.66

98.16

1.6

1.3

559.14

529.62

mg/l

0.73

2110

8733

Neuromuscular dysfunction of bladder

307

837

3.89

98.07

1.4

1.3

614.77

554.31

mg/l

0.34

286

795

Liquid cancers, including Hilmo

885

3635

2.20

98.06

2.5

1.3

631.57

542.81

mg/l

2.69

858

3464

Asthma, excluding more controls

1607

4540

1.84

97.78

1.3

513.68

540.11

mg/l

0.45

1538

4356

Hard cardiovascular diseases

1837

6308

1.75

96.60

1.4

554.76

548.96

mg/l

0.09

1767

6049

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

2244

9219

1.64

96.40

1.4

586.84

521.46

mg/l

2.02

2140

8854

Asthma

1638

4703

1.82

96.14

1.3

515.68

539.93

mg/l

0.41

1568

4515

Spirochaetal infections, other/unspecified, including avohilmo

862

4050

2.19

96.00

1.2

1.4

567.28

531.38

mg/l

1.23

838

3868

Cerebral aneurysm, nonruptured

293

788

3.95

95.59

1.6

1.2

557.96

554.71

mg/l

0.03

279

753

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2410

7970

1.63

95.21

1.4

538.83

547.96

mg/l

0.14

2327

7625

Other and unspecified visual disturbances

354

1081

3.45

95.03

1.2

1.3

451.65

547.97

mg/l

3.49

337

1032

Other spirochaetal diseases, including avohilmo

869

4112

2.17

95.01

1.2

1.4

567.04

530.23

mg/l

1.30

845

3927

Symptoms and signs involving the urinary system

1696

7406

1.75

94.96

1.4

1.3

608.42

546.69

mg/l

0.87

1614

7107

Other spirochaetal diseases

861

4063

2.18

94.82

1.2

1.4

569.15

530.66

mg/l

1.37

837

3880

Myalgia

642

2681

2.47

94.66

1.3

471.51

523.64

mg/l

1.61

616

2563

Lyme disease

855

4028

2.18

94.57

1.2

1.4

568.83

531.94

mg/l

1.27

831

3849

Lyme disease, including avohilmo

855

4028

2.18

94.57

1.2

1.4

568.83

531.94

mg/l

1.27

831

3849

Septicaemia

953

4228

2.10

94.56

2.0

1.4

672.46

534.50

mg/l

3.51

902

4049

Other septicaemia, including avohilmo

872

3905

2.14

91.72

2.0

1.3

651.46

523.95

mg/l

2.94

824

3736

Fall on same level

2543

8643

1.59

91.03

1.3

1.4

540.28

529.10

mg/l

0.21

2440

8301

Undefined dementia

279

676

3.94

91.02

1.2

610.59

601.29

mg/l

0.03

263

639

Other septicaemia

851

3823

2.14

89.95

2.0

1.3

641.38

524.47

mg/l

2.56

804

3658

Benign neoplasm of meninges

331

1005

3.48

89.78

1.4

1.2

733.99

557.83

mg/l

2.71

317

957

Triptan medication for migraine, single purchase ok

1766

7079

1.72

89.64

1.3

453.94

538.51

mg/l

5.04

1694

6797

Migraine, single triptan purchase ok & required. ICD-code if available is included

1766

7079

1.72

89.64

1.3

453.94

538.51

mg/l

5.04

1694

6797

Benign neoplasm: Cerebral meninges

311

917

3.59

88.46

1.3

738.71

542.69

mg/l

3.04

298

873

Spondylosis

1132

4633

1.94

88.43

1.4

1.3

590.45

569.02

mg/l

0.23

1096

4443

Abdominal and pelvic pain

2088

6391

1.66

88.40

1.4

509.43

543.15

mg/l

1.54

2004

6115

Diseases of the musculoskeletal system and connective tissue

1203

3112

1.97

88.39

1.6

1.4

486.09

535.41

mg/l

1.13

1146

2985

Other specific joint derangements/joint disorders

1726

6322

1.73

88.21

1.2

1.4

514.71

515.47

mg/l

0.01

1647

6063

Second line medication for Crohn's disease

1363

7677

1.81

88.15

1.9

1.3

544.07

530.32

mg/l

0.15

1323

7350

COPD/asthma related infections

2151

6624

1.65

88.09

1.4

1.3

540.97

520.96

mg/l

0.43

2038

6362

COPD/asthma/ILD related infections

2151

6624

1.65

88.09

1.4

1.3

540.97

520.96

mg/l

0.43

2038

6362

Antihypertensive medication - note that there are other indications

1457

4212

1.84

87.83

1.4

460.53

508.35

mg/l

1.33

1393

4034

Asthma, unspecified (mode), excluding more controls

1137

4257

1.94

87.42

1.4

1.3

528.37

542.12

mg/l

0.19

1091

4089

L04AX Other immunosuppressants

1322

7409

1.82

87.13

1.9

1.3

540.76

530.31

mg/l

0.11

1283

7090

Transient ischemic attack

1051

4305

1.98

87.05

1.4

1.3

536.91

568.55

mg/l

0.92

1010

4102

Other disorders of eye and adnexa

444

1629

2.85

86.18

1.4

1.5

463.85

521.13

mg/l

2.12

429

1552

Asthma, unspecified (mode)

1153

4405

1.92

85.75

1.4

1.3

527.10

541.78

mg/l

0.21

1107

4235

Cervicalgia

515

2033

2.61

85.70

1.3

467.08

510.07

mg/l

1.13

490

1954

Hypertensive diseases (excluding secondary)

1172

3578

1.94

85.44

1.4

1.3

517.85

496.85

mg/l

0.44

1119

3422

Cystitis

1799

6400

1.69

85.23

1.4

1.3

545.57

530.65

mg/l

0.25

1716

6152

L04AA Selective immunosuppressants

612

2646

2.39

83.84

1.6

1.4

555.04

524.55

mg/l

0.27

590

2528

Traumatic subarachnoid haemorrhage

11.56

83.74

1.5

1.1

626.51

599.40

mg/l

0.06

Somatoform disorder

456

1725

2.74

83.11

1.3

1.4

552.43

524.39

mg/l

0.14

431

1650

Follow-up examination after treatment for conditions other than malignant neoplasms

859

2760

2.11

81.40

1.3

483.77

558.11

mg/l

2.11

817

2660

Asthma (only as main-diagnosis), excluding more controls

1447

4540

1.79

81.23

1.3

486.56

540.11

mg/l

1.77

1384

4356

Hypertension, essential

1688

5676

1.71

80.87

1.3

563.41

529.11

mg/l

0.76

1611

5439

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

152

165

6.60

80.32

1.3

1.4

723.20

479.30

mg/l

0.73

141

155

Other pulmonary diagnosis

1623

4753

1.73

80.31

1.4

1.3

520.13

539.45

mg/l

0.43

1549

4564

Bipolar affective disorders

505

2040

2.56

80.27

1.3

451.55

506.75

mg/l

1.77

491

1964

Asthma (only as main-diagnosis)

1469

4703

1.77

80.14

1.3

485.43

539.93

mg/l

1.90

1405

4515

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

773

3745

2.12

79.53

1.3

464.57

488.33

mg/l

0.70

735

3594

COPD differential diagnosis

1613

4741

1.73

78.82

1.4

1.3

524.67

539.65

mg/l

0.30

1539

4553

ILD differential diagnosis

1611

4740

1.72

78.42

1.4

1.3

524.94

539.63

mg/l

0.30

1537

4552

Excluding asthma or asthma-COPD overlap

1613

4753

1.72

78.09

1.4

1.3

524.23

539.45

mg/l

0.31

1539

4564

Hemiplegia

192

440

4.69

78.07

1.6

1.3

458.37

509.42

mg/l

1.13

184

417

Other functional intestinal disorders

1063

5235

1.88

77.02

1.4

1.5

578.18

538.93

mg/l

0.43

1004

5015

Viral infections characterized by skin and mucous membrane lesions

1004

5391

1.90

76.21

1.6

1.4

572.98

528.95

mg/l

0.98

974

5166

Other general symptoms and signs

162

324

5.23

76.05

1.7

1.5

401.28

524.51

mg/l

3.00

156

313

Cervicobrachial syndrome

528

2233

2.43

75.72

1.4

1.3

484.76

511.10

mg/l

0.75

511

2146

2373

7859

1.55

75.51

1.4

1.3

536.80

539.32

mg/l

0.03

2272

7536

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

203

502

4.25

74.04

1.5

1.3

505.18

619.76

mg/l

2.57

194

471

Diarrhoea and gastroenteritis of presumed infectious origin

1568

8556

1.66

73.88

1.4

566.20

516.62

mg/l

0.58

1505

8187

Intestinal infectious diseases

2057

9898

1.56

73.79

1.4

534.17

527.55

mg/l

0.11

1981

9481

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1325

7639

1.73

73.58

1.6

1.3

595.45

532.17

mg/l

1.18

1271

7323

Dental caries

619

2665

2.25

73.34

1.9

1.3

595.36

566.51

mg/l

0.21

595

2564

Acute upper respiratory infections of multiple and unspecified sites

1677

7556

1.64

73.18

1.5

1.3

504.52

528.21

mg/l

0.35

1607

7242

All influenza

625

2884

2.22

72.81

1.5

1.4

538.36

538.92

mg/l

0.00

596

2774

All kidney diseases

2125

9272

1.55

72.75

1.4

623.80

512.08

mg/l

2.24

2031

8898

Diseases of the myoneural junction and muscle

347

1228

2.95

72.15

1.5

1.4

557.00

561.67

mg/l

0.04

333

1163

Non-selective monoamine reuptake inhibitors

726

3408

2.08

71.74

1.3

515.27

579.33

mg/l

1.06

686

3292

Other disorders of lacrimal gland

862

4509

1.95

71.25

1.4

1.3

524.10

536.67

mg/l

0.13

815

4307

Acute upper respiratory infections

2182

8573

1.54

70.92

1.4

1.3

541.72

536.56

mg/l

0.07

2088

8217

Acute sinusitis

1196

6267

1.76

70.56

1.4

1.3

559.85

520.38

mg/l

0.44

1138

6017

Exposure to unspecified factor

2200

9892

1.53

70.51

1.4

552.05

529.87

mg/l

0.47

2114

9482

Exclusions for E4_PCOS_BROAD

490

2077

2.44

70.26

1.4

1.6

523.04

511.36

mg/l

0.20

467

1989

Bronchitis

2313

9231

1.52

70.18

1.4

1.3

507.63

543.15

mg/l

0.83

2215

8850

Somnolence, stupor and coma

146

291

5.35

70.06

1.6

1.5

430.66

559.77

mg/l

2.67

140

278

Other diseases of spinal cord

126

221

6.25

69.98

1.9

1.2

997.08

521.60

mg/l

1.27

118

210

Falls/tendency to fall

2239

7360

1.54

69.74

1.4

536.20

531.53

mg/l

0.07

2145

7064

Factors influencing health status and contact with health services

564

1179

2.44

69.73

1.3

1.2

549.68

556.58

mg/l

0.05

532

1132

Diagnoses used for exclusion with ILD

578

2635

2.25

69.51

1.5

1.3

696.75

544.29

mg/l

1.42

550

2519

Systemic connective tissue disorders

784

4014

2.00

69.04

1.3

575.47

534.55

mg/l

0.30

744

3827

Complications of procedures, not elsewhere classified

1720

8786

1.60

68.53

1.4

1.3

557.41

529.10

mg/l

0.55

1654

8415

Disorders of lipoprotein metabolism and other lipidaemias

1649

6243

1.63

67.24

1.3

562.02

554.77

mg/l

0.16

1589

5982

Oxycodone

832

3711

1.95

67.18

1.5

1.3

637.77

539.49

mg/l

1.30

795

3565

Caries of dentine

546

2372

2.28

67.09

1.6

1.3

627.27

552.11

mg/l

0.64

526

2283

Poisoning by medicine

578

2678

2.22

67.04

1.2

1.3

452.05

496.43

mg/l

2.03

547

2569

Symptoms and signs concerning food and fluid intake

240

711

3.48

66.88

1.6

1.3

459.82

535.00

mg/l

1.48

231

676

Speech and linguistic disorders, excluding more controls

240

664

3.53

66.75

2.0

513.85

466.58

mg/l

0.45

234

640

Persons encountering health services in other circumstances

925

4997

1.86

66.57

1.4

530.47

517.47

mg/l

0.15

880

4769

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

1961

10038

1.54

66.08

1.5

1.4

530.87

529.31

mg/l

0.03

1898

9609

Other sleep disorders

282

932

3.14

66.02

1.2

1.3

453.13

555.38

mg/l

2.98

268

891

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

2152

9194

1.52

65.83

1.4

511.86

536.81

mg/l

0.59

2074

8800

Intracerebral haemorrhage

291

980

3.07

65.81

2.1

1.3

815.71

599.15

mg/l

1.73

275

926

Use of hypnotics and sedatives

2227

8509

1.51

65.53

1.3

1.4

521.73

550.39

mg/l

0.81

2132

8177

Poisoning by drugs, medicaments and biological substances

618

2965

2.14

65.45

1.2

1.3

448.17

503.07

mg/l

3.00

586

2846

Pure hypercholesterolaemia

1487

5788

1.65

65.19

1.3

589.72

559.12

mg/l

0.72

1431

5545

Hypertension

1660

5864

1.62

65.14

1.4

555.60

524.92

mg/l

0.66

1589

5624

Hypertensive diseases

1661

5871

1.62

65.07

1.4

556.42

524.61

mg/l

0.69

1590

5631

Triptan medication for migraine, min. 3 purchases

1313

5891

1.69

64.71

1.4

1.3

435.41

504.63

mg/l

2.77

1260

5663

Renal tubulo-interstitial diseases

1828

8713

1.55

64.07

1.4

618.05

514.63

mg/l

2.41

1742

8376

Endocrine, nutritional and metabolic diseases

1686

5343

1.61

63.86

1.4

498.18

517.79

mg/l

0.50

1618

5119

Other joint disorders

1906

6440

1.56

63.58

1.3

1.4

478.55

514.78

mg/l

1.67

1830

6175

Intestinal infectious diseases, including avohilmo, including avohilmo

2392

9086

1.48

63.37

1.4

527.95

538.92

mg/l

0.22

2305

8700

Unspecified mental disorder

925

5134

1.84

63.35

1.2

1.3

481.62

526.50

mg/l

1.45

879

4935

Shoulder lesions

1520

5639

1.63

63.33

1.4

1.3

511.20

572.60

mg/l

2.99

1470

5397

Cervical disc disorders

725

3720

1.99

63.30

1.4

1.3

493.50

569.03

mg/l

2.36

690

3565

Radiculopathy

357

1369

2.68

63.19

1.3

496.00

548.63

mg/l

1.16

345

1302

Constipation

1854

8197

1.55

63.18

1.4

552.01

541.00

mg/l

0.16

1751

7894

Other diseases of intestines

2253

8473

1.50

62.89

1.4

501.14

534.27

mg/l

1.11

2165

8131

Paraplegia, diplegia of upper limbs

110

189

6.53

62.83

1.7

1.5

962.96

483.64

mg/l

2.74

179

Ocular pain

277

945

3.08

61.88

1.4

1.5

432.02

511.35

mg/l

3.11

268

905

Behavioural syndromes associated with physiological disturbances and physical factors

2001

9032

1.52

61.52

1.4

477.72

547.32

mg/l

4.86

1917

8665

Post-traumatic stress disorder

269

907

3.09

61.11

1.3

387.91

472.65

mg/l

2.85

249

875

Diseases of the ear and mastoid process

2380

8157

1.48

60.88

1.4

1.3

543.85

533.66

mg/l

0.18

2277

7823

Focal brain injury

102

164

6.39

60.81

1.6

1.1

848.62

532.49

mg/l

0.76

155

Disorders of other endocrine glands

983

5534

1.78

60.58

1.4

509.60

508.35

mg/l

0.02

937

5307

Disorders of vestibular function (Vertigo)

976

5427

1.78

60.42

1.3

486.14

552.53

mg/l

3.58

945

5177

Mental and behavioural disorders due to psychoactive substance use

1279

7171

1.66

60.38

1.3

524.94

552.80

mg/l

0.66

1215

6889

Unspecified fall

1104

6404

1.72

60.34

1.3

1.4

515.48

525.52

mg/l

0.19

1054

6128

Substance abuse

1246

7048

1.67

60.23

1.3

527.43

554.01

mg/l

0.60

1185

6770

Sleep disorders (combined)

2238

7929

1.49

60.22

1.3

1.4

494.54

543.78

mg/l

2.87

2135

7613

Acute tubulo-interstitial nephritis

1332

6934

1.64

60.19

1.5

1.4

631.95

512.37

mg/l

1.94

1264

6653

Disorders of lacrimal system

963

5402

1.78

59.99

1.4

1.3

527.62

536.83

mg/l

0.11

913

5166

Retention of urine

695

2868

2.00

59.35

1.4

1.3

587.57

562.43

mg/l

0.24

658

2746

Sleep disorders

1924

8854

1.51

58.92

1.3

475.29

542.76

mg/l

4.65

1847

8490

Disorders of eyelid, lacrimal system and orbit

1795

8684

1.53

58.82

1.4

1.3

523.27

540.65

mg/l

0.39

1721

8330

Dementia in other diseases classified elsewhere

139

308

4.78

58.81

1.2

1.3

530.19

646.95

mg/l

1.35

128

299

Herpesviral [herpes simplex] infections

330

1270

2.70

58.45

1.5

1.4

589.61

516.04

mg/l

1.35

319

1211

Diseases of oesophagus, stomach and duodenum

2189

8826

1.48

58.40

1.3

1.4

511.57

541.18

mg/l

0.93

2079

8482

Other external causes of accidental injury

1621

5169

1.59

57.90

1.4

514.39

533.97

mg/l

0.46

1543

4961

Urinary track infection

1251

3740

1.70

57.82

1.4

1.3

490.11

484.76

mg/l

0.07

1195

3601

Fibromyalgia

262

899

3.03

57.69

1.2

1.3

393.47

494.87

mg/l

5.38

249

863

Spinal stenosis

926

3836

1.80

57.42

1.4

1.3

702.90

583.65

mg/l

1.45

885

3668

Visual field defects

237

773

3.21

57.16

1.6

1.3

635.53

567.31

mg/l

0.51

228

736

Certain disorders involving the immune mechanism

467

2121

2.27

57.07

2.3

1.4

588.06

527.58

mg/l

0.48

447

2033

Accidents

1616

5169

1.58

56.98

1.4

519.26

533.97

mg/l

0.31

1533

4961

Disorders of adult personality and behaviour

703

3707

1.94

56.96

1.3

436.96

489.71

mg/l

2.46

669

3561

Endovascular or surgical operations to intracerebral aneurysms

189

540

3.70

56.60

1.8

1.2

584.93

573.23

mg/l

0.08

183

517

Pain in thoracic spine

358

1466

2.51

55.36

1.4

434.82

513.13

mg/l

4.43

347

1406

Other CVD (FINNGEN)

283

761

2.93

55.32

1.4

1.2

550.81

524.66

mg/l

0.32

270

711

Asthma-related infections

1259

7696

1.62

54.43

1.4

527.54

529.34

mg/l

0.02

1209

7381

Asthma, hospital admission 2, infections

1259

7696

1.62

54.43

1.4

527.54

529.34

mg/l

0.02

1209

7381

Gastrointestinal diseases

1263

3850

1.66

54.32

1.6

1.3

469.15

531.86

mg/l

2.22

1207

3704

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1184

7309

1.64

54.31

1.6

1.3

602.37

534.53

mg/l

1.14

1135

7000

Cluster headache, wide

128

284

4.79

54.16

1.4

1.2

422.03

533.08

mg/l

2.62

123

272

Personality disorders

663

3489

1.94

54.11

1.2

1.3

437.36

492.22

mg/l

2.20

631

3351

Osteopathies and chondropathies

1167

6564

1.65

54.01

1.5

1.3

606.14

536.27

mg/l

0.95

1107

6290

Other medical care

973

4778

1.73

53.83

1.6

1.4

645.65

525.54

mg/l

4.66

930

4581

severe traumatic brain injury, does not include concussion

470

2189

2.20

53.67

1.5

1.3

666.95

559.71

mg/l

0.73

444

2082

Invasive ventilation

224

735

3.21

53.67

1.5

1.6

1183.51

567.60

mg/l

1.32

210

699

371

1569

2.44

53.62

1.5

1.3

489.94

517.77

mg/l

0.38

355

1492

Kela-code for severe mental illness

808

4535

1.82

53.50

1.2

1.3

479.44

531.81

mg/l

1.91

768

4355

Nonorganic sleeping disorders

555

2760

2.06

53.48

1.4

419.11

505.00

mg/l

7.90

538

2636

Dissociative [conversion] disorders

144

355

4.34

53.37

1.2

1.5

453.73

495.31

mg/l

0.24

138

337

Generalized anxiety disorder

420

1875

2.30

53.20

1.2

1.3

405.86

490.31

mg/l

4.31

405

1809

990

5849

1.71

52.83

1.4

530.52

511.01

mg/l

0.22

953

5605

Dyspnoea

1832

8965

1.49

52.71

1.3

1.4

509.16

544.05

mg/l

1.06

1770

8586

Other viral diseases, including avohilmo

888

5092

1.76

52.62

1.6

1.4

504.56

486.10

mg/l

0.23

857

4897

Neoplasms

1656

5698

1.54

52.52

1.9

1.3

548.11

496.96

mg/l

0.72

1583

5464

Benign neoplasm of brain and other parts of central nervous system

203

637

3.37

52.52

1.8

1.4

686.01

552.87

mg/l

1.27

197

606

Any death

1233

5367

1.63

52.21

1.5

1.3

736.57

548.87

mg/l

3.71

1165

5145

Diseases of inner ear

1087

6357

1.66

52.08

1.3

487.23

560.38

mg/l

4.45

1052

6080

Zoster [herpes zoster]

422

1912

2.27

51.80

1.7

1.3

584.47

541.26

mg/l

0.94

412

1818

Hyperkinetic disorders, excluding more controls

320

1189

2.58

51.75

1.5

1.6

420.71

456.49

mg/l

0.52

312

1145

Other and unspecified nonorganic psychotic disorders

493

2380

2.13

51.54

1.2

1.3

463.29

507.66

mg/l

1.18

467

2279

Fungal Sepsis

137

334

4.36

51.45

1.6

1.2

693.71

514.95

mg/l

0.42

126

315

Other heart diseases

963

3658

1.73

51.03

1.4

512.87

493.45

mg/l

0.37

924

3498

External causes of morbidity and mortality

1294

4043

1.62

50.48

1.4

523.07

510.11

mg/l

0.33

1224

3883

Suicide or other Intentional self-harm

583

3012

1.98

50.34

1.3

482.71

512.43

mg/l

0.76

549

2890

Alcohol abuse, main dg, excluding more controls

312

1257

2.55

49.96

1.2

1.3

595.85

563.07

mg/l

0.24

301

1214

Psychotic depression

144

370

4.04

49.93

1.3

1.5

448.16

592.87

mg/l

2.53

135

364

Specific personality disorders

574

2967

1.98

49.51

1.2

1.3

437.21

487.93

mg/l

1.87

545

2846

Hypothyroidism, drug reimbursement

265

658

2.87

49.47

1.3

1.2

538.63

434.72

mg/l

1.45

255

635

Schizophrenia, schizotypal and delusional disorders

711

3936

1.84

49.39

1.2

1.3

487.58

523.49

mg/l

1.03

675

3770

Other viral diseases

689

3772

1.86

49.07

1.7

1.5

519.63

490.88

mg/l

0.29

665

3621

Mental and behavioural disorders due to alcohol

1052

6168

1.65

49.01

1.3

522.71

552.01

mg/l

0.72

1002

5914

Other diseases of blood and blood-forming organs, wide

496

2455

2.07

48.45

2.0

1.4

613.38

541.24

mg/l

0.66

479

2342

Diseases of the respiratory system

1245

3893

1.62

48.45

1.4

1.3

535.26

519.43

mg/l

0.37

1178

3745

Schizophrenia or delusion

706

3929

1.83

48.21

1.2

1.3

486.41

523.69

mg/l

1.08

670

3764

Insomnia

1841

8839

1.46

48.16

1.3

477.15

539.89

mg/l

3.96

1761

8470

Other necrotizing vasculopathies (FG)

173

521

3.49

47.74

1.4

1.2

517.37

560.69

mg/l

0.38

163

490

Implicit fungal Sepsis

127

313

4.32

47.07

1.5

1.2

479.91

505.10

mg/l

0.30

116

297

Polyuria

470

2317

2.07

46.34

1.3

506.55

550.92

mg/l

1.34

449

2215

Use of levodopa decarboxylase inhibitor

303

1251

2.50

46.24

1.3

519.68

586.97

mg/l

1.49

290

1186

Gastro-oesophageal reflux disease

1376

7674

1.53

46.05

1.3

1.4

495.95

551.10

mg/l

3.29

1304

7382

Finngen Rheumatological endpoints

1957

7773

1.44

45.77

1.3

531.04

523.49

mg/l

0.11

1875

7449

Alcohol use disorder, Swedish definition

1101

6328

1.60

45.60

1.3

532.73

556.37

mg/l

0.52

1048

6063

Arthropathies

1853

6462

1.46

45.56

1.3

1.4

511.04

514.16

mg/l

0.05

1771

6197

Mental and behavioural disorders due to alcohol, excluding acute intoxication

904

5428

1.68

45.29

1.3

533.54

563.00

mg/l

0.61

859

5210

1221

6887

1.56

44.96

1.3

523.48

556.78

mg/l

0.86

1163

6605

Cervicocranial syndrome

256

989

2.67

44.94

1.2

1.3

569.02

515.85

mg/l

0.21

248

947

1166

6703

1.57

44.56

1.3

528.10

559.47

mg/l

0.75

1111

6423

Asthma (diagnoses ohter than nonallergic)

1768

9975

1.44

44.42

1.4

519.49

528.94

mg/l

0.16

1688

9576

Other systemic involvement of connective tissue (FG)

538

2765

1.95

44.40

1.3

590.77

519.25

mg/l

0.39

510

2632

Other and unspecified myopathies

222

804

2.87

44.40

1.5

1.4

563.95

594.01

mg/l

0.18

213

762

Alzheimer’s disease (Atypical or mixed)

200

677

2.99

43.74

1.2

1.3

493.07

666.56

mg/l

3.05

182

650

Hypothyroidism, strict autoimmune

1338

5780

1.53

43.74

1.3

476.73

527.30

mg/l

2.76

1284

5521

Pneumonitis due to solids and liquids

202

703

2.98

43.42

1.6

1.4

806.11

589.41

mg/l

0.76

190

663

Brachial plexus disorders

250

975

2.66

43.25

1.3

501.31

497.87

mg/l

0.04

242

935

Injuries to the abdomen, lower back, lumbar spine and pelvis

827

4886

1.69

43.13

1.4

546.18

526.72

mg/l

0.22

781

4672

Genitourinary diseases

1125

3536

1.61

43.12

1.4

1.5

534.07

538.28

mg/l

0.07

1073

3408

Other disorders of nervous system

173

555

3.26

43.02

1.7

1.2

607.84

595.10

mg/l

0.07

165

524

Other strabismus

507

2629

1.97

42.87

1.4

1.6

444.97

509.78

mg/l

3.05

482

2521

Abnormalities of heart beat

723

4058

1.75

42.77

1.3

451.96

543.79

mg/l

5.91

687

3885

Other symptoms and signs involving general sensations and perceptions

115

282

4.29

42.76

1.2

1.5

477.22

527.54

mg/l

0.54

109

272

Other and unspecified nerve root and plexus disorders, also in other diseases

453

2281

2.03

42.19

1.3

524.14

529.71

mg/l

0.07

429

2183

Herpesviral [herpes simplex] infections, including avohilmo

590

3242

1.86

42.16

1.4

534.33

487.73

mg/l

1.24

573

3103

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

644

3590

1.81

42.06

2.3

1.3

404.36

473.72

mg/l

6.10

617

3454

Panic disorder

358

1655

2.22

41.93

1.3

561.32

494.29

mg/l

0.18

345

1596

Superficial injury of head

505

2649

1.94

41.47

1.4

1.5

537.54

518.63

mg/l

0.10

490

2539

Hypopituitarism

220

824

2.79

41.46

1.4

2.0

511.67

507.41

mg/l

0.05

211

790

Open wound of head

1051

6322

1.58

41.40

1.4

533.42

557.59

mg/l

0.50

1001

6064

Hypotension

339

1541

2.25

41.27

1.4

1.3

549.37

592.69

mg/l

0.66

323

1456

Sleep apnoea

1844

8235

1.42

41.19

1.3

564.51

553.29

mg/l

0.12

1762

7891

Brain meningioma, including Hilmo

160

506

3.34

40.99

1.5

1.2

817.57

493.57

mg/l

3.33

153

478

ILD medications: azathioprine

337

1540

2.25

40.66

1.4

1.3

532.67

503.63

mg/l

0.42

328

1472

Other necrotizing vasculopathies

192

676

2.97

40.65

1.3

515.97

567.38

mg/l

0.54

181

642

Use of galantamine

174

579

3.11

40.50

1.2

1.3

485.68

610.47

mg/l

2.89

165

548

Unknown and unspecified causes of morbidity

143

423

3.49

40.31

1.3

837.70

547.35

mg/l

0.77

132

405

Alcohol use disorder, ICD-based

827

5057

1.66

40.12

1.2

1.3

534.71

555.64

mg/l

0.36

784

4848

Rotator cuff syndrome

1147

5137

1.55

40.11

1.3

541.82

579.74

mg/l

1.03

1108

4919

Injury, poisoning and certain other consequences of external causes

1021

3189

1.62

40.09

1.5

1.4

506.93

511.71

mg/l

0.09

969

3052

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

408

2023

2.07

39.88

1.3

446.32

491.24

mg/l

1.67

385

1943

Brain meningioma

155

494

3.31

39.23

1.4

1.2

781.95

481.07

mg/l

3.04

148

468

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

236

941

2.60

39.07

1.4

1.3

568.83

532.75

mg/l

0.12

224

899

Transport accidents

920

4804

1.61

38.90

1.3

1.4

514.04

530.73

mg/l

0.22

881

4612

Sarcoidosis

311

1407

2.28

38.64

1.5

1.3

642.29

549.32

mg/l

0.53

298

1334

Other systemic involvement of connective tissue

550

3040

1.84

38.54

1.3

586.20

533.75

mg/l

0.27

522

2903

Vascular dementia

160

500

3.16

38.40

1.4

1.3

713.31

637.09

mg/l

0.19

151

483

Coxibs

509

1379

1.96

38.17

1.3

514.20

550.72

mg/l

0.54

480

1317

Injuries to the thorax

886

5571

1.61

38.16

1.3

545.03

552.32

mg/l

0.08

831

5344

Other disorders of ear

1780

8224

1.41

37.94

1.4

562.69

542.90

mg/l

0.36

1710

7896

Diffuse brain injury

6.91

37.92

1.5

1.2

491.06

587.42

mg/l

0.52

Other CVD

375

1836

2.08

37.70

1.4

1.3

552.14

587.53

mg/l

0.53

357

1745

Dermatitis

1238

8221

1.49

37.34

1.4

522.79

537.49

mg/l

0.24

1186

7887

Optic atrophy

158

5.45

37.32

1.6

1.9

611.89

453.96

mg/l

0.66

148

Undetermined asthma, excluding more controls

279

1220

2.34

37.30

1.5

1.3

504.91

514.32

mg/l

0.09

265

1170

Asthma, including avohilmo

2323

9530

1.35

37.21

1.3

1.4

509.27

542.25

mg/l

0.98

2229

9137

Other viral diseases, not elsewhere classified, including avohilmo

607

3471

1.77

37.10

1.7

1.5

463.27

490.54

mg/l

0.72

591

3329

Undetermined asthma

279

1228

2.32

36.74

1.5

1.3

504.91

514.55

mg/l

0.10

265

1179

Optic atrophy, wide definition

160

5.35

36.74

1.6

1.9

611.89

446.19

mg/l

0.71

151

Other acute lower respiratory infections

1049

6578

1.54

36.62

1.4

522.95

524.55

mg/l

0.02

1001

6309

Dermatitis and eczema

2198

9662

1.36

36.52

1.4

524.67

538.58

mg/l

0.32

2111

9265

Other shoulder lesions

229

929

2.54

36.47

1.3

481.68

534.68

mg/l

0.93

222

887

Agranulocytosis

269

1177

2.36

36.28

2.2

1.3

677.77

535.84

mg/l

0.76

260

1115

Cough

797

4609

1.63

36.21

1.6

1.4

471.24

566.09

mg/l

3.81

758

4427

Use of glatiramer acetate

160

5.32

35.83

1.1

1.4

412.35

445.05

mg/l

0.48

151

Speech and linguistic disorders

250

1018

2.44

35.81

2.0

538.74

425.22

mg/l

1.26

244

971

Other viral diseases, not elsewhere classified

427

2229

1.95

35.61

1.8

1.5

468.27

494.44

mg/l

0.55

416

2146

Sleep apnoea, including avohilmo

1923

8499

1.38

35.52

1.3

526.52

546.75

mg/l

0.51

1838

8151

Cardiac arrhythmias

1137

4848

1.52

35.44

1.3

494.20

485.30

mg/l

0.19

1078

4656

Special screening examination for infectious and parasitic diseases

455

1742

1.93

35.23

1.3

509.01

547.05

mg/l

0.36

434

1677

Other and unspecified effects of external causes

605

3535

1.74

35.09

1.3

1.5

477.88

497.38

mg/l

0.22

585

3390

Disorders of psychological development

315

1374

2.19

35.02

1.8

480.44

435.05

mg/l

0.56

308

1309

Injuries to the neck

514

2872

1.82

34.89

1.3

453.12

509.44

mg/l

2.91

492

2750

Hypokalaemia

260

1138

2.34

34.89

1.8

1.3

600.70

560.33

mg/l

0.27

249

1083

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

695

4221

1.67

34.82

1.4

569.35

511.29

mg/l

0.79

667

4042

Neuralgia and neuritis, unspecified

144

474

3.17

34.42

1.4

1.3

475.94

544.19

mg/l

0.92

139

449

Azathioprine

337

1645

2.10

34.41

1.4

532.67

500.96

mg/l

0.48

328

1575

Visual impairment including blindness (binocular or monocular)

164

580

2.93

34.36

1.6

1.4

557.40

563.31

mg/l

0.03

154

558

Phobic anxiety disorders

312

1476

2.16

34.32

1.4

424.83

500.33

mg/l

3.02

300

1426

Vocal cord dysfunction

268

1040

2.31

34.28

1.3

1.4

488.74

518.47

mg/l

0.53

258

992

Exposure to other specified factors

1618

10030

1.40

34.12

1.4

500.81

536.10

mg/l

0.97

1561

9610

Disorders of sclera, cornea, iris and ciliary body

1083

7305

1.50

34.05

1.3

557.16

538.72

mg/l

0.35

1042

6998

Other and unspecified dermatitis

1040

6958

1.51

34.00

1.5

1.4

526.73

540.13

mg/l

0.18

996

6671

Other bacterial intestinal infections

365

1844

2.02

33.78

1.6

1.3

553.50

543.04

mg/l

0.13

349

1748

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

515

2518

1.82

33.74

1.6

438.58

438.66

mg/l

0.00

495

2420

Emotionally unstable personality disorder

313

1499

2.15

33.74

1.2

1.3

413.26

477.92

mg/l

2.04

296

1441

Chronic sinusitis

842

5392

1.58

33.56

1.4

1.3

483.49

542.43

mg/l

1.97

801

5180

Other problems related to primary support group, including family circumstances

294

1338

2.20

33.52

3.6

1.4

379.59

466.49

mg/l

4.96

286

1287

Sequelae of external causes of morbidity and mortality

512

2896

1.80

33.32

1.5

1.3

617.89

542.83

mg/l

1.08

488

2769

Abnormal findings on examination of blood, without diagnosis

874

5115

1.57

33.03

1.3

1.4

584.22

569.18

mg/l

0.16

840

4904

Other bacterial intestinal infections, including avohilmo

463

2548

1.85

32.99

1.5

1.4

524.66

537.75

mg/l

0.21

440

2431

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

812

3207

1.61

32.94

1.4

1.3

508.42

480.16

mg/l

0.77

783

3065

Other disorders of bladder

241

1047

2.36

32.94

1.4

1.2

529.52

572.13

mg/l

0.45

231

993

Asthma, hospital admissions 3, pneumonia

685

4187

1.65

32.88

1.5

1.4

567.92

534.80

mg/l

0.30

651

4005

Asthma-related pneumonia or sepsis

685

4187

1.65

32.88

1.5

1.4

567.92

534.80

mg/l

0.30

651

4005

Infections of the skin and subcutaneous tissue

1175

7971

1.47

32.88

1.6

1.4

525.75

536.24

mg/l

0.15

1132

7645

Parkinson's disease, including avohilmo

304

1455

2.14

32.68

1.4

1.3

483.76

600.39

mg/l

4.52

288

1379

Asthma-related pneumonia

682

4178

1.65

32.46

1.5

1.4

560.95

535.32

mg/l

0.22

648

3997

Other and unspecified mood [affective] disorders

183

706

2.68

32.46

1.3

1.4

489.07

490.06

mg/l

0.01

167

680

Inflammatory diseases of female pelvic organs

1228

5798

1.46

32.43

1.3

438.26

501.58

mg/l

3.50

1164

5571

Chronic lower respiratory diseases

2348

9408

1.32

32.38

1.3

1.4

500.09

542.03

mg/l

1.46

2242

9032

Brain glioblastoma

124

5.71

32.25

1.5

1.2

817.48

484.82

mg/l

1.74

118

Benign paroxysmal vertigo

558

3265

1.74

32.22

1.3

501.40

540.93

mg/l

1.04

539

3111

Polyarthropathies

1259

5616

1.45

31.66

1.3

1.4

609.25

519.05

mg/l

1.60

1217

5387

Other and unspecified drugs and medicaments

216

913

2.45

31.66

1.4

455.95

549.28

mg/l

2.38

207

869

Zoster [herpes zoster], including avohilmo

962

6204

1.51

31.50

1.5

1.3

535.51

547.17

mg/l

0.26

934

5921

Benign neoplasm: Pituitary gland, craniopharyngeal duct

152

545

2.92

31.34

1.3

529.58

530.23

mg/l

0.01

146

518

Trigeminal neuralgia

154

555

2.89

31.31

1.4

1.3

523.82

524.72

mg/l

0.01

146

527

Dental pulpitis, including avohilmo

1831

8700

1.36

31.20

1.3

528.49

533.46

mg/l

0.06

1746

8368

Brain glioblastoma, helper endpoint

128

5.53

31.14

1.5

1.2

817.48

504.44

mg/l

1.57

122

Substance use, excluding alcohol

430

2363

1.86

30.92

1.3

534.98

518.47

mg/l

0.18

406

2263

Enthesopathies of lower limb, excluding foot

430

2360

1.85

30.92

1.3

1.4

513.20

518.25

mg/l

0.08

408

2270

Injuries to the ankle and foot

1459

9003

1.40

30.74

1.4

482.05

527.05

mg/l

2.11

1395

8641

Irritable bowel syndrome

566

3368

1.71

30.72

1.3

445.13

510.74

mg/l

3.80

541

3216

Persistent mood disorders

375

1978

1.93

30.61

1.2

1.3

484.33

538.62

mg/l

1.23

352

1899

Hypothyreosis and Thyroxine purchase for inclusion criteria

1729

8370

1.36

30.30

1.3

511.16

529.58

mg/l

0.44

1660

8017

Hypothyroidism, other/unspecified

1669

8073

1.37

30.13

1.3

512.46

530.78

mg/l

0.42

1601

7728

Other nutritional deficiencies

1331

8696

1.41

30.09

1.3

1.4

522.34

523.87

mg/l

0.02

1264

8355

Mycoses, including avohilmo

1789

10167

1.35

30.07

1.3

1.4

512.90

538.16

mg/l

0.61

1714

9751

Rheumatism, unspecified

273

1296

2.16

30.06

1.3

459.55

541.22

mg/l

2.13

262

1239

Cluster headache, strict, including avohilmo

145

520

2.92

29.88

1.4

1.3

414.78

507.18

mg/l

3.08

140

493

Temporomandibular joint disorders, including avohilmo

932

6065

1.51

29.84

1.3

513.75

485.13

mg/l

0.28

891

5827

Acute bronchitis

765

4837

1.57

29.72

1.4

499.69

528.61

mg/l

0.58

726

4628

Functional dyspepsia

536

3173

1.72

29.70

1.3

479.16

533.24

mg/l

2.01

517

3053

Volume depletion

191

784

2.50

29.66

1.4

552.63

585.85

mg/l

0.23

176

743

Candidiasis, including avohilmo

624

3849

1.65

29.50

1.4

1.3

526.48

513.60

mg/l

0.11

598

3691

Irregular menses

982

4983

1.50

29.45

1.4

1.3

489.73

480.62

mg/l

0.08

942

4797

Obesity related asthma

687

4340

1.61

29.39

1.4

1.3

531.10

541.19

mg/l

0.08

657

4164

Diseases of the skin and subcutaneous tissue

1871

7006

1.35

29.28

1.4

1.3

520.70

533.35

mg/l

0.25

1794

6716

Restless leg syndrome

313

1580

2.03

29.25

1.2

1.3

517.67

542.54

mg/l

0.16

297

1513

Injuries to the wrist and hand

1965

9875

1.33

29.10

1.3

1.4

532.63

534.06

mg/l

0.02

1893

9465

Other specified/unspecified arthritis

530

3149

1.71

28.96

1.3

1.4

524.36

509.33

mg/l

0.24

518

3018

Chronic apical periodontitis

2124

9103

1.32

28.79

1.3

531.92

530.02

mg/l

0.03

2022

8732

Lung diseases due to external agents

259

1225

2.16

28.75

1.5

1.3

760.26

589.71

mg/l

0.75

246

1162

Other and unspecified anaemias

742

4488

1.57

28.71

1.6

1.3

570.51

556.55

mg/l

0.23

700

4289

Congenital malformations of the nervous system

245

3.91

28.65

1.8

3.0

609.73

414.90

mg/l

1.13

236

Urticaria and erythema

742

4805

1.57

28.47

1.5

1.4

528.61

496.65

mg/l

0.59

702

4618

Other and unspecified paralytic syndromes

115

5.51

28.42

1.4

1.2

473.12

447.65

mg/l

0.25

110

Supplementary factors related to causes of morbidity and mortality classified elsewhere

627

3911

1.63

28.32

1.5

1.4

649.64

521.44

mg/l

0.93

590

3745

Cluster headache, wide,, including avohilmo

148

552

2.80

28.31

1.4

1.3

424.65

519.87

mg/l

2.93

142

524

Cramp and spasm

138

497

2.91

28.27

1.5

1.4

782.24

530.41

mg/l

0.53

131

473

Asthma, hospital admissions , main diagnosis only

1558

10033

1.36

28.25

1.4

479.38

532.42

mg/l

2.91

1488

9621

Disorders of the thyroid gland

1767

8592

1.34

28.18

1.3

523.04

534.76

mg/l

0.25

1697

8231

Other anaemias

745

4517

1.56

28.15

1.6

1.3

570.46

558.16

mg/l

0.20

703

4318

Viral pneumonia

274

1337

2.10

28.09

1.5

1.4

729.07

546.75

mg/l

0.94

261

1276

Osteoporosis

467

2475

1.76

28.04

1.6

1.3

648.10

543.91

mg/l

0.71

435

2356

Aplastic and other anaemias

800

4821

1.53

27.93

1.6

1.4

570.28

552.75

mg/l

0.33

754

4606

Any event in cancer register

1751

7649

1.35

27.86

1.9

1.3

614.31

509.54

mg/l

2.12

1690

7331

Other arthritis (FG)

599

3716

1.63

27.66

1.3

527.52

509.80

mg/l

0.33

586

3546

Pain and other conditions associated with female genital organs and menstrual cycle

454

2176

1.77

27.48

1.3

401.18

495.89

mg/l

3.42

433

2098

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

989

6602

1.46

27.13

1.3

1.4

509.92

547.21

mg/l

1.17

951

6338

Heterophoria

202

889

2.35

27.05

1.5

1.7

431.82

499.55

mg/l

1.82

189

853

Type 2 diabetes, wide definition

1438

6631

1.38

26.90

1.3

630.29

551.59

mg/l

2.08

1370

6369

Hypersomnia

121

5.24

26.85

1.2

419.41

461.24

mg/l

0.42

112

Bacterial intestinal infections, IBD co-morbidities

353

1908

1.88

26.81

1.6

1.3

552.26

555.99

mg/l

0.04

337

1813

Fracture of rib(s), sternum and thoracic spine

558

3430

1.65

26.76

1.4

1.3

543.85

571.49

mg/l

0.26

526

3286

Dislocation, sprain and strain of joints and ligaments at neck level

352

1905

1.89

26.75

1.3

1.4

423.75

508.59

mg/l

5.01

339

1825

Benign neoplasms

1866

7699

1.33

26.71

1.3

1.4

523.06

525.91

mg/l

0.06

1779

7395

Type of accident

577

3581

1.63

26.66

1.5

1.4

650.58

519.22

mg/l

0.88

542

3430

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1878

9046

1.32

26.55

1.7

1.3

550.98

522.51

mg/l

0.62

1799

8686

Other infectious diseases, including avohilmo

200

884

2.33

26.45

1.4

489.22

570.14

mg/l

1.74

190

841

Iridocyclitis

442

2569

1.75

26.31

1.3

1.4

531.82

525.70

mg/l

0.08

423

2458

Other infectious diseases

171

709

2.49

26.19

1.4

494.94

571.50

mg/l

1.33

162

674

Diseases of pulp and periapical tissues, including avohilmo

1937

7650

1.32

26.08

1.3

1.4

510.04

530.05

mg/l

0.53

1843

7347

Benign neoplasm of other and unspecified endocrine glands

281

1424

2.02

26.06

1.3

522.63

547.72

mg/l

0.39

267

1354

Deforming dorsopathies

489

2930

1.69

25.85

1.3

1.4

492.53

522.03

mg/l

0.54

465

2807

Other symptoms and signs involving the urinary system

224

1048

2.19

25.76

1.5

1.4

569.03

565.61

mg/l

0.02

209

994

Other diseases of upper respiratory tract

2008

8053

1.31

25.54

1.3

1.4

514.59

543.65

mg/l

0.91

1906

7725

Emotional disorders starting during childhood or adolecense, excluding more controls

112

368

3.05

25.25

3.0

2.2

410.22

390.46

mg/l

0.13

105

352

Voice disturbances

505

3076

1.67

25.22

1.3

490.91

539.68

mg/l

1.33

488

2938

Lesion of lateral popliteal nerve

126

461

2.85

25.03

1.3

466.68

564.48

mg/l

1.40

116

432

Disorders of conjunctiva

1604

9396

1.33

24.91

1.4

476.31

534.36

mg/l

2.14

1546

9003

Parkinson's disease

274

1402

1.99

24.64

1.4

1.2

488.43

600.37

mg/l

3.87

259

1329

Temporal arteritis

320

3.25

24.64

1.3

1.2

480.38

558.37

mg/l

0.94

304

Disorders of synovium and tendon

960

5690

1.44

24.62

1.4

1.3

525.53

550.90

mg/l

0.34

920

5447

Drug-induced neutropenia

174

752

2.40

24.43

1.9

1.3

763.84

536.04

mg/l

0.83

167

715

Problems related to lifestyle

233

1130

2.11

24.40

1.4

1.3

488.40

526.47

mg/l

0.61

223

1076

Giant cell arteritis with polymyalgia rheumatica

322

3.23

24.39

1.3

480.38

560.18

mg/l

0.98

305

Coagulation defects, purpura and other haemorrhagic conditions

386

2208

1.78

24.38

1.9

1.4

542.48

526.01

mg/l

0.20

370

2108

Injuries to the shoulder and upper arm

1593

9312

1.33

24.36

1.4

534.25

550.40

mg/l

0.35

1530

8928

Giant cell arteritis

109

376

3.03

24.21

1.3

469.81

552.43

mg/l

1.21

102

357

Exclusions for E4_PCOS_CONSORTIUM

1379

6362

1.36

24.18

1.3

1.4

513.19

498.29

mg/l

0.26

1322

6110

Secondary and unspecified malignant neoplasm of lymph nodes

187

836

2.30

24.15

1.7

1.2

578.94

506.02

mg/l

0.88

177

787

Inflammatory disease of uterus

306

1639

1.91

24.09

1.3

383.77

465.11

mg/l

5.09

287

1576

All influenza (not pneumonia)

303

1617

1.91

24.04

1.5

548.07

521.76

mg/l

0.11

286

1550

Allergic asthma (mode)

420

2404

1.73

24.02

1.3

520.03

479.85

mg/l

0.26

402

2313

Allergic asthma (mode), excluding more controls

420

2404

1.73

24.01

1.3

520.03

477.50

mg/l

0.28

402

2311

Fracture of skull and facial bones

414

2427

1.73

23.92

1.4

532.58

528.83

mg/l

0.05

392

2331

Fracture of lumbar spine and pelvis

393

2265

1.76

23.88

1.4

1.3

604.24

568.47

mg/l

0.20

365

2152

Missing teeth due to accident, extraction or parodontitis

1099

7075

1.40

23.84

1.4

1.3

560.50

559.99

mg/l

0.01

1030

6806

Acetic acid derivatives and related substances

449

1342

1.75

23.78

1.3

530.46

550.73

mg/l

0.26

425

1280

Carpal tunnel syndrome

1058

6563

1.41

23.76

1.3

592.59

540.26

mg/l

0.77

1025

6291

Disturbance of activity and attention

313

1653

1.89

23.74

1.5

1.7

422.52

424.69

mg/l

0.02

307

1584

Injuries to the knee and lower leg

2233

9520

1.27

23.70

1.3

1.4

536.03

530.25

mg/l

0.10

2159

9122

Erysipelas

929

5606

1.44

23.67

1.3

584.27

534.06

mg/l

1.39

881

5381

Other disorders of bone

393

2291

1.75

23.25

1.4

1.3

511.69

513.46

mg/l

0.02

380

2197

Other heart diseases, wide

1783

8326

1.30

23.01

1.3

1.4

507.89

536.03

mg/l

0.92

1703

7993

Conjunctivitis

1457

8860

1.33

22.98

1.4

450.84

526.66

mg/l

6.96

1405

8492

Disorders of refraction and accommodation

565

3604

1.58

22.94

1.5

430.31

497.96

mg/l

4.86

536

3460

Dentofacial anomalies [including malocclusion]

1365

7994

1.35

22.87

1.4

1.3

511.61

515.58

mg/l

0.04

1314

7676

Malignant neoplasm, wide definition

1627

7226

1.32

22.69

1.9

1.3

623.84

522.23

mg/l

1.81

1574

6920

Diseases of male genital organs

875

3027

1.47

22.46

1.3

1.5

597.24

599.78

mg/l

0.02

836

2911

Fall on and from stairs and steps

503

3154

1.62

22.40

1.3

1.4

557.08

533.23

mg/l

0.19

479

3023

Social phobias

190

881

2.21

22.37

1.4

411.76

481.65

mg/l

2.57

183

849

Dental caries, including avohilmo

1252

4697

1.37

22.33

1.5

1.4

549.54

562.05

mg/l

0.22

1187

4515

Continuous positive airway pressure

309

1400

1.86

22.33

1.5

655.49

529.51

mg/l

0.74

289

1352

Erysipelas, including avohilmo

1235

6762

1.36

22.29

1.3

618.28

530.24

mg/l

1.59

1178

6489

Early lumbar disc prolapse, operated

202

962

2.15

22.21

1.2

1.3

501.50

509.87

mg/l

0.06

197

932

Adrenocortical insufficiency

101

351

3.02

22.20

1.5

1.4

610.21

527.22

mg/l

0.63

334

Hyperlipidaemia, other/unspecified

629

3719

1.54

22.18

1.3

550.74

578.31

mg/l

0.57

603

3544

Unspecified/other endometriosis

214

1022

2.10

22.09

1.3

368.22

445.46

mg/l

4.16

202

991

Malignant neoplasm, including Hilmo

1620

7223

1.31

22.07

1.9

1.3

625.02

522.00

mg/l

1.83

1567

6917

Monoamine oxidase A inhibitors

205

984

2.13

22.06

1.2

1.3

439.82

569.81

mg/l

6.32

198

950

Sequelae of injuries, of poisoning and of other consequences of external causes

459

2827

1.65

22.03

1.4

1.3

536.67

532.31

mg/l

0.04

434

2711

Persons encountering health services for specific procedures, not carried out

191

894

2.19

22.03

1.3

1.4

557.80

507.02

mg/l

0.16

176

860

Vascular dementia (subcortical)

176

3.88

21.95

1.3

582.02

636.11

mg/l

0.36

169

Bacterial pneumonia, not elsewhere classified

656

3829

1.52

21.94

1.5

1.3

600.51

525.44

mg/l

0.99

627

3673

Superficial injury of abdomen, lower back and pelvis

326

1833

1.81

21.93

1.4

468.47

520.15

mg/l

1.51

311

1745

Superficial injury of lower leg

510

3225

1.60

21.91

1.3

1.4

503.95

510.88

mg/l

0.07

489

3093

Disorders of muscles

204

983

2.12

21.77

1.2

1.3

555.37

526.56

mg/l

0.11

194

938

Conductive and sensorineural hearing loss

1365

6809

1.34

21.71

1.4

1.3

596.53

558.59

mg/l

0.64

1301

6533

Mycoses

531

3398

1.58

21.69

1.5

1.4

543.01

534.07

mg/l

0.06

508

3254

Persons with potential health hazards related to communicable diseases

749

5116

1.47

21.36

1.6

1.4

493.84

472.50

mg/l

0.35

714

4918

Sequelae with surgical and medical care as external cause

375

2213

1.72

21.26

1.5

1.3

633.80

549.87

mg/l

0.99

359

2113

Polycystic ovarian syndrome, consortium definition

1321

5666

1.35

21.24

1.4

1.3

493.25

490.23

mg/l

0.03

1260

5443

Hyperkinetic disorders

325

1799

1.80

21.12

1.5

1.7

420.30

419.47

mg/l

0.01

317

1721

Paracetamol or NSAID medication

278

722

1.96

21.10

1.9

1.8

481.68

492.73

mg/l

0.12

265

695

Other and unspecified tonsillitis

658

3665

1.51

21.07

1.4

1.3

490.45

502.65

mg/l

0.17

631

3525

Dystonia

134

553

2.51

20.93

1.3

423.84

515.91

mg/l

2.83

128

529

Urticaria

595

3937

1.53

20.88

1.6

1.4

496.52

502.06

mg/l

0.08

561

3782

Covid-19 suspected case

432

2658

1.65

20.86

1.3

1.4

440.87

492.66

mg/l

1.79

424

2538

Malignant neoplasm

1567

7052

1.31

20.85

2.0

1.3

633.46

525.53

mg/l

1.87

1512

6754

Malignant neoplasm

1566

7047

1.31

20.84

2.0

1.3

633.58

525.52

mg/l

1.87

1511

6749

Other symptoms and signs involving the circulatory and respiratory systems

150

652

2.37

20.75

1.4

550.78

571.79

mg/l

0.14

139

619

Other and unspecified iron deficiency

600

3979

1.52

20.58

1.4

509.61

536.73

mg/l

0.62

571

3801

Thrombocytopenia, unspecified

160

719

2.29

20.51

2.6

1.4

611.50

577.85

mg/l

0.27

153

683

Other symptoms and signs involving the digestive system and abdomen

304

1709

1.81

20.43

1.4

505.35

533.64

mg/l

0.39

283

1631

Sensorineural hearing loss

1274

6377

1.34

20.42

1.3

609.71

562.25

mg/l

0.79

1213

6120

Conjunctivitis (acute, non atopic)

559

3654

1.54

20.36

1.5

482.38

514.76

mg/l

0.78

538

3501

Parkinson's disease, strict definition

245

1290

1.94

20.36

1.4

1.2

488.17

609.26

mg/l

3.86

232

1222

Infections with a predominantly sexual mode of transmission, including avohilmo

788

5054

1.44

20.28

1.3

462.14

470.10

mg/l

0.15

759

4848

Anterior Iridocyclitis

381

2293

1.69

20.10

1.3

1.4

522.09

527.50

mg/l

0.07

365

2195

Vitamin deficiency, wide

118

468

2.61

20.05

1.2

1.5

462.92

510.32

mg/l

0.74

106

447

Vitamin deficiency

118

468

2.61

20.05

1.2

1.5

462.92

510.32

mg/l

0.74

106

447

Bacterial pneumoniae

687

4124

1.48

20.04

1.5

1.4

596.64

533.98

mg/l

0.78

655

3959

Statin medication

1235

5199

1.35

19.80

1.3

515.39

531.34

mg/l

0.35

1179

4971

Propionic acid derivatives

473

1467

1.64

19.77

1.5

1.6

503.55

535.79

mg/l

0.53

442

1404

Acute and subacute iridocyclitis

358

2131

1.71

19.71

1.3

1.4

529.82

524.20

mg/l

0.06

343

2037

Enterocolitis due to Clostridium difficile

202

1007

2.05

19.71

1.7

1.4

545.99

561.90

mg/l

0.15

193

952

Sequelae of injuries of head

130

545

2.47

19.64

1.6

1.3

463.26

550.30

mg/l

2.28

116

519

Caries of dentine, including avohilmo

1341

5180

1.33

19.61

1.4

547.98

558.72

mg/l

0.19

1276

4986

Diaphragmatic hernia

606

4079

1.50

19.58

1.3

541.71

546.64

mg/l

0.04

577

3892

Acute alcohol intoxication

453

2863

1.60

19.56

1.2

1.3

556.28

560.66

mg/l

0.04

429

2743

Thiamine deficiency

7.05

19.53

1.1

1.3

441.63

518.79

mg/l

0.48

Adverse effects, not elsewhere classified

399

2449

1.66

19.53

1.4

1.5

490.11

501.45

mg/l

0.08

387

2340

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

165

769

2.21

19.37

1.4

604.04

487.15

mg/l

0.83

156

736

Internuclear ophthalmoplegia

17.86

19.20

1.3

666.10

485.52

mg/l

0.34

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

757

5269

1.43

19.12

1.3

1.4

468.54

490.42

mg/l

0.57

719

5070

Acute pharyngitis

317

1827

1.75

18.92

1.6

1.3

440.07

488.66

mg/l

1.20

307

1760

Explicit bacterial Sepsis

181

881

2.09

18.82

1.9

1.3

844.99

547.63

mg/l

3.74

176

836

Other enthesopathies

519

3410

1.54

18.82

1.3

537.16

568.74

mg/l

0.23

498

3270

Disorders of lens

1130

5227

1.35

18.80

1.3

604.06

582.61

mg/l

0.20

1089

5013

Dental operations

1007

3772

1.38

18.79

1.4

1.3

546.99

567.98

mg/l

0.36

952

3622

Use of pramipexole

375

2288

1.66

18.77

1.3

562.02

568.77

mg/l

0.04

357

2179

Disorders of mineral metabolism

173

832

2.13

18.69

1.3

1.4

464.49

563.54

mg/l

2.79

163

788

Hyperosmolality and hypernatraemia

107

4.59

18.63

1.4

535.80

489.53

mg/l

0.31

101

Alcohol abuse, main dg

312

1819

1.75

18.61

1.2

1.4

595.85

534.06

mg/l

0.56

301

1745

Diseases of pulp and periapical tissues and dental caries

1103

4187

1.36

18.58

1.5

1.4

559.92

550.71

mg/l

0.15

1046

4023

Explicit bacterial Sepsis, including avohilmo

184

908

2.06

18.44

1.9

1.3

838.66

550.63

mg/l

3.62

179

861

Purpura and other haemorrhagic conditions

260

1446

1.83

18.26

2.1

1.4

552.11

547.44

mg/l

0.05

251

1378

Other disorders of adrenal gland

114

467

2.53

18.18

1.5

1.6

600.58

541.06

mg/l

0.45

108

445

Acute alcohol intoxication, ICD10

388

2410

1.63

18.13

1.2

1.3

547.68

531.22

mg/l

0.15

370

2309

Other metabolic disorders

257

1428

1.83

18.10

1.5

1.3

514.93

510.56

mg/l

0.04

245

1370

Mixed and other personality disorders

179

884

2.08

18.08

1.2

1.4

385.71

504.30

mg/l

7.46

173

845

Haemorrhage from respiratory passages

566

3368

1.50

18.07

1.4

544.53

591.11

mg/l

0.97

540

3222

Chronic rhinitis, nasopharyngitis and pharyngitis

597

4073

1.48

18.07

1.3

1.4

481.49

512.52

mg/l

0.82

568

3922

Other diseases of hard tissues of teeth

927

3476

1.39

18.01

1.5

1.3

546.06

566.58

mg/l

0.36

881

3341

Leisure time condition

348

2109

1.68

17.95

1.5

1.4

649.87

522.55

mg/l

0.49

327

2013

Hernia of abdominal wall, postoperative

296

1702

1.75

17.95

1.3

1.2

504.39

515.69

mg/l

0.16

285

1631

Diseases of oral cavity, salivary glands and jaws

933

3485

1.39

17.94

1.4

1.3

551.84

566.62

mg/l

0.23

886

3349

Mental and behavioural disorders due to opioids

102

400

2.65

17.84

1.4

557.58

458.69

mg/l

0.55

385

Obesity and other hyperalimentation

1182

8488

1.32

17.77

1.3

529.42

520.25

mg/l

0.13

1133

8143

Anti-inflammatory and antirheumatic products, non-steroids

463

1468

1.60

17.77

1.5

1.6

525.64

535.60

mg/l

0.12

434

1405

Heart failure, not strict

1255

6457

1.31

17.69

1.4

585.03

568.03

mg/l

0.25

1200

6196

Other and unspecified injuries of head

155

731

2.17

17.65

1.4

1.5

469.97

577.54

mg/l

2.84

148

701

231

3.23

17.61

1.4

1.2

440.97

506.46

mg/l

1.10

220

Unspecified haematuria

672

3814

1.45

17.60

1.4

710.87

571.12

mg/l

0.95

647

3656

Bacterial pneumonia (organism specified)

741

4775

1.42

17.54

1.5

1.3

604.16

541.73

mg/l

0.84

708

4571

Obesity

1175

8459

1.32

17.54

1.3

528.55

520.08

mg/l

0.11

1126

8115

Internal derangement of knee

660

4567

1.44

17.54

1.3

509.14

527.83

mg/l

0.23

635

4381

Assault by bodily force

179

894

2.05

17.53

1.2

1.5

466.01

491.18

mg/l

0.50

171

858

Nutritional anaemias

831

5755

1.39

17.52

1.4

518.52

535.83

mg/l

0.41

791

5501

Iron deficiency anaemia

723

5038

1.42

17.50

1.4

517.95

532.07

mg/l

0.30

687

4818

KRA_PSY_EATING, excluding more controls

157

738

2.15

17.48

1.2

1.4

357.50

458.94

mg/l

2.99

149

716

Other disorders of glucose regulation and pancreatic internal secretion

177

881

2.06

17.47

1.6

1.7

482.34

545.40

mg/l

1.35

168

842

Secondary uncertain malignant neoplasm

237

1299

1.86

17.45

1.7

1.2

600.61

548.53

mg/l

0.49

225

1226

Hypermobility syndrome

133

594

2.31

17.44

1.2

1.4

397.51

462.29

mg/l

1.45

127

571

Hypoglycaemia, other or unspecified

150

703

2.19

17.41

1.6

1.7

460.73

534.59

mg/l

1.90

142

673

Spondyloarthritis

308

1823

1.71

17.33

1.3

680.14

536.27

mg/l

0.72

296

1734

Other disorders of skin and subcutaneous tissue

1264

8250

1.30

17.09

1.4

1.3

594.66

541.09

mg/l

0.77

1203

7917

Lesion of ulnar nerve

250

1405

1.81

16.97

1.3

491.28

541.85

mg/l

1.07

240

1342

Oter anti-inflammatory and antirheumatic agents, non-steroids

332

1074

1.72

16.96

1.2

1.3

646.93

582.86

mg/l

0.30

306

1028

Assault

280

1629

1.75

16.90

1.2

1.4

468.06

495.86

mg/l

0.56

266

1562

Appendectomy

1175

8599

1.31

16.88

1.3

512.96

535.68

mg/l

0.38

1126

8244

Hyperplasia of prostate

555

2092

1.51

16.80

1.3

593.98

619.22

mg/l

0.36

526

2013

Striking against or struck by other objects

635

4441

1.44

16.78

1.4

475.77

522.50

mg/l

1.70

605

4265

Infections with a predominantly sexual mode of transmission

592

4085

1.46

16.78

1.4

1.3

481.59

466.97

mg/l

0.23

571

3916

Chronic diseases of tonsils and adenoids

1431

7072

1.28

16.72

1.3

1.4

486.71

534.60

mg/l

1.34

1368

6790

Diseases of the digestive system

759

5446

1.39

16.62

1.4

519.02

549.39

mg/l

0.58

723

5201

Oxicams

351

1203

1.67

16.50

1.3

527.81

563.13

mg/l

0.44

336

1150

Spondylolisthesis/Spondylolysis

294

1743

1.71

16.48

1.2

1.3

527.77

522.99

mg/l

0.04

275

1669

Vascular syndromes of brain in cerebrovascular disorders

294

2.84

16.41

1.3

546.52

660.24

mg/l

1.14

282

Fitting and adjustment of other devices

566

3420

1.47

16.35

1.4

1.3

602.67

534.38

mg/l

1.26

531

3265

Degeneration of the brain due to alcohol

180

3.45

16.29

1.2

1.3

460.87

605.71

mg/l

2.35

166

Agoraphobia

285

2.87

16.25

1.2

1.3

422.97

509.78

mg/l

1.43

272

Superficial injury of hip and thigh

265

1538

1.75

16.07

1.2

1.3

507.48

546.16

mg/l

0.44

256

1459

Other disorders of eyelid

702

4749

1.41

16.06

1.3

546.89

559.32

mg/l

0.21

675

4534

Diseases of arteries, arterioles and capillaries (FINNGEN)

374

1612

1.62

16.01

1.4

1.2

569.93

534.84

mg/l

0.55

362

1529

Alcohol dependence

449

2970

1.53

15.93

1.2

1.3

533.25

574.86

mg/l

0.56

426

2856

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

195

1037

1.92

15.93

1.9

1.3

539.55

564.03

mg/l

0.23

190

988

Unspecified acute lower respiratory infection

286

1704

1.70

15.81

1.4

1.5

578.48

532.96

mg/l

0.20

277

1638

Ptosis of eyelid

206

1117

1.88

15.81

1.5

1.3

479.92

562.25

mg/l

2.60

201

1061

Congenital malformations, deformations and chromosomal abnormalities

1076

7828

1.31

15.72

1.4

487.56

515.24

mg/l

0.75

1031

7520

Fenamates

239

905

1.82

15.64

1.4

1.3

483.57

552.05

mg/l

1.71

229

866

Ovarian cyst

617

2451

1.45

15.62

1.4

1.3

447.47

503.64

mg/l

1.37

586

2359

Hypothyroidism, strict autoimmune, 3 medication purchases required

1458

7780

1.27

15.44

1.3

482.03

527.57

mg/l

2.31

1401

7457

Asthma and allergy, excluding more controls

234

1311

1.79

15.34

1.3

448.30

461.99

mg/l

0.17

226

1255

Pain associated with micturition

229

1295

1.80

15.32

1.4

502.87

537.64

mg/l

0.62

213

1231

Other diseases of the respiratory system

322

1993

1.64

15.31

1.7

1.4

498.91

576.16

mg/l

2.69

307

1894

Other respiratory disorders and diseases

322

1993

1.64

15.31

1.7

1.4

498.91

576.16

mg/l

2.69

307

1894

Soft tissue disorders related to use, overuse and pressure

455

3045

1.51

15.27

1.3

489.47

559.69

mg/l

2.13

438

2906

Acute renal failure

357

2269

1.59

15.20

1.4

1.3

643.11

581.67

mg/l

0.65

336

2158

Paralytic ileus and intestinal obstruction

409

2681

1.54

15.08

1.4

501.48

560.78

mg/l

1.62

388

2557

Fall on same level involving ice and snow

1018

7806

1.31

15.07

1.3

1.4

520.31

542.11

mg/l

0.49

973

7482

Keratitis

632

4513

1.41

15.04

1.4

1.3

577.83

527.06

mg/l

0.91

604

4326

Asthma and allergy

233

1311

1.78

15.04

1.3

449.94

462.55

mg/l

0.15

225

1257

Disorders of skin appendages

915

6887

1.33

14.99

1.3

1.4

524.03

508.91

mg/l

0.15

876

6612

Non-allergic asthma (mode)

297

1793

1.66

14.99

1.3

453.32

505.05

mg/l

1.34

277

1724

Insulin, intermediate and long-acting

915

6674

1.33

14.98

1.4

670.68

539.67

mg/l

2.80

876

6395

Obesity due to excess calories

878

6609

1.34

14.96

1.3

1.4

541.12

513.25

mg/l

0.34

838

6358

Non-allergic asthma (mode), excluding more controls

297

1795

1.66

14.92

1.3

453.32

505.84

mg/l

1.38

277

1721

Superficial injury of wrist and hand

403

2647

1.54

14.86

1.4

1.5

509.44

500.79

mg/l

0.03

389

2540

Excessive, frequent and irregular menstruation

675

2562

1.42

14.85

1.4

1.3

446.51

497.98

mg/l

1.40

641

2467

Diseases of liver

587

4148

1.43

14.85

1.3

559.66

555.32

mg/l

0.04

561

3980

Other and unspecified urticaria

372

2407

1.57

14.72

1.5

486.07

501.17

mg/l

0.20

351

2300

Noninfective enteritis and colitis

822

6138

1.35

14.65

1.3

1.4

511.57

524.86

mg/l

0.30

784

5893

Acute and transient psychotic disorders

227

1299

1.78

14.62

1.2

1.3

475.21

517.22

mg/l

0.72

217

1245

Tinnitus

410

2713

1.53

14.61

1.2

1.3

501.59

533.00

mg/l

0.66

396

2611

Misadventures to patients during surgical and medical care

256

1515

1.72

14.57

1.5

1.3

597.57

534.77

mg/l

0.52

247

1442

Disorders of calcium metabolism

127

601

2.17

14.45

1.3

1.4

471.64

576.72

mg/l

2.12

121

567

Conjunctivitis (acute, non atopic), including avohilmo

1817

8982

1.23

14.35

1.4

479.14

553.52

mg/l

6.47

1754

8597

Heartburn

203

1134

1.82

14.16

1.3

484.52

543.11

mg/l

0.96

192

1083

Disorders of choroid and retina

1337

7446

1.26

14.09

1.4

1.3

550.84

567.04

mg/l

0.43

1275

7141

Other noninfective gastroenteritis and colitis

433

2921

1.50

14.00

1.4

1.5

499.00

510.82

mg/l

0.20

407

2798

Mental disorders, not otherwise specified

178

961

1.89

13.97

1.2

1.4

498.65

490.12

mg/l

0.05

170

922

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

146

738

2.03

13.95

1.3

1.4

437.32

523.61

mg/l

1.30

138

706

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

355

2305

1.56

13.86

1.3

421.38

462.32

mg/l

0.95

335

2224

Degeneration of nervous system due to alcohol

199

3.11

13.86

1.2

460.87

578.26

mg/l

1.86

183

Streptococcal septicaemia

156

809

1.96

13.77

1.9

1.3

814.54

532.25

mg/l

3.20

151

770

Arthrosis

1187

5091

1.28

13.76

1.3

549.83

530.67

mg/l

0.46

1139

4883

Injuries to the hip and thigh

791

5310

1.34

13.76

1.3

1.4

557.82

551.30

mg/l

0.08

749

5075

Mental and behavioural disorders due to sedatives or hypnotics

147

749

2.01

13.74

1.2

1.3

461.17

527.46

mg/l

0.97

138

718

Obsessive-compulsive disorder

139

693

2.05

13.73

1.3

1.5

390.27

460.61

mg/l

1.72

132

663

Schizoaffective disorder

162

854

1.94

13.70

1.2

1.4

473.29

513.39

mg/l

0.49

153

817

Gingivitis and periodontal diseases

1726

7276

1.23

13.70

1.4

531.01

539.04

mg/l

0.15

1649

6977

Abnormal findings on diagnostic imaging of other body structures

255

1535

1.69

13.66

1.3

543.16

539.00

mg/l

0.04

243

1461

Streptococcal septicaemia, including avohilmo

159

834

1.94

13.57

1.9

1.3

807.77

534.75

mg/l

3.12

154

794

Pulmonary embolism

455

3121

1.47

13.55

1.5

1.3

583.10

561.48

mg/l

0.31

440

2969

Senile cataract

986

4604

1.31

13.52

1.3

590.90

587.68

mg/l

0.03

950

4413

Pulmonary heart disease

455

3123

1.47

13.50

1.5

1.3

583.10

561.55

mg/l

0.31

440

2971

Insulin, combination of fast acting with intermediate-acting or long-acting

1016

7161

1.29

13.50

1.4

662.55

534.18

mg/l

3.15

972

6855

Alcohol withdrawal state with delirium

133

658

2.07

13.50

1.3

560.50

592.98

mg/l

0.14

127

625

Convergent concomitant strabismus

126

612

2.11

13.46

1.3

1.8

439.95

490.86

mg/l

0.96

119

588

Secondary hypertension

134

654

2.05

13.42

1.3

1.4

532.12

504.21

mg/l

0.20

125

616

Endometriosis

580

2386

1.43

13.41

1.3

446.15

508.67

mg/l

1.93

548

2300

GI-bleeding

487

3399

1.45

13.22

1.4

530.05

557.34

mg/l

0.37

461

3244

Other diseases of the digestive system

489

3419

1.44

13.16

1.4

529.37

562.32

mg/l

0.47

463

3263

Adhesive capsulitis of shoulder

265

1626

1.65

13.15

1.4

1.3

469.29

552.29

mg/l

2.65

258

1551

Paroxysmal tachycardia

361

1964

1.54

13.13

1.3

1.4

497.21

501.43

mg/l

0.07

345

1869

Insulin medication

1015

6561

1.29

13.10

1.4

662.72

528.21

mg/l

3.37

971

6297

Other obstetric conditions, not elsewhere classified

614

2789

1.40

13.09

1.3

430.83

416.90

mg/l

0.31

596

2672

Abnormal weight loss

176

967

1.86

13.07

1.3

1.5

477.51

577.53

mg/l

1.72

167

918

Viral and other specified intestinal infections, including avohilmo

514

3494

1.43

13.02

1.5

1.4

456.21

482.01

mg/l

0.41

498

3350

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1164

8422

1.27

12.99

1.4

484.18

521.78

mg/l

1.24

1114

8085

Excessive vomiting in pregnancy

171

934

1.87

12.97

1.3

416.05

452.14

mg/l

0.49

159

890

Amenorrhoea

147

764

1.97

12.96

1.3

471.43

440.00

mg/l

0.24

140

740

Weight loss

189

1064

1.81

12.94

1.6

1.5

475.74

570.72

mg/l

1.75

180

1010

Postprocedural endocrine and metabolic disorders, not elsewhere classified

223

1316

1.72

12.90

1.5

1.3

497.33

508.71

mg/l

0.12

212

1262

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

601

2723

1.40

12.88

1.3

417.74

415.00

mg/l

0.06

583

2608

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

261

1606

1.65

12.85

1.6

1.3

562.50

550.47

mg/l

0.11

248

1519

Venous thromboembolism

846

6231

1.32

12.83

1.4

1.3

578.29

553.70

mg/l

0.41

820

5948

Intestinal stricture

479

3354

1.44

12.82

1.4

501.98

565.38

mg/l

2.13

456

3201

Candidiasis

264

1632

1.64

12.78

1.4

1.3

590.37

529.20

mg/l

0.25

250

1555

Cutaneous abscess, furuncle and carbuncle

466

3255

1.45

12.69

1.3

552.01

523.15

mg/l

0.20

449

3114

Trochanteric bursitis

241

1458

1.68

12.67

1.3

460.75

539.72

mg/l

2.61

235

1392

Hypermetropia

154

820

1.92

12.63

1.7

1.9

395.86

526.92

mg/l

4.81

146

785

Pulmonary heart disease, diseases of pulmonary circulation

481

3380

1.44

12.61

1.5

1.3

579.66

559.12

mg/l

0.31

466

3218

All chronic kidney diseases

879

5383

1.31

12.60

1.4

618.71

525.38

mg/l

1.56

848

5152

Inflammatory diseases of prostate (prostatitis)

201

1160

1.76

12.59

1.4

1.3

519.23

584.56

mg/l

2.00

193

1109

Otalgia

172

950

1.85

12.58

1.8

1.6

494.47

503.95

mg/l

0.06

167

913

Maternal care for other conditions predominantly related to pregnancy

388

2555

1.50

12.55

1.3

450.38

438.68

mg/l

0.21

372

2446

Abnormal blood-pressure reading, without diagnosis

102

470

2.23

12.51

1.4

1.5

542.17

585.98

mg/l

0.27

450

Cellulitis

390

2641

1.49

12.51

1.7

1.4

580.78

528.90

mg/l

0.91

379

2528

Diseases of middle ear and mastoid

1036

6664

1.28

12.27

1.5

1.3

562.60

504.42

mg/l

0.98

994

6394

Insulin, fast-acting

601

4407

1.37

12.25

1.4

680.97

524.29

mg/l

2.06

573

4227

Faecal incontinence

154

828

1.89

12.24

1.4

1.3

449.14

534.32

mg/l

2.18

146

794

Diabetic neuropathy

181

1018

1.80

12.23

1.4

1.3

846.16

592.84

mg/l

0.80

172

968

Other specified and unspecified personality disorders

180

1018

1.80

12.19

1.3

1.4

419.03

514.55

mg/l

3.76

174

977

Failure and rejection of transplanted organs and tissues

131

3.49

12.04

3.0

1.3

734.65

460.22

mg/l

0.95

123

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

509

3647

1.41

12.02

1.4

1.3

475.66

540.09

mg/l

2.72

491

3495

Acute appendicitis, no complications

978

7651

1.28

11.99

1.3

507.46

540.99

mg/l

0.56

936

7360

Reimbursement for rheumatic diseases

949

7403

1.28

11.89

1.3

1.4

590.53

533.35

mg/l

0.58

917

7086

Beningn neoplasm: Meninges, unspecified

137

3.39

11.88

1.6

1.2

1085.50

477.77

mg/l

1.75

129

Other gastritis (incl. Duodenitis)

348

2328

1.51

11.86

1.3

596.43

577.65

mg/l

0.08

338

2237

Asthma/COPD (KELA code 203)

1693

9396

1.21

11.85

1.3

1.4

479.87

542.35

mg/l

3.62

1614

9021

Decubitus ulcer and pressure area

106

508

2.13

11.74

1.7

1.3

713.15

611.18

mg/l

0.33

481

Diverticular disease of intestine

1128

5591

1.26

11.72

1.3

528.35

578.03

mg/l

2.15

1089

5369

Menorrhagia

564

2269

1.40

11.65

1.3

475.10

518.63

mg/l

0.87

530

2191

Unspecified visual impairment (binocular)

134

3.37

11.58

1.3

1.6

424.93

471.55

mg/l

0.46

128

Maltreatment syndromes

114

566

2.07

11.55

1.2

1.5

468.62

480.90

mg/l

0.09

109

545

Emotional disorders and disorders of social functioning with onset specific to childhood

120

594

2.03

11.51

2.8

2.2

407.94

385.27

mg/l

0.16

111

565

DVT of lower extremities and pulmonary embolism

631

4689

1.35

11.50

1.4

1.3

557.37

556.15

mg/l

0.02

612

4473

Viral and other specified intestinal infections

379

2532

1.48

11.48

1.5

466.55

477.11

mg/l

0.10

368

2426

Disorders of vitreous body and globe

820

6003

1.30

11.42

1.3

595.20

560.39

mg/l

0.31

785

5746

Chronic gastritis

395

2731

1.46

11.39

1.2

1.3

559.51

569.98

mg/l

0.05

373

2613

Superficial injury of thorax

260

1650

1.60

11.33

1.3

554.82

543.34

mg/l

0.09

241

1573

Glomerular diseases

293

1915

1.55

11.21

1.4

567.49

544.45

mg/l

0.21

285

1822

Amblyopia ex anopsia

414

2.24

11.16

1.5

2.2

473.71

467.36

mg/l

0.04

396

Fracture of foot, except ankle

443

3143

1.42

11.14

1.4

499.17

503.14

mg/l

0.05

422

3023

Benign neoplasm of colon, rectum, anus and anal canal

988

6629

1.27

11.08

1.3

579.73

576.08

mg/l

0.04

940

6355

Other viral hepatitis, including avohilmo

137

736

1.90

11.04

1.3

516.63

505.92

mg/l

0.07

131

704

Insulin, fast-acting or short human

603

4500

1.35

11.02

1.4

680.67

526.96

mg/l

2.01

575

4313

Contact with and exposure to communicable diseases

564

4151

1.36

11.01

1.4

477.55

454.97

mg/l

0.30

535

3992

Impingement syndrome of shoulder

366

2512

1.47

11.01

1.4

1.3

575.48

589.90

mg/l

0.13

353

2407

Gonarthrosis

1014

4532

1.27

10.99

1.3

559.19

542.13

mg/l

0.26

976

4347

Diseases of appendix

1286

9410

1.23

10.95

1.3

522.81

539.88

mg/l

0.30

1229

9040

Diseases of salivary glands

553

4083

1.37

10.92

1.3

492.81

523.70

mg/l

0.72

531

3910

Viral hepatitis, including avohilmo

154

863

1.82

10.84

1.3

1.4

524.95

520.44

mg/l

0.03

147

826

Early lumbar disc prolapse operation

207

1259

1.67

10.81

1.2

1.3

504.72

498.53

mg/l

0.04

201

1217

Other arrhythmias

1126

6780

1.25

10.81

1.3

509.88

542.05

mg/l

0.67

1071

6509

Fracture at wrist and hand level

599

4470

1.35

10.77

1.3

1.4

494.74

528.78

mg/l

1.27

573

4292

Other disorders of patella

295

1949

1.53

10.75

1.3

461.41

500.84

mg/l

1.02

285

1872

Disorders of vitreous body

794

5873

1.29

10.73

1.3

594.14

562.12

mg/l

0.27

762

5620

Abnormal findings on diagnostic imaging of lung

717

5210

1.31

10.73

1.3

580.56

572.09

mg/l

0.07

691

4981

Appendicitis, broad definition

1274

9368

1.23

10.73

1.3

523.01

540.29

mg/l

0.30

1218

9001

Nephropathy related operations

212

1300

1.66

10.72

1.6

1.5

579.56

562.15

mg/l

0.17

203

1243

Tubulo-interstitial nephritis, not specified as acute or chronic

117

603

1.98

10.64

1.5

1.3

548.70

526.87

mg/l

0.18

112

574

Open wound of wrist and hand

781

5864

1.30

10.64

1.3

1.4

526.88

538.65

mg/l

0.18

751

5628

Emotional disorders starting during childhood or adolescence

113

571

2.01

10.63

3.0

2.1

408.95

379.30

mg/l

0.21

106

542

Osteoporosis with pathological fracture (FG)

115

591

1.98

10.55

1.6

1.3

988.84

515.47

mg/l

0.89

108

567

Other viral hepatitis

128

690

1.90

10.25

1.3

517.26

506.48

mg/l

0.07

123

660

Generalized epilepsy

416

2.17

10.22

1.3

1.8

501.01

488.98

mg/l

0.05

401

Unspecified privation

189

1140

1.68

10.21

1.4

510.42

549.45

mg/l

0.59

183

1089

Acute appendicitis

1198

9111

1.23

10.18

1.3

524.08

542.16

mg/l

0.30

1146

8749

Solid cancers, including Hilmo

1461

7070

1.21

10.13

1.4

1.3

642.39

525.04

mg/l

1.94

1412

6770

Budesonide

245

1576

1.57

10.13

1.3

496.92

510.90

mg/l

0.17

237

1506

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

958

7353

1.25

10.10

1.4

440.71

512.20

mg/l

5.66

923

7044

Dislocation, sprain and strain of joints and ligaments of knee

1079

7916

1.24

10.07

1.3

526.06

528.56

mg/l

0.03

1040

7591

Secondary thrombocytopenia

105

3.52

10.06

1.9

1.2

687.31

469.42

mg/l

1.01

Other arthrosis

838

4406

1.28

10.06

1.3

564.73

543.03

mg/l

0.27

814

4231

Other maternal disorders predominantly related to pregnancy

961

4793

1.26

10.03

1.3

459.48

503.16

mg/l

1.31

926

4596

False labour

543

2489

1.37

10.01

1.3

413.61

458.38

mg/l

0.87

521

2390

Chondropathies

269

1775

1.54

9.94

1.5

1.4

512.36

519.00

mg/l

0.07

259

1697

Thyroiditis, ILD-related definition

195

1194

1.66

9.93

1.4

563.50

503.17

mg/l

0.22

188

1138

Disorders of gallbladder, biliary tract and pancreas

1663

8722

1.19

9.90

1.4

1.3

565.09

539.74

mg/l

0.40

1590

8365

Meniscus derangement

875

4589

1.27

9.89

1.3

518.45

540.36

mg/l

0.64

833

4405

Lesion of radial nerve

344

2.27

9.85

1.3

537.32

530.10

mg/l

0.04

326

Acute suppurative otitis media

489

3356

1.37

9.79

2.0

1.4

533.83

466.21

mg/l

1.27

472

3224

Suppurative and unspecified otitis media

650

4415

1.31

9.75

1.8

1.3

568.70

489.10

mg/l

0.89

626

4238

Renal failure

703

4637

1.30

9.72

1.4

629.26

572.14

mg/l

0.63

670

4433

Early onset COPD, excluding more controls

277

1845

1.51

9.68

1.3

582.07

567.20

mg/l

0.13

260

1781

Car occupant injured in other and unspecified transport accidents

332

2299

1.46

9.64

1.3

486.46

512.81

mg/l

0.49

318

2193

Childhood asthma (age<16)

213

1038

1.62

9.64

1.4

1.3

466.34

438.55

mg/l

0.30

203

992

Dialysis, with operation codes

214

1352

1.61

9.62

1.6

1.5

546.94

562.03

mg/l

0.22

204

1289

Viral hepatitis

143

814

1.79

9.60

1.3

1.4

525.21

518.45

mg/l

0.04

137

778

Myeloid leukaemia

224

2.58

9.59

2.5

1.3

500.14

544.01

mg/l

0.37

214

Benign neoplasm: Colon

824

6128

1.27

9.59

1.3

574.37

581.25

mg/l

0.07

785

5866

Fentanyl

146

834

1.77

9.52

1.4

1.3

790.55

560.51

mg/l

0.61

137

796

Respiratory insufficiency

112

589

1.92

9.52

1.6

1.3

503.48

538.53

mg/l

0.52

106

562

Other hearing loss

398

2760

1.41

9.49

1.3

581.98

550.30

mg/l

0.21

388

2632

Childhood asthma (age<16), excluding more controls

212

1036

1.61

9.49

1.4

1.3

468.02

436.33

mg/l

0.35

202

990

Other female pelvic inflammatory diseases

267

1778

1.52

9.47

1.3

426.96

506.29

mg/l

2.86

251

1709

Spondylopathies (FG)

233

1507

1.57

9.45

1.3

574.05

503.80

mg/l

0.37

221

1436

Disease of hard tissues of teeth, NOS

831

3420

1.28

9.44

1.3

540.61

558.66

mg/l

0.31

801

3288

Gout

390

2384

1.41

9.43

1.5

1.3

655.05

565.32

mg/l

2.17

374

2273

Fracture of lower leg, including ankle

910

7181

1.25

9.41

1.3

1.4

553.95

543.03

mg/l

0.18

878

6874

Procreative management

597

3744

1.32

9.38

1.4

1.5

503.11

516.30

mg/l

0.16

569

3583

Mouth breathing

644

4965

1.30

9.37

1.3

1.5

515.59

549.34

mg/l

1.01

617

4769

Congenital iodine-deficiency syndrome/hypothyroidism

233

2.52

9.32

1.3

1.6

523.19

522.11

mg/l

0.00

219

Obesity, other/unspecified

587

4482

1.32

9.30

1.3

468.10

497.65

mg/l

0.96

569

4308

Complications of genitourinary prosthetic devices, implants and grafts

228

2.54

9.26

1.4

1.3

692.84

519.95

mg/l

0.49

214

Examination and encounter for administrative purposes

112

597

1.90

9.24

1.3

479.53

613.78

mg/l

2.02

106

581

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

511

3830

1.35

9.23

1.4

565.04

502.74

mg/l

0.52

494

3676

Persistent delusional disorders

133

750

1.81

9.22

1.3

470.86

550.47

mg/l

1.93

126

713

Injuries to the elbow and forearm

1219

8658

1.21

9.21

1.3

1.4

516.90

528.86

mg/l

0.19

1155

8312

Diabetic retinopathy, excluding more controls

381

1502

1.43

9.16

1.4

1.3

573.42

546.09

mg/l

0.48

362

1432

Other condition

253

1679

1.53

9.14

1.6

1.4

626.64

527.64

mg/l

0.56

240

1601

Tonsillectomy and adenotomy

1023

5787

1.24

9.14

1.4

488.93

487.71

mg/l

0.01

972

5573

Diseases of external ear

579

4424

1.32

9.13

1.3

1.4

610.55

527.88

mg/l

0.71

543

4245

Other fall from one level to another

387

2781

1.40

9.12

1.8

1.5

530.61

508.48

mg/l

0.29

371

2660

Lateral epicondylitis

211

1346

1.59

9.10

1.3

483.45

524.74

mg/l

0.57

204

1288

Sicca syndrome [Sjögren]

146

850

1.75

9.07

1.4

1.3

404.99

518.02

mg/l

5.15

141

812

Other/unspecified enthesopathies of lower limb, excluding foot

122

674

1.84

9.04

1.3

1.4

556.39

526.42

mg/l

0.25

115

648

Allergic conjunctivitis

996

7819

1.23

8.96

1.4

441.84

512.96

mg/l

5.75

960

7493

Disorders of parathyroid gland

294

1993

1.47

8.96

1.3

556.18

566.42

mg/l

0.08

279

1892

Fibroblastic disorders

325

2273

1.44

8.94

1.2

1.3

527.69

586.30

mg/l

0.93

313

2176

Other disorders of the musculoskeletal system and connective tissue

240

1587

1.53

8.84

1.4

1.3

533.06

556.56

mg/l

0.22

233

1514

Metatarsalgia

158

946

1.69

8.83

1.2

1.4

667.10

524.71

mg/l

0.39

151

906

Panniculitis affecting regions of neck and back

308

2.26

8.82

1.4

1.3

521.47

530.14

mg/l

0.06

296

Diabetes medication

1794

8972

1.17

8.81

1.3

1.4

592.85

525.03

mg/l

2.21

1711

8621

Diabetes mellitus

1771

8750

1.17

8.78

1.3

1.4

590.71

524.01

mg/l

2.11

1693

8402

Familial hypercholesterolemia

204

1305

1.58

8.70

1.3

726.94

589.94

mg/l

0.67

194

1240

Care involving dialysis

126

712

1.80

8.69

1.4

1.5

572.47

548.45

mg/l

0.27

120

678

Acute lymphadenitis

111

605

1.87

8.65

1.9

1.5

425.67

510.03

mg/l

1.97

104

577

Other retinal disorders

985

6111

1.23

8.55

1.4

1.3

554.79

568.83

mg/l

0.30

935

5854

Other diseases of anus and rectum

460

3425

1.35

8.48

1.3

1.4

570.60

550.98

mg/l

0.15

437

3268

Atrial fibrillation and flutter

430

2032

1.37

8.47

1.3

1.2

554.80

521.44

mg/l

0.53

407

1935

Haemorrhage in early pregnancy

465

3385

1.35

8.43

1.3

420.66

479.88

mg/l

2.70

452

3244

Endometriosis of pelvic peritoneum

274

1705

1.48

8.41

1.3

418.47

516.58

mg/l

2.62

256

1648

Vasomotor and allergic rhinitis

638

4880

1.29

8.36

1.3

1.4

439.00

504.25

mg/l

2.98

614

4695

Superficial injury of forearm

188

1194

1.60

8.34

1.3

1.6

509.30

509.50

mg/l

0.00

178

1137

Noninfectious colitis NAS

233

1551

1.52

8.34

1.3

1.5

492.40

531.71

mg/l

0.75

220

1484

Gonarthrosis [arthrosis of knee](FG)

1181

5641

1.21

8.33

1.3

555.81

548.77

mg/l

0.10

1135

5404

Diabetes, varying definitions

1758

8754

1.17

8.33

1.3

1.4

593.09

523.79

mg/l

2.23

1680

8408

Other or unspecified ileus, impaction or obstruction

270

1850

1.47

8.31

1.5

1.4

520.34

581.49

mg/l

1.02

259

1763

Anogenital herpesviral [herpes simplex] infection, including avohilmo

212

1386

1.55

8.28

1.4

1.3

404.73

454.09

mg/l

1.73

206

1317

Other diseases of liver

299

2093

1.44

8.28

1.4

570.37

542.76

mg/l

0.22

288

2002

Deviated nasal septum

511

3892

1.32

8.22

1.3

610.74

565.35

mg/l

0.34

487

3735

Other specified/unspecified inflammatory spondylopathies

425

2.02

8.19

1.3

501.51

517.94

mg/l

0.12

411

Unspecified urinary incontinence

146

876

1.69

8.16

1.3

662.23

539.38

mg/l

0.45

139

839

Other inflammation of eyelid

235

1580

1.50

8.04

1.6

1.4

483.39

536.82

mg/l

1.22

227

1508

Solid cancers

1390

6891

1.19

8.03

1.4

1.3

653.21

528.48

mg/l

1.97

1338

6600

Ischemic heart diseases

1347

6767

1.19

8.00

1.3

1.4

556.21

563.46

mg/l

0.09

1294

6491

Disorder of the sleep-wake schedule

172

2.66

7.98

1.5

2.1

411.43

471.92

mg/l

0.61

166

Urolithiasis

478

3628

1.33

7.98

1.4

1.3

717.47

558.80

mg/l

0.72

460

3472

Type 1 diabetes

415

3082

1.36

7.97

1.4

1.5

577.02

508.16

mg/l

1.46

396

2958

Other abnormal immunological findings in serum

196

2.54

7.96

1.2

1.8

683.35

482.19

mg/l

0.45

188

Malignant neoplasm of digestive organs

324

3436

0.72

7.90

1.3

585.12

555.15

mg/l

0.42

317

3266

Other keratitis

199

1297

1.55

7.90

1.4

1.3

577.55

522.25

mg/l

0.44

190

1236

Disorders of tooth development and eruption

273

1535

1.46

7.86

1.6

1.3

480.85

506.36

mg/l

0.18

258

1480

Redundant prepuce, phimosis and paraphimosis

310

2168

1.42

7.86

1.2

1.4

652.35

570.10

mg/l

0.44

292

2086

Cholecystectomy

1122

7964

1.20

7.82

1.3

577.95

539.63

mg/l

0.45

1073

7635

Disorder of lipoprotein metabolism, unspecified

181

1157

1.58

7.81

1.2

1.3

588.10

567.84

mg/l

0.19

175

1099

Hernia

1549

8816

1.17

7.80

1.3

1.4

574.21

545.82

mg/l

0.40

1491

8457

Rheumatoid arthritis

473

3180

1.33

7.74

1.3

688.05

529.39

mg/l

0.94

451

3045

Type 2 diabetes

1658

8259

1.17

7.71

1.3

595.18

531.15

mg/l

1.81

1583

7925

Calculus of kidney and ureter

446

3371

1.33

7.70

1.4

1.3

721.01

554.37

mg/l

0.70

429

3224

Orchitis and epididymitis

135

806

1.70

7.68

1.5

1.4

653.49

576.38

mg/l

0.45

129

765

Chronic viral hepatitis

103

571

1.84

7.67

1.3

540.02

493.53

mg/l

0.27

548

Cerebral oedema

11.09

7.66

2.9

1.4

590.21

488.87

mg/l

0.30

Infection of intervertebral disc (pyogenic)

108

3.09

7.64

1.3

675.63

508.17

mg/l

1.02

102

Crohn disease

227

1535

1.50

7.59

1.3

1.4

474.38

518.44

mg/l

0.92

219

1468

Chronic periodontitis, including avohilmo

1660

9141

1.16

7.54

1.3

551.91

547.03

mg/l

0.06

1601

8757

Gastroduodenal ulcer

348

2533

1.38

7.53

1.4

1.3

556.79

584.17

mg/l

0.37

326

2431

Fissure and fistula of anal and rectal regions

375

2773

1.36

7.51

1.4

1.3

564.19

552.94

mg/l

0.07

354

2658

Corneal ulcer

305

2182

1.41

7.51

1.3

605.62

523.97

mg/l

0.96

291

2088

Haemorrhage, not elsewhere classified

219

2.37

7.51

2.3

1.2

523.80

588.80

mg/l

0.46

207

Cardiodefibrillation

275

3851

0.71

7.43

1.3

569.20

593.93

mg/l

0.33

265

3675

Atopic dermatitis

1040

6906

1.20

7.42

1.3

1.4

468.38

504.81

mg/l

1.10

1002

6637

Sequelae of other external causes

105

592

1.81

7.40

1.6

1.3

636.42

547.61

mg/l

0.43

565

Dipeptidyl peptidase 4 (DPP-4) inhibitors

813

5190

1.23

7.39

1.3

643.92

556.95

mg/l

1.52

770

4972

Periodontitis

1660

9147

1.16

7.37

1.3

551.55

546.84

mg/l

0.06

1601

8763

Localized swelling, mass and lump of skin and subcutaneous tissue

488

3759

1.31

7.36

1.6

1.4

498.29

538.29

mg/l

0.90

468

3603

Necrosis of pulp, including avohilmo

1007

8307

1.20

7.31

1.3

506.26

532.80

mg/l

0.54

958

7986

Other enthesopathy of foot (+metatarsalgia)

166

1058

1.59

7.30

1.2

1.4

651.09

550.01

mg/l

0.27

159

1017

Nonsuppurative otitis media, including avohilmo

551

3726

1.29

7.25

1.5

1.4

564.10

481.32

mg/l

0.86

534

3565

Schizophrenia

261

1831

1.44

7.21

1.2

1.3

535.70

519.73

mg/l

0.17

248

1754

Medical abortion

1017

4570

1.21

7.21

1.3

464.99

483.53

mg/l

0.37

974

4377

Chronic iridocyclitis

510

1.86

7.20

1.4

484.97

521.02

mg/l

0.34

486

Polyarthrosis

297

1915

1.41

7.16

1.3

559.78

557.68

mg/l

0.01

286

1825

Gastric ulcer

242

1675

1.46

7.16

1.4

1.3

514.57

593.72

mg/l

1.38

230

1605

Rash and other nonspecific skin eruption

153

962

1.61

7.15

1.6

1.4

468.64

538.44

mg/l

1.57

146

915

Heart failure and antihypertensive medication

347

1643

1.38

7.14

1.5

1.3

545.52

595.22

mg/l

0.61

334

1560

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

364

2705

1.36

7.12

1.3

514.66

461.43

mg/l

0.69

354

2596

Artrosis, including avohilmo

1395

6526

1.17

7.10

1.3

530.87

540.99

mg/l

0.22

1329

6259

Viral pneumonia (unknown virus, not influenza)

122

727

1.71

7.08

1.5

1.4

835.47

548.61

mg/l

0.67

115

695

Diseases of peritoneum

159

1012

1.59

7.07

1.4

1.3

494.70

557.57

mg/l

1.25

149

964

Carrier of infectious disease

220

2.34

7.05

1.3

1.4

496.31

427.46

mg/l

0.73

211

Fracture of shoulder and upper arm

548

4306

1.28

7.01

1.5

1.4

524.19

532.94

mg/l

0.11

519

4114

Other and unspecified local infections of skin and subcutaneous tissue

166

1070

1.57

6.99

2.1

1.4

489.92

557.32

mg/l

0.74

159

1014

Speech therapy

386

2902

1.34

6.98

1.4

569.99

538.48

mg/l

0.25

376

2774

Other local infections of skin and subcutaneous tissue

175

1143

1.55

6.95

2.0

1.4

488.40

552.51

mg/l

0.74

168

1082

Other diseases of oesophagus

142

883

1.63

6.95

1.4

1.3

511.47

586.37

mg/l

0.85

133

835

Superficial injury of shoulder and upper arm

203

1368

1.50

6.94

1.3

1.4

586.17

532.13

mg/l

0.24

193

1304

Excessive attrition of teeth

1046

8716

1.19

6.93

1.3

1.4

491.70

522.56

mg/l

0.66

1001

8367

Vitreous haemorrhage

163

1049

1.57

6.92

1.3

543.23

558.94

mg/l

0.21

153

993

Other diseases of pleura

637

4432

1.26

6.89

1.5

1.4

601.12

564.85

mg/l

0.32

602

4237

Other disorders of penis

149

939

1.60

6.87

1.3

1.8

506.60

557.75

mg/l

0.78

140

896

Collagenous colitis

156

998

1.59

6.81

1.3

1.4

503.01

540.79

mg/l

0.38

147

948

Injury of muscle and tendon at shoulder and upper arm level

537

4235

1.28

6.78

1.2

1.3

554.63

575.16

mg/l

0.33

518

4064

Other peripheral vertigo

145

915

1.61

6.72

1.3

1.2

438.51

571.86

mg/l

4.50

138

868

Gout, FINNGEN

390

2933

1.33

6.70

1.5

1.3

655.05

575.43

mg/l

1.69

374

2797

Other and unspecified mononeuropathies of upper limb

264

2.17

6.69

1.6

1.3

562.32

503.69

mg/l

0.32

249

Methotrexate

211

1444

1.48

6.68

1.3

676.19

522.21

mg/l

0.60

199

1377

Polymyalgia rheumatica

183

1217

1.52

6.68

1.3

927.39

593.40

mg/l

0.71

169

1156

Other skin changes

286

2071

1.39

6.61

1.4

514.45

557.08

mg/l

0.87

268

1973

Abnormal serum enzyme levels

434

3224

1.31

6.60

1.3

536.10

593.97

mg/l

1.35

411

3078

Other coagulation defects

128

788

1.65

6.58

1.4

473.28

513.84

mg/l

0.57

122

758

Astigmatism

118

711

1.69

6.57

2.3

1.9

400.40

524.03

mg/l

3.05

109

683

Acute laryngitis and tracheitis

205

1378

1.48

6.56

1.9

1.4

455.75

480.87

mg/l

0.31

196

1326

Other (not insulin) diabetes medications

1611

8227

1.15

6.54

1.3

598.73

528.95

mg/l

2.13

1535

7902

Noninflammatory disorders of female genital tract

642

2574

1.26

6.54

1.4

1.3

434.42

497.33

mg/l

1.79

610

2479

Toxic effects of substances chiefly nonmedicinal as to source

197

1340

1.49

6.48

1.3

1.5

465.21

528.41

mg/l

0.96

187

1279

403

1.90

6.45

1.3

1.2

424.70

593.74

mg/l

3.67

386

Otitis externa

371

2810

1.33

6.42

1.2

1.4

615.87

520.15

mg/l

0.60

349

2693

Presence of other devices

343

2526

1.35

6.40

1.4

1.3

579.64

555.04

mg/l

0.28

325

2413

Haemophagocytic lymphohistiocytosis

12.35

6.40

2.1

1.5

410.73

529.36

mg/l

0.27

Hereditary hypogammaglobulinemia

6.90

6.38

1.7

1.3

400.60

534.00

mg/l

0.81

Complications of internal orthopaedic prosthetic devices, implants and grafts

306

2254

1.37

6.37

1.4

1.3

659.27

551.65

mg/l

1.12

292

2133

Cholelithiasis, broad definition with cholecystitis

1393

8011

1.16

6.37

1.3

562.09

543.34

mg/l

0.23

1327

7681

Acute myeloid leukaemia

103

2.93

6.37

2.7

1.2

498.72

522.99

mg/l

0.10

Acute myeloid leukaemia, helper endpoint

103

2.93

6.37

2.7

1.2

498.72

522.99

mg/l

0.10

Acute myeloid leukaemia, including Hilmo

103

2.93

6.37

2.7

1.2

498.72

522.99

mg/l

0.10

Other peripheral vascular diseases

133

834

1.62

6.35

1.2

1.3

436.05

549.55

mg/l

2.64

128

793

Nonsuppurative otitis media

395

2617

1.32

6.31

1.7

1.4

591.35

481.34

mg/l

0.83

382

2499

Chronic laryngitis and laryngotracheitis

213

1479

1.45

6.29

1.3

473.73

539.24

mg/l

1.96

204

1413

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1555

8040

1.15

6.21

1.3

1.4

605.50

538.65

mg/l

1.78

1488

7716

Use of disulfiram, acamprosate or naltrexone

149

969

1.56

6.11

1.3

642.99

549.27

mg/l

0.49

142

923

Other and unspecified injuries of lower leg

137

874

1.59

6.11

1.2

1.4

706.57

524.24

mg/l

0.54

131

835

Other cataract

647

3908

1.24

6.05

1.3

570.04

570.54

mg/l

0.00

627

3737

Raynaud syndrome

154

1013

1.54

6.00

1.2

1.3

433.35

518.96

mg/l

2.15

147

970

Caries of enamel

1664

9567

1.14

5.99

1.5

1.3

487.06

542.49

mg/l

2.73

1614

9158

Nail disorders

145

942

1.56

5.98

1.4

718.51

535.59

mg/l

0.47

137

898

Fracture of femur

344

2342

1.33

5.98

1.3

570.18

574.44

mg/l

0.03

322

2230

Moderate visual impairment, binocular

223

2.20

5.97

1.6

1.3

473.73

538.47

mg/l

0.58

213

Inflammatory bowel disease

506

4030

1.26

5.95

1.3

1.4

502.85

516.04

mg/l

0.26

489

3855

Malignant neoplasm of digestive organs, including Hilmo

388

3687

0.77

5.93

1.3

582.10

559.76

mg/l

0.29

379

3511

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

132

842

1.59

5.89

1.3

1.4

448.02

501.65

mg/l

0.94

124

814

Cholecystitis

196

1360

1.45

5.83

1.3

567.64

572.52

mg/l

0.03

183

1290

Hyperparathyroidism

241

1716

1.40

5.81

1.3

537.14

567.98

mg/l

0.28

229

1631

Recurrent aphthous stomatitis , including avohilmo

235

1687

1.41

5.81

2.6

1.4

477.27

527.97

mg/l

0.59

227

1607

Ganglion

316

2376

1.34

5.79

1.3

512.48

530.82

mg/l

0.21

310

2272

Any event in hilmo or specialist outpatient

+∞

5.77

1.4

0.0

318.29

—

mg/l

—

Extracorporeal dialysis

592

1.70

5.76

1.5

1.4

587.06

557.68

mg/l

0.30

558

Achilles tendinitis

149

982

1.53

5.75

1.2

1.3

558.81

533.04

mg/l

0.24

140

941

Pedestrian injured in transport accident

116

723

1.63

5.73

1.2

1.3

508.81

541.95

mg/l

0.26

108

689

Crushed, pushed or stepped on by crowd or human stampede

137

888

1.56

5.73

1.3

1.7

465.88

500.06

mg/l

0.46

130

843

Other diseases of arteries and capillaries

139

905

1.55

5.69

1.2

1.3

555.38

575.29

mg/l

0.17

130

858

Molar incisor enamel hypoplasia, with caries

104

2.83

5.67

11.5

2.6

555.29

372.13

mg/l

0.25

104

Retinal detachments and breaks

500

4001

1.26

5.66

1.3

530.83

571.83

mg/l

1.07

480

3822

Effects of foreign body entering through natural orifice

387

3004

1.30

5.65

1.4

555.80

525.89

mg/l

0.35

370

2878

Scleritis

128

2.60

5.65

1.1

1.3

371.72

456.33

mg/l

1.43

122

Biguanides

1557

8254

1.14

5.64

1.3

600.28

531.99

mg/l

2.01

1480

7927

Sulfasalazine

423

3322

1.28

5.62

1.3

674.54

520.14

mg/l

0.88

405

3187

Dermatophytosis

211

1496

1.42

5.62

1.4

500.22

555.49

mg/l

0.81

202

1422

Other predominantly sexually transmitted diseases, not elsewhere classified

292

2183

1.35

5.61

1.3

532.52

470.49

mg/l

0.65

284

2092

Cholelithiasis

1328

7887

1.15

5.60

1.3

575.73

543.10

mg/l

0.44

1266

7565

Recurrent dislocation and subluxation of joint

113

705

1.62

5.56

1.3

1.5

431.40

502.97

mg/l

1.69

107

681

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1560

8671

1.14

5.56

1.3

580.73

542.59

mg/l

0.60

1505

8307

Other diseases of intestine

226

1624

1.40

5.56

1.4

1.3

642.43

563.09

mg/l

0.29

218

1550

Glaucoma

796

5672

1.20

5.50

1.4

1.3

554.43

566.70

mg/l

0.23

759

5418

Injury of muscle and tendon at wrist and hand level

212

1511

1.42

5.49

1.3

531.71

539.95

mg/l

0.09

200

1447

Fracture of neck

585

1.68

5.48

1.3

574.98

605.48

mg/l

0.22

554

Diabetic maculopathy, excluding more controls

165

1123

1.49

5.48

1.3

603.05

528.43

mg/l

0.87

154

1076

Dermatophytosis, including avohilmo

1076

9084

1.16

5.47

1.3

501.90

545.92

mg/l

1.45

1025

8721

Atopic dermatitis, strict definition with reimbursement

509

3936

1.25

5.46

1.4

465.42

467.72

mg/l

0.03

488

3778

Eating disorders

186

1295

1.45

5.45

1.2

1.5

395.93

450.39

mg/l

1.35

175

1242

Disorders of breast

781

5770

1.20

5.41

1.3

450.79

506.76

mg/l

2.57

748

5535

Disorders of multiple cranial nerves

16.82

5.38

1.3

1.2

478.75

550.83

mg/l

—

Abnormal results of function studies

143

950

1.52

5.37

1.3

1.4

435.66

540.25

mg/l

4.28

133

910

Adenomyosis (Endometriosis of uterus)

205

1458

1.42

5.33

1.4

1.3

438.73

536.67

mg/l

2.66

193

1409

Special screening examination for neoplasms

476

1.74

5.31

1.2

1.3

514.99

578.49

mg/l

0.74

456

Otitis media, unspecified

198

1290

1.43

5.30

1.9

1.5

632.59

464.32

mg/l

0.61

188

1229

Pruritus

178

1238

1.45

5.29

1.4

1.3

634.05

516.34

mg/l

1.09

170

1181

Event of undetermined intent

115

732

1.59

5.26

1.5

1.4

514.95

525.23

mg/l

0.05

109

691

Other diseases of stomach and duodenum

101

623

1.64

5.24

1.5

1.3

465.42

601.19

mg/l

2.32

590

Other diseases of lip and oral mucosa

666

5540

1.21

5.23

1.4

494.53

528.14

mg/l

0.93

630

5315

Stomatitis and related lesions

320

2450

1.32

5.23

2.3

1.3

481.82

521.73

mg/l

0.59

308

2342

Iron deficiency

341

1.89

5.21

1.4

1.8

375.23

443.88

mg/l

1.19

324

Excessive earwax

988

7694

1.17

5.18

1.4

529.38

554.28

mg/l

0.45

947

7373

Neurological devices associated with adverse incidents

23.01

5.11

1.7

1.4

695.29

481.40

mg/l

—

Later onset COPD

196

2189

0.71

5.09

1.2

1.3

539.18

593.81

mg/l

0.83

185

2084

Intracranial nontraumatic haemorrhage of fetus and newborn

6.33

5.06

4.4

8.1

638.85

455.88

mg/l

0.30

Pregnancy examination and test

267

1229

1.36

5.04

1.4

1.2

432.45

415.78

mg/l

0.27

261

1175

Mixed conductive and sensorineural hearing loss

171

1195

1.44

4.98

1.3

476.43

554.50

mg/l

1.92

162

1139

Other disorders of skin and subcutaneous tissue, not elsewhere classified

206

1488

1.40

4.97

1.3

521.88

551.89

mg/l

0.33

197

1421

Eosinophilic disease (BM)

118

2.53

4.95

1.2

1.4

473.97

483.04

mg/l

0.05

113

Other sexually transmitted chlamydial diseases

117

759

1.56

4.94

1.4

393.66

443.64

mg/l

1.14

112

720

Coxarthrosis

717

3874

1.20

4.94

1.3

655.75

554.13

mg/l

1.39

678

3714

Bacterial, viral and other infectious agents, including avohilmo

150

1027

1.48

4.90

1.3

1.5

521.62

531.13

mg/l

0.07

139

984

Erosion of teeth , including avohilmo

448

3607

1.25

4.90

1.5

1.4

433.42

495.00

mg/l

4.44

433

3459

Hydrocele

145

985

1.48

4.89

1.2

1.5

520.14

584.95

mg/l

1.58

138

938

Eating disorder

157

1083

1.46

4.88

1.2

1.5

357.50

426.10

mg/l

2.11

149

1040

Chronic kidney disease

413

3167

1.26

4.87

1.3

1.4

562.91

561.69

mg/l

0.02

401

3016

Phlebitis and thrombophlebitis (not including DVT)

328

2547

1.30

4.85

1.3

508.63

529.89

mg/l

0.35

314

2444

Burkitt lymphoma

13.04

4.85

3.9

1.3

306.13

560.00

mg/l

—

Burkitt lymphoma, including Hilmo

13.04

4.85

3.9

1.3

306.13

560.00

mg/l

—

Open wound of ankle and foot

167

1170

1.44

4.83

1.3

1.5

544.01

539.95

mg/l

0.04

160

1119

Type 1 diabetes, wide definition, subgroup 1

329

2555

1.30

4.83

1.3

1.4

572.84

495.94

mg/l

1.90

314

2455

Wegener granulomatosis

132

2.43

4.82

1.4

1.3

746.42

488.34

mg/l

0.58

126

Cushing syndrome

114

2.56

4.81

1.3

443.82

497.78

mg/l

0.49

107

Moyamoya

9.79

4.81

1.6

1.4

470.56

497.18

mg/l

—

Bulimia nervosa (incl. atypical)

351

1.83

4.78

1.2

1.4

389.48

440.32

mg/l

0.58

336

Other noninflammatory disorders of vagina

122

805

1.53

4.77

1.6

1.3

595.50

541.50

mg/l

0.22

115

782

Specific developmental disorder of motor function

179

2.19

4.77

2.2

4.6

272.46

353.11

mg/l

1.40

174

Papulosquamous disorders

595

4945

1.21

4.77

1.2

1.3

504.36

544.70

mg/l

1.38

565

4737

Burns and corrosions

220

1619

1.37

4.76

1.2

1.5

706.55

529.46

mg/l

0.32

210

1554

Other disorders of the genitourinary system

178

1266

1.42

4.74

1.3

595.61

562.73

mg/l

0.22

166

1204

Kidney transplant status

571

1.64

4.73

1.4

1.7

607.02

538.42

mg/l

0.40

543

Other inflammation of eyelid, including avohilmo

732

6201

1.19

4.72

1.4

474.17

503.09

mg/l

0.85

708

5942

Diabetic retinopathy, strict definition

228

1496

1.36

4.72

1.3

565.71

596.21

mg/l

0.30

215

1429

Colonic or urogenital fistula

399

3186

1.26

4.71

1.4

1.3

584.46

525.33

mg/l

0.52

378

3049

Diabetes, insulin treatment (Kela reimbursement)

1629

8642

1.12

4.70

1.3

1.4

602.74

539.99

mg/l

1.74

1558

8286

Primary hyperparathyroidism

158

1102

1.45

4.69

1.2

1.3

467.75

551.71

mg/l

2.85

150

1052

Myopia

212

1556

1.37

4.68

1.3

1.5

438.54

499.25

mg/l

1.76

200

1494

Allergic urticaria

136

923

1.49

4.67

1.8

1.6

487.80

509.32

mg/l

0.17

123

877

Other ill-defined and unspecified causes of mortality

117

769

1.54

4.66

1.4

1.3

535.32

601.80

mg/l

0.79

111

723

Injury of eye and orbit

218

1608

1.37

4.65

1.3

1.4

530.16

527.63

mg/l

0.02

212

1549

Glomerular disorders in diseases classified elsewhere

169

1196

1.43

4.64

1.3

581.82

570.69

mg/l

0.06

162

1137

Superficial injury of ankle and foot

212

1559

1.37

4.63

1.7

1.5

490.77

486.08

mg/l

0.04

204

1497

Family history of certain disabilities and chronic diseases leading to disablement

536

1.65

4.60

1.3

547.07

475.26

mg/l

0.35

510

Congenital malformations of the circulatory system

235

1707

1.35

4.58

1.7

1.8

453.38

510.17

mg/l

1.76

224

1642

Percutaneous Coronary Intervention

1214

6478

1.14

4.57

1.3

1.4

562.60

566.93

mg/l

0.05

1164

6215

Presence of other functional implants

858

5034

1.17

4.57

1.3

577.57

572.53

mg/l

0.05

812

4828

Wide developmental disorders, excluding more controls

277

1.90

4.53

1.5

2.6

370.96

435.82

mg/l

0.77

266

Female genital prolapse

423

1881

1.26

4.52

1.2

1.3

458.55

541.72

mg/l

2.18

403

1815

Late syphilis, including avohilmo

143

2.30

4.48

1.6

1.2

633.00

487.55

mg/l

1.14

135

Coronary revascularization (ANGIO or CABG)

1214

6481

1.14

4.47

1.3

1.4

563.26

566.90

mg/l

0.04

1164

6218

Cardiac murmurs and other cardiac sounds

146

1002

1.45

4.45

1.7

435.32

529.25

mg/l

2.03

140

958

Drug-induced hypoglycaemia without coma

131

2.35

4.42

1.3

1.5

441.70

473.51

mg/l

0.23

126

Type 2 diabetes, definitions combined

1524

7905

1.12

4.42

1.3

597.19

530.87

mg/l

1.83

1459

7588

Rheumatoid arthritis, including avohilmo

538

4465

1.21

4.41

1.3

660.05

534.71

mg/l

0.81

514

4258

Acute peritonitis

597

1.60

4.40

1.5

1.3

492.26

572.22

mg/l

1.40

569

Other disorders of breast

214

1590

1.36

4.40

1.3

420.23

490.45

mg/l

2.65

205

1525

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

191

1386

1.38

4.39

1.5

1.9

399.91

468.73

mg/l

1.87

186

1333

Diabetic nephropathy, excluding more controls

190

1124

1.39

4.37

1.5

1.3

694.57

550.16

mg/l

0.70

182

1071

Haemorrhoids and perianal venous thrombosis

484

3951

1.22

4.36

1.3

514.44

558.40

mg/l

0.79

463

3779

Pregnancy with abortive outcome

1017

4604

1.15

4.34

1.3

502.62

482.61

mg/l

0.26

970

4411

Ovarian dysfunction

136

938

1.47

4.33

1.3

400.52

440.03

mg/l

0.74

130

897

Traumatic cerebral oedema

12.24

4.33

1.6

1.3

480.71

390.00

mg/l

—

Postmenopausal osteoporosis with pathological fracture

537

1.62

4.32

1.4

1.2

788.16

547.59

mg/l

0.41

514

Mental and behavioural disorders due to tobacco

140

972

1.46

4.31

1.3

535.55

551.17

mg/l

0.10

132

928

Type 2 diabetes, strict (exclude DM1)

1531

7957

1.12

4.31

1.3

596.65

531.05

mg/l

1.81

1466

7638

Other embolism and thrombosis

180

1306

1.39

4.30

1.4

1.3

544.70

539.70

mg/l

0.03

174

1246

Other and unspecified disorders of vitreous body

603

4956

1.19

4.29

1.3

601.78

562.87

mg/l

0.26

583

4735

Hypoplasia of dental enamel

121

2.42

4.25

11.2

4.2

251.68

345.84

mg/l

1.48

121

Convalescence

493

1.65

4.25

1.4

1.3

792.23

500.44

mg/l

0.41

474

Open wound of lower leg

220

1650

1.34

4.25

1.3

1.4

519.80

527.06

mg/l

0.07

210

1569

Smoking dependency

140

975

1.45

4.25

1.3

535.55

554.61

mg/l

0.13

132

931

Other congenital malformations of brain

3.17

4.24

1.4

4.4

380.12

445.82

mg/l

0.29

Major coronary heart disease event

1291

6839

1.13

4.23

1.3

1.4

557.57

565.24

mg/l

0.10

1238

6560

Bacterial, viral and other infectious agents

137

951

1.46

4.23

1.3

1.5

539.25

533.78

mg/l

0.03

126

909

Heart failure and coronary heart disease

391

3385

0.80

4.21

1.3

640.33

586.10

mg/l

0.35

375

3223

Preterm labour and delivery

387

3123

1.25

4.21

1.3

465.31

508.48

mg/l

0.76

374

3001

Glaucoma suspect

496

4108

1.21

4.16

1.3

526.17

547.15

mg/l

0.45

473

3920

Bitten or struck by other mammals

189

1392

1.37

4.14

1.2

1.4

465.77

499.49

mg/l

0.28

182

1336

Dementia due to Parkinson's disease

195

2.04

4.13

1.3

574.29

600.12

mg/l

0.10

181

Arthropod-borne viral fevers and viral haemorrhagic fevers

140

981

1.44

4.12

1.4

1.3

533.74

577.61

mg/l

0.50

135

934

Type 1 diabetes, wide definition

337

2685

1.26

4.08

1.3

1.5

570.85

495.51

mg/l

1.89

322

2577

Sub-endpoint used in defining T1D endpoints

416

3339

1.23

4.07

1.4

1.5

587.05

519.27

mg/l

1.50

397

3199

Benign neoplasm of other and ill-defined parts of digestive system

244

1874

1.31

4.01

1.3

487.50

547.19

mg/l

1.18

235

1785

Atopic dermatitis, strict definition

494

4018

1.21

3.99

1.4

1.5

460.18

468.46

mg/l

0.10

475

3862

Biological medication for rheuma

286

2246

1.28

3.97

1.3

1.5

657.99

498.72

mg/l

0.62

271

2153

Burkitt lymphoma, helper endpoint

8.61

3.97

3.9

2.9

306.13

495.50

mg/l

—

Nonalcoholic fatty liver disease

159

1148

1.40

3.96

1.5

1.3

627.39

532.91

mg/l

0.53

152

1098

Type 2 diabetes, definitions combined, including avohilmo

1529

7937

1.12

3.96

1.3

608.89

533.44

mg/l

1.87

1462

7620

Spontaneous rupture of synovium and tendon

114

775

1.49

3.93

1.3

766.59

566.80

mg/l

0.38

107

738

Periapical abscess

729

6278

1.17

3.93

1.4

540.49

549.08

mg/l

0.09

701

6032

Other abnormal uterine and vaginal bleeding

330

1886

1.26

3.92

1.4

1.3

489.79

532.40

mg/l

0.63

306

1818

Drug-induced osteoporosis with pathological fracture

152

2.17

3.91

2.1

1.3

1438.22

511.12

mg/l

0.60

145

Otitis externa, unspecified

186

1381

1.36

3.90

1.2

1.5

667.37

527.04

mg/l

0.46

177

1319

Exposure to other and unspecified inanimate mechanical forces

129

901

1.45

3.89

1.4

1.5

474.79

524.13

mg/l

0.77

121

858

Degenerative macular diseases

151

1084

1.40

3.88

1.5

1.3

556.43

593.78

mg/l

0.47

145

1030

Endometriosis ASRM stages 1,2

279

2192

1.28

3.88

1.3

423.46

470.71

mg/l

1.40

261

2100

Other abnormalities of plasma proteins

133

2.24

3.86

1.4

1.2

624.72

486.03

mg/l

0.36

124

Ischaemic heart disease, wide definition

1136

6187

1.13

3.84

1.3

567.39

571.00

mg/l

0.04

1084

5934

Coxarthrosis [arthrosis of hip](FG)

769

4567

1.16

3.82

1.3

651.20

566.80

mg/l

1.13

725

4369

5-aminosalicylic acid

311

2480

1.26

3.81

1.3

513.36

510.74

mg/l

0.03

300

2377

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

127

873

1.45

3.80

1.9

2.1

425.36

449.83

mg/l

0.16

121

839

Fracture of forearm

855

6699

1.15

3.80

1.3

1.4

516.90

525.11

mg/l

0.11

807

6427

Allergic rhinitis

505

4179

1.20

3.79

1.3

1.5

415.87

488.55

mg/l

4.09

487

4009

Seronegative rheumatoid arthritis

157

1140

1.39

3.79

1.2

1.3

619.82

524.11

mg/l

0.87

148

1082

Torticollis

134

2.21

3.78

1.2

1.4

554.07

474.82

mg/l

0.28

129

Ill-defined and unknown causes of mortality

121

839

1.45

3.78

1.3

528.35

595.18

mg/l

0.84

115

791

Injury of other and unspecified intrathoracic organs

637

1.53

3.76

1.3

1.4

566.63

598.36

mg/l

0.18

605

Salpingitis and oophoritis

249

1937

1.29

3.75

1.5

1.3

478.82

519.17

mg/l

0.68

236

1867

Perineal laceration during delivery

179

1932

0.74

3.75

1.2

1.3

454.99

408.61

mg/l

0.67

169

1848

Malignant neoplasm of other connective and soft tissue

224

1.91

3.73

1.1

1.3

650.05

523.59

mg/l

0.86

214

Cachexia

5.19

3.73

1.3

385.70

649.75

mg/l

—

Benign neoplasm: Adrenal gland

119

826

1.46

3.73

1.3

537.89

573.96

mg/l

0.38

111

785

Other contact dermatitis

120

835

1.45

3.70

1.3

1.4

434.47

530.07

mg/l

2.80

115

804

Toxic effect of organic solvents

4.67

3.70

1.4

1.2

453.45

614.40

mg/l

0.51

Glucosamine medication

594

4029

1.18

3.69

1.3

611.56

570.92

mg/l

0.42

571

3832

Status post-ami

204

2029

0.76

3.69

1.3

632.88

581.47

mg/l

0.23

195

1927

Acute pancreatitis

269

2119

1.28

3.67

1.8

1.3

555.27

554.12

mg/l

0.01

258

2027

Thyrotoxicosis, other and/or unspecified

295

2352

1.26

3.64

1.4

1.3

625.38

515.97

mg/l

0.68

281

2251

COPD (mode)

367

2328

1.23

3.63

1.3

559.30

564.90

mg/l

0.06

346

2236

Viral warts, including avohilmo

339

2747

1.24

3.62

1.3

1.5

527.99

501.79

mg/l

0.18

325

2628

Ulcer of lower limb, not elsewhere classified

188

1417

1.34

3.58

1.5

1.3

799.97

577.32

mg/l

0.82

178

1347

Coronary artery bypass grafting

200

1941

0.76

3.58

1.2

1.3

602.76

587.22

mg/l

0.21

191

1845

Thiazolidinediones

148

1076

1.39

3.57

1.3

1.2

603.32

559.57

mg/l

0.48

142

1022

Human immunodeficiency virus [HIV] disease, including avohilmo

172

2.02

3.54

1.1

1.3

548.53

515.60

mg/l

0.17

165

L04AC Interleukin inhibitors

110

761

1.46

3.54

1.3

1.4

805.06

522.79

mg/l

0.38

103

724

Hypertrophic disorders of skin

614

1.52

3.53

1.5

1.4

425.07

486.44

mg/l

1.02

587

Presbyopia

118

827

1.44

3.53

1.2

500.90

543.70

mg/l

0.56

110

791

Other specified and unspecified retinal disorders

317

1.73

3.52

2.3

1.3

448.25

558.44

mg/l

1.75

299

Other abnormal findings of blood chemistry

495

1.58

3.51

1.5

1.3

761.23

551.39

mg/l

0.28

467

Retinal detachment with retinal break

172

1284

1.35

3.51

1.2

1.3

532.36

566.67

mg/l

0.41

166

1219

Other bursopathies

169

1258

1.35

3.51

1.3

562.73

551.44

mg/l

0.10

162

1198

Other sexually transmitted chlamydial diseases, including avohilmo

169

1259

1.35

3.51

1.3

385.23

435.27

mg/l

1.73

160

1200

Other disorders of conjunctiva

193

1466

1.33

3.50

1.2

1.4

653.36

560.23

mg/l

0.30

186

1391

Emergency coronary revascularization (for ACS)

1279

6922

1.12

3.50

1.3

1.4

562.13

569.52

mg/l

0.09

1226

6640

Eosinophilia

139

2.14

3.49

1.2

1.7

473.97

447.72

mg/l

0.19

130

Diabetic maculopathy

163

1140

1.36

3.48

1.3

600.85

586.82

mg/l

0.10

153

1088

Benign neoplasm: Stomach

131

938

1.41

3.48

1.4

1.3

436.13

578.07

mg/l

6.63

126

885

Injuries to unspecified part of trunk, limb or body region

153

1124

1.37

3.48

1.2

1.5

712.86

554.32

mg/l

0.42

148

1071

Melanocytic naevi of trunk

188

1425

1.33

3.47

1.3

1.4

558.45

531.56

mg/l

0.26

176

1357

Atrial fibrillation and flutter with reimbursement

310

1564

1.25

3.46

1.2

608.43

536.83

mg/l

0.99

289

1485

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

258

2038

1.27

3.46

1.7

1.5

514.02

531.30

mg/l

0.25

251

1949

Other and unspecified epidermal thickening

252

1.82

3.46

1.6

1.5

471.40

488.02

mg/l

0.13

239

Abscess of anal and rectal regions

128

914

1.41

3.45

1.3

1.4

609.16

560.54

mg/l

0.35

120

869

Human immunodeficiency virus [HIV] disease

167

2.02

3.44

1.1

1.3

551.64

520.14

mg/l

0.16

160

Crohn's disease NAS

103

709

1.47

3.41

1.3

1.5

512.36

518.18

mg/l

0.04

675

Lesion of femoral nerve

2.72

3.37

1.1

1.2

472.24

492.02

mg/l

0.13

Hordeolum and other deep inflammation of eyelid

654

1.49

3.36

2.1

1.4

460.09

517.72

mg/l

0.94

632

Helminthiases, including avohilmo

446

1.59

3.34

1.5

1.9

503.03

470.64

mg/l

0.28

426

Adalimumab

158

1176

1.36

3.33

1.4

1.5

512.39

504.39

mg/l

0.06

150

1123

Melanocytic naevi

475

4014

1.19

3.32

1.4

1.3

525.59

500.58

mg/l

0.46

449

3852

Prolonged pregnancy

155

1767

0.74

3.30

1.2

1.3

350.87

426.70

mg/l

5.00

146

1698

Infectious mononucleosis

139

1016

1.38

3.29

1.4

423.82

451.98

mg/l

0.31

131

972

Infectious mononucleosis, including avohilmo

139

1016

1.38

3.29

1.4

423.82

451.98

mg/l

0.31

131

972

Coeliac disease

182

1388

1.32

3.25

1.4

1.5

540.77

529.19

mg/l

0.08

175

1320

Hallux valgus (acquired)

454

2727

1.19

3.24

1.3

641.86

526.25

mg/l

0.79

437

2607

Retinal haemorrhage

214

1.86

3.22

2.2

1.3

686.71

536.55

mg/l

0.25

200

Benign neoplasm: Ascending colon

186

1427

1.31

3.18

1.3

710.08

568.21

mg/l

0.47

177

1352

Diabetic retinopathy

447

2328

1.20

3.18

1.4

1.3

582.26

595.13

mg/l

0.18

423

2226

Anorexia (incl.atypical)

629

1.48

3.16

1.2

1.4

435.95

490.01

mg/l

0.62

605

ILD, hospital admission 2, with pulmonary infections

116

829

1.41

3.14

1.3

756.50

585.93

mg/l

0.33

108

798

Intentional self-harm by other and unspecified firearm discharge

8.14

3.13

2.3

1.1

386.83

372.38

mg/l

—

Alcoholic liver disease

138

1017

1.37

3.12

1.3

558.48

594.56

mg/l

0.24

130

967

Insulin, fast-acting (human)

203

1581

1.29

3.11

1.3

547.36

511.16

mg/l

0.43

193

1519

Other (seronegative) rheumatoid arthritis, wide

249

1988

1.26

3.11

1.2

1.3

605.89

554.54

mg/l

0.55

234

1898

Personal history of malignant neoplasm

126

916

1.39

3.11

3.2

1.3

469.35

507.58

mg/l

0.41

121

878

Palmar fascial fibromatosis [Dupuytren]

173

1319

1.32

3.09

1.2

1.3

568.21

583.83

mg/l

0.11

166

1250

Von Hippel-Lindau syndrome

11.55

3.09

1.4

1.0

784.60

502.00

mg/l

—

Benign neoplasm: Rectum, anus and anal canal

260

2088

1.25

3.08

1.3

530.31

570.96

mg/l

0.70

245

1985

Rosacea

192

1488

1.30

3.07

1.3

467.10

526.28

mg/l

1.34

184

1425

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

229

1815

1.27

3.04

1.8

1.5

524.75

533.94

mg/l

0.11

223

1729

Acute pancreatitis (for exclusion)

269

2175

1.24

3.01

1.8

1.3

555.27

547.67

mg/l

0.05

258

2072

Perforation of tympanic membrane

147

1101

1.35

3.01

1.4

535.32

539.30

mg/l

0.02

138

1045

Rhabdomyosarcoma

7.76

2.99

1.2

1.0

211.67

528.00

mg/l

—

Autoimmune hyperthyroidism

555

1.49

2.99

1.5

1.3

504.24

503.80

mg/l

0.00

531

Deep endometriosis

139

1035

1.36

2.97

1.2

1.3

407.13

491.05

mg/l

2.51

134

993

Autoimmune hepatitis, wide definition

412

1.57

2.95

1.3

1.5

462.98

523.54

mg/l

0.91

389

Benign neoplasm: Sigmoid colon

245

1966

1.25

2.95

1.4

1.3

541.27

564.37

mg/l

0.31

228

1869

L02BA Anti-estrogens

134

1791

0.74

2.94

1.2

1.3

535.58

532.71

mg/l

0.02

127

1721

Any prescribed medicine buy

6.76

2.93

1.4

1.2

328.57

546.83

mg/l

—

Chronic myeloproliferative disease

115

2.14

2.93

1.3

1.2

640.08

530.27

mg/l

0.32

108

Sequelae of injuries of upper limb

145

1089

1.34

2.93

1.3

1.4

487.97

547.48

mg/l

0.94

139

1042

Other and unspecified rosacea

133

986

1.36

2.92

1.3

479.82

528.94

mg/l

0.83

126

939

Disorders of continuity of bone

148

1116

1.34

2.91

1.7

1.3

611.95

511.21

mg/l

0.29

141

1067

Malignant neoplasm of bronchus and lung, including Hilmo

168

1816

0.77

2.90

1.2

1.3

739.40

570.47

mg/l

0.52

161

1719

Other diseases of pericardium

446

1.54

2.90

1.5

1.4

505.17

570.56

mg/l

0.62

430

Burns and corrosions of external body surface, specified by site

167

1282

1.31

2.89

1.3

1.6

461.60

527.85

mg/l

1.48

157

1220

Other otitis externa (chronic)

100

709

1.43

2.88

1.2

1.4

574.87

538.42

mg/l

0.13

671

Follicular cysts of skin and subcutaneous tissue

261

2116

1.24

2.87

1.4

1.3

557.92

537.98

mg/l

0.10

251

2025

Seborrhoeic dermatitis

140

1050

1.34

2.86

1.5

1.4

594.14

549.44

mg/l

0.38

131

998

Diseases of arteries, arterioles and capillaries

924

6055

1.12

2.84

1.3

604.18

564.01

mg/l

0.44

884

5789

Hypertrophy of breast in women and men

290

2382

1.22

2.83

1.5

1.3

463.95

499.35

mg/l

0.74

276

2280

Malignant melanoma of skin, including Hilmo

186

1453

1.29

2.82

1.3

1.2

553.62

543.49

mg/l

0.10

177

1374

Benign neoplasm of other and unspecified sites

308

1.65

2.80

1.3

1.2

572.58

503.03

mg/l

0.28

294

Other histiocytosis syndromes

6.65

2.78

1.2

732.67

452.00

mg/l

—

Pediculosis, acariasis and other infestations, including avohilmo

276

2262

1.23

2.76

1.3

1.4

526.77

490.07

mg/l

0.52

259

2173

Gout, idiopatic and unspecified

307

2543

1.21

2.75

1.3

672.40

574.14

mg/l

2.02

295

2423

Benign neoplasm: Rectum

231

1859

1.25

2.74

1.3

539.66

563.46

mg/l

0.32

217

1766

Other and unspecified abdominal hernia

365

1.58

2.72

1.2

1.3

483.14

538.84

mg/l

0.45

344

IBD patients in KELA-register

347

2911

1.20

2.72

1.4

508.88

516.38

mg/l

0.10

338

2786

Flat foot [pes planus] (acquired)

131

981

1.35

2.72

1.2

1.4

464.67

528.02

mg/l

1.44

124

940

Infections of genitourinary tract in pregnancy

144

1094

1.33

2.72

1.3

408.70

466.01

mg/l

1.83

139

1044

Chronic ulcer of skin, not elsewhere classified

634

1.43

2.71

1.3

574.55

590.04

mg/l

0.07

600

Postprocedural musculoskeletal disorders, not elsewhere classified

101

727

1.40

2.70

1.5

1.3

601.72

569.51

mg/l

0.12

688

Open wound of forearm

136

1026

1.34

2.69

1.2

1.4

545.75

553.99

mg/l

0.05

129

981

Thyrotoxicosis

356

2998

1.19

2.68

1.4

1.3

614.61

520.78

mg/l

0.71

340

2877

Hallux rigidus

174

1358

1.29

2.68

1.3

628.84

535.01

mg/l

0.75

165

1295

Blepharochalasis

374

3163

1.19

2.68

1.3

539.96

551.09

mg/l

0.13

360

3011

Malignant melanoma, including Hilmo

222

1784

1.25

2.67

1.3

561.02

539.57

mg/l

0.28

212

1691

Galactorrhea

113

2.10

2.67

1.4

1.5

336.57

407.08

mg/l

1.13

106

Unspecified severe protein-energy malnutrition

5.04

2.67

3.3

1.1

297.71

513.27

mg/l

—

Asthma mixed form (mode)

423

1.53

2.65

1.3

513.50

526.05

mg/l

0.06

400

Benign neoplasm: Other/unspecified site

134

1.98

2.64

1.3

1.2

626.46

516.80

mg/l

0.23

127

Gonarthrosis,primary

1302

7163

1.10

2.63

1.3

575.64

570.47

mg/l

0.07

1249

6871

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

194

1539

1.27

2.63

1.3

561.68

570.09

mg/l

0.06

185

1468

Other abnormal products of conception

494

2796

1.16

2.62

1.3

445.48

456.63

mg/l

0.17

476

2687

Perioral dermatitis

237

1.72

2.61

1.3

1.4

424.20

471.76

mg/l

0.32

224

Bronchitis, not specified as acute or chronic

115

850

1.36

2.61

1.2

1.3

447.87

541.07

mg/l

2.17

108

811

Intestinal malabsorption

491

1.48

2.59

1.3

1.4

429.19

553.09

mg/l

2.30

467

Intestinal adhesions without obstruction

111

817

1.37

2.59

1.3

1.4

515.48

580.36

mg/l

0.87

104

774

Acne, including avohilmo

369

2526

1.19

2.58

1.4

408.81

433.04

mg/l

0.63

356

2416

Other disorders of kidney and ureter

173

1358

1.28

2.57

1.2

1.3

672.01

565.21

mg/l

0.84

165

1290

Infective dermatitis

154

1191

1.30

2.56

1.3

723.27

551.58

mg/l

0.56

147

1131

Colour vision deficiencies

3.35

2.56

1.1

1.4

375.80

509.94

mg/l

—

Retinal vascular occlusion

140

1069

1.32

2.56

1.4

1.3

549.85

577.27

mg/l

0.32

130

1011

Diaper [napkin] dermatitis

4.79

2.55

1.3

6.4

375.57

603.13

mg/l

—

Nightmares

3.69

2.55

1.3

1.2

395.89

346.23

mg/l

—

Ulcerative colitis, NAS

202

1617

1.26

2.55

1.3

1.4

470.16

520.15

mg/l

1.01

193

1551

2.21

2.54

1.4

1.2

492.74

496.52

mg/l

0.02

Retinal vascular disorders

141

1079

1.31

2.53

1.4

1.3

549.36

576.76

mg/l

0.33

131

1020

Tumor necrosis factor alpha inhibitors

248

2032

1.23

2.53

1.3

1.4

684.42

500.80

mg/l

0.62

235

1949

Bicipital tendinitis

445

1.50

2.52

1.3

501.41

577.53

mg/l

0.81

422

Ulcerative colitis

355

3009

1.18

2.51

1.2

1.4

501.53

521.97

mg/l

0.35

343

2880

Cutaneous lupus erythematosus

225

1.72

2.50

1.4

420.00

535.52

mg/l

1.51

213

Osteonecrosis due to drugs

137

1.94

2.50

3.5

1.2

776.42

505.83

mg/l

0.36

130

Calcific tendinitis

2.44

2.49

1.3

1.2

441.20

454.02

mg/l

0.07

Other or ill-defined heart diseases

545

1.44

2.48

1.8

1.3

506.42

560.59

mg/l

0.49

524

Benign neoplasm: Colon, unspecified

316

2654

1.20

2.48

1.2

1.3

628.86

576.26

mg/l

0.26

305

2526

Thyroiditis

103

756

1.38

2.48

1.6

1.3

693.84

514.50

mg/l

0.37

724

Myocardial infarction, strict

477

3888

0.87

2.47

1.3

582.78

586.16

mg/l

0.03

454

3710

Embolic stroke

326

1.58

2.46

1.3

485.17

652.53

mg/l

2.04

308

Other and unspecified acne

145

1.90

2.46

1.7

417.63

410.93

mg/l

0.03

138

Asthma mixed form (mode), excluding more controls

431

1.50

2.45

1.3

513.50

528.95

mg/l

0.08

408

Chondromalacia

265

1.65

2.44

1.3

537.19

509.59

mg/l

0.09

251

Malignant melanoma

197

1581

1.25

2.44

1.3

569.79

542.70

mg/l

0.34

189

1498

Seropositive rheumatoid arthritis

315

2635

1.19

2.43

1.3

756.14

531.80

mg/l

0.90

302

2508

Other inherited muscular atrophy

4.47

2.43

8.6

1.3

330.29

394.06

mg/l

—

Spontaneous abortion

678

4026

1.13

2.43

1.3

509.80

482.61

mg/l

0.26

653

3862

Personal history of other diseases and conditions

179

1415

1.27

2.43

1.7

1.5

479.55

456.71

mg/l

0.16

173

1365

Gout, unspecified

245

2014

1.22

2.42

1.4

1.3

660.90

577.85

mg/l

1.37

239

1918

Inflammatory bowel disease, strict (require KELA)

347

2946

1.18

2.42

1.4

508.88

513.78

mg/l

0.06

338

2817

Helminthiases

153

1.87

2.42

1.2

1.6

630.32

468.45

mg/l

0.97

146

Chronic periodontitis, complicated

826

7241

1.11

2.41

1.3

610.91

558.09

mg/l

0.49

790

6951

Phakomatoses, not elsewhere classified

111

2.03

2.40

1.3

2.3

558.95

434.23

mg/l

0.78

106

Pilonidal cyst

128

976

1.32

2.40

1.4

595.56

508.59

mg/l

0.68

123

935

Viral conjunctivitis

213

1.72

2.39

1.3

1.5

442.33

467.55

mg/l

0.22

203

Exposure to other and unspecified man-made environmental factors

183

1.78

2.39

1.9

1.3

547.16

440.20

mg/l

0.82

175

Blood alcohol or alcohol intoxication level

229

1.69

2.36

1.2

1.5

689.61

492.90

mg/l

0.36

219

Psoriatic and enteropathic arthropathies

158

1242

1.28

2.35

1.2

1.3

500.53

528.91

mg/l

0.40

152

1178

Other/unspecified rheumatoid arthritis

150

1172

1.29

2.34

1.3

553.54

556.04

mg/l

0.02

142

1108

Unspecified nephritic syndrome

192

1.75

2.33

1.2

460.12

475.81

mg/l

0.13

180

Schizoid personality disorder

148

1.86

2.32

1.0

1.3

631.93

494.68

mg/l

0.45

140

Acne

168

1327

1.27

2.30

1.5

429.89

443.43

mg/l

0.16

161

1266

Procedures for purposes other than remedying health state

216

1.69

2.28

1.5

1.3

425.28

480.11

mg/l

0.70

207

Psoriasis

399

3445

1.16

2.27

1.2

1.3

482.60

531.39

mg/l

1.87

377

3308

ILD, hospital admissions 3, with pneumonia sepsis

725

1.36

2.26

1.4

1.3

806.82

598.76

mg/l

0.33

687

Entropion and trichiasis of eyelid

708

1.37

2.26

1.3

615.05

586.74

mg/l

0.17

665

Corns and callosities

667

1.38

2.24

1.6

1.3

786.79

577.13

mg/l

0.31

634

Other and unspecified psoriasis

710

1.36

2.24

1.3

496.10

575.49

mg/l

1.22

674

Chronic inflammatory disorders of orbit

3.52

2.23

1.6

1.4

401.63

417.54

mg/l

—

Drug-induced Cushing's syndrome

4.73

2.22

1.5

1.3

428.67

544.43

mg/l

—

Burn and corrosion of shoulder and upper limb, except wrist and hand

195

1.72

2.22

1.5

1.6

464.24

469.27

mg/l

0.02

187

Acute nasopharyngitis (common cold)

163

1286

1.26

2.22

1.6

1.3

477.64

548.94

mg/l

2.06

156

1242

Non-small cell lung cancer, squamous, helper endpoint

377

0.53

2.22

1.5

1.2

552.00

642.68

mg/l

0.53

354

Malignant melanoma of skin

152

1200

1.27

2.21

1.4

1.2

560.92

527.13

mg/l

0.43

145

1127

Chronic pancreatitis

162

1289

1.26

2.20

1.2

1.3

540.44

568.37

mg/l

0.30

156

1224

Dysplasia of cervi uteri

343

2057

1.18

2.20

1.2

1.3

520.42

509.12

mg/l

0.07

328

1983

Diabetic nephropathy

192

1538

1.24

2.19

1.5

1.3

693.25

603.23

mg/l

0.37

184

1467

3.89

2.19

1.0

1.2

353.57

329.89

mg/l

—

Other obstructive and reflux uropathy

418

1.47

2.19

1.2

1.5

492.75

491.80

mg/l

0.01

398

DVT of lower extremities

235

1947

1.21

2.19

1.3

523.39

547.59

mg/l

0.34

227

1858

Endometriosis of ovary

234

1826

1.21

2.16

1.3

464.57

525.47

mg/l

0.96

220

1763

Drug-induced obesity

2.06

2.15

1.1

1.6

491.26

430.24

mg/l

0.27

Glucagon-like peptide-1 (GLP-1) analogues

451

3948

1.15

2.14

1.4

1.3

580.04

541.66

mg/l

0.83

430

3799

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

451

3948

1.15

2.14

1.4

1.3

580.04

541.66

mg/l

0.83

430

3799

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

907

6404

1.10

2.14

1.3

502.78

510.40

mg/l

0.10

873

6145

Unspecified kidney failure

120

924

1.31

2.12

1.5

1.3

747.46

573.16

mg/l

0.37

115

873

Presbycusis

134

1034

1.28

2.11

1.3

702.40

587.20

mg/l

0.30

129

977

Female infertility

419

2179

1.16

2.11

1.3

475.24

507.48

mg/l

0.37

402

2095

Allergic contact dermatitis

189

1540

1.23

2.10

1.3

1.4

498.28

505.04

mg/l

0.07

183

1472

Nasal polyp

245

2048

1.20

2.09

1.3

568.64

540.85

mg/l

0.29

234

1964

Unspecified threat to breathing

103

1.99

2.09

1.4

1.5

346.90

477.70

mg/l

1.64

Persons encountering health services in circumstances related to reproduction

907

5531

1.10

2.08

1.5

1.4

506.13

548.29

mg/l

0.97

870

5308

Hypertrophy of breast

248

2077

1.20

2.08

1.3

432.50

485.92

mg/l

1.26

235

1993

Vitamin B12 deficiency anaemia

121

936

1.30

2.08

1.3

473.37

587.36

mg/l

3.19

113

886

Peritonsillar abscess

299

2547

1.18

2.06

1.3

535.81

505.19

mg/l

0.16

288

2452

Haemolytic anaemias

334

1.52

2.06

1.2

1.6

454.53

489.78

mg/l

0.37

316

Other puerperal infections

125

974

1.29

2.05

1.3

448.85

427.40

mg/l

0.13

118

933

Suggestive for eosinophilic asthma

124

965

1.29

2.05

1.3

593.86

557.72

mg/l

0.20

116

921

Labyrinthitis

3.21

2.05

1.6

1.2

320.13

449.54

mg/l

—

Foreign body entering into or through eye or natural orifice

115

887

1.31

2.04

1.5

1.6

578.90

539.92

mg/l

0.24

110

841

Medicines for HER+ breast cancer

374

4007

0.87

2.03

1.3

561.67

531.88

mg/l

0.31

356

3841

Malignant neoplasm of bronchus and lung

150

1566

0.80

2.02

1.2

1.3

743.15

572.02

mg/l

0.46

143

1480

Foreign body in respiratory tract

518

1.40

2.02

2.2

1.6

434.31

518.43

mg/l

1.42

492

Lichen planus

171

1386

1.24

2.01

1.4

1.3

549.88

556.68

mg/l

0.07

162

1313

FESS (DNB20)

177

1441

1.24

2.00

1.3

616.72

529.42

mg/l

0.66

169

1378

Pregnancy hypertension

619

4957

1.12

2.00

1.3

467.54

489.92

mg/l

0.38

599

4759

Assault by other and unspecified firearm discharge

4.03

1.98

2.2

1.6

421.67

527.81

mg/l

—

Other and unspecified heterotropia

2.87

1.98

1.1

2.4

324.78

478.48

mg/l

—

Need for immunization against certain single viral diseases

3.99

1.98

1.5

2.2

472.00

313.44

mg/l

—

Contraceptive management

635

3980

1.12

1.97

1.3

471.84

533.70

mg/l

1.88

610

3826

Acne vulgaris

132

1040

1.28

1.96

1.4

1.5

433.60

427.40

mg/l

0.06

126

991

Diabetes mellitus in pregnancy

495

2779

1.14

1.95

1.3

473.99

439.83

mg/l

0.54

481

2664

Fall on and from ladder

745

1.33

1.94

1.3

605.78

588.19

mg/l

0.09

705

Endometriosis ASRM stages 3,4

318

2738

1.17

1.94

1.3

456.25

494.93

mg/l

0.81

300

2630

Disorders of puberty

150

1.76

1.93

2.3

3.1

455.85

437.13

mg/l

0.06

143

Combinations of oral blood glucose lowering drugs

367

3194

1.15

1.93

1.3

753.12

570.95

mg/l

1.29

358

3062

Uterine polyps

384

1949

1.15

1.93

1.2

1.3

589.07

536.03

mg/l

0.22

370

1883

Other inflammatory liver diseases

668

1.34

1.93

1.3

460.44

554.41

mg/l

2.38

636

Human immunodeficiency virus [HIV] disease resulting in other conditions

158

1.74

1.92

1.1

1.3

600.63

515.08

mg/l

0.45

151

Viral warts

139

1108

1.26

1.91

1.4

1.5

602.11

511.64

mg/l

0.28

132

1056

Malignant neoplasm of rectosigmoid junction, including Hilmo

253

0.47

1.91

1.2

1.3

705.33

539.68

mg/l

0.42

242

Isolated growth hormone deficiency

100

1.97

1.91

2.0

5.3

345.42

335.03

mg/l

0.06

100

Asymptomatic human immunodeficiency virus [HIV] infection status

2.47

1.88

1.1

1.2

715.82

475.30

mg/l

0.61

Human immunodeficiency virus [HIV] disease resulting in other conditions, including avohilmo

159

1.73

1.88

1.1

1.3

600.63

514.29

mg/l

0.45

152

Complications predominantly related to the puerperium

382

3343

1.15

1.88

1.3

429.80

470.02

mg/l

0.94

363

3213

Pityriasis lichenoides et varioliformis acuta

4.46

1.86

1.0

1.1

833.20

602.50

mg/l

—

Benign muscular dystrophy (Becker)

4.46

1.86

3.8

5.0

523.20

463.08

mg/l

—

Other pleural conditions

115

899

1.29

1.86

1.4

1.3

523.30

618.78

mg/l

1.12

109

848

Pedal cyclist injured in transport accident

321

2778

1.16

1.85

1.3

1.4

566.83

509.31

mg/l

0.38

312

2654

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

3.21

1.84

1.7

1.4

377.57

516.87

mg/l

—

Trigger finger

182

1501

1.22

1.84

1.3

534.65

546.85

mg/l

0.14

174

1439

Mixed connective tissue disease

168

1.69

1.83

2.0

1.3

650.14

477.85

mg/l

0.78

161

Ethmoidectomy

181

1494

1.22

1.82

1.3

612.91

527.00

mg/l

0.67

173

1430

Umbilical hernia

374

3277

1.15

1.81

1.4

1.3

483.97

549.04

mg/l

2.63

367

3142

COPD, hospital admissions 1, only main diagnosis

313

3104

0.86

1.81

1.2

1.3

537.53

588.89

mg/l

0.94

296

2954

Atrophic disorders of skin

216

1814

1.20

1.81

1.5

1.3

515.77

531.11

mg/l

0.12

207

1735

Other and unspecified injuries of abdomen, lower back and pelvis

132

1.77

1.76

1.4

1.2

427.35

436.30

mg/l

0.06

125

Atherosclerosis, excluding cerebral and coronary sclerosis

382

3407

0.88

1.74

1.3

663.97

579.04

mg/l

0.60

368

3238

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

677

5331

1.10

1.74

1.3

466.26

492.99

mg/l

0.53

656

5112

Calcification and ossification of muscle

3.99

1.73

1.4

1.1

345.00

429.38

mg/l

—

Hydronephrosis

142

1150

1.24

1.73

1.3

541.16

545.48

mg/l

0.03

134

1096

Psoriatic arthropathies

126

1008

1.26

1.72

1.2

1.4

489.82

528.94

mg/l

0.53

120

962

Scabies, including avohilmo

228

1935

1.18

1.71

1.3

1.5

535.88

479.12

mg/l

0.76

212

1857

Abnormal findings in nipple discharge synovial fluid wound secretions

141

1.73

1.71

1.3

400.71

472.67

mg/l

0.66

135

Primary open-angle glaucoma, strict

299

2585

1.16

1.71

1.3

555.98

582.16

mg/l

0.38

288

2449

142

1153

1.24

1.70

1.2

1.3

416.28

425.65

mg/l

0.11

136

1109

Benign neoplasm: Caecum

134

1081

1.25

1.70

1.2

688.44

582.71

mg/l

0.22

126

1020

Disorder of visual pathways, unspecified

3.36

1.70

1.3

2.9

2317.83

320.68

mg/l

—

Impacted cerumen

146

1189

1.23

1.70

1.5

1.4

655.33

564.19

mg/l

0.29

134

1131

Female infertility, associated with anovulation

112

885

1.27

1.70

1.3

483.84

417.16

mg/l

0.27

105

861

Nontoxic multinodular goitre

235

2001

1.18

1.70

1.3

496.24

535.26

mg/l

0.74

227

1895

Toxic liver disease

134

1.75

1.68

1.7

1.4

518.26

479.25

mg/l

0.27

128

Congenital retinoschisis

2.93

1.68

1.1

2.7

411.29

417.64

mg/l

—

Anorexia

142

1.72

1.67

3.8

1.5

481.17

451.39

mg/l

0.14

135

Female infertility, cervical, vaginal, other or unspecified origin

379

2132

1.14

1.66

1.3

466.32

501.91

mg/l

0.41

364

2052

Early onset COPD

277

2394

1.16

1.66

1.3

582.07

584.03

mg/l

0.02

260

2288

Disorders of puberty, all

181

1.63

1.66

2.3

3.1

463.48

421.18

mg/l

0.17

173

Autism spe, excluding more controls

204

1.58

1.65

1.2

2.5

343.34

452.69

mg/l

1.66

194

Burns and corrosions confined to eye and internal organs

261

1.51

1.65

1.2

1.4

1769.79

493.51

mg/l

0.46

250

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system

3.75

1.64

3.2

1.4

781.00

407.86

mg/l

—

Female infertility, tubal origin

496

1.36

1.64

1.3

517.27

465.92

mg/l

0.35

485

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

1.86

1.63

1.4

1.2

603.94

515.79

mg/l

0.20

Postpartum care and examination

209

1106

1.19

1.61

1.3

1.2

455.79

409.71

mg/l

0.38

198

1056

Other and unspecified vascular occlusions

104

821

1.27

1.60

1.4

1.2

506.33

586.76

mg/l

1.44

777

Non-small cell lung cancer, squamous

338

0.59

1.59

1.5

1.2

552.00

626.18

mg/l

0.29

313

Toxic effect of carbon monoxide

152

1.67

1.58

1.4

1.3

454.36

480.71

mg/l

0.22

146

Benign neoplasm of ovary

210

1785

1.18

1.58

1.3

478.46

530.58

mg/l

0.96

198

1716

Iron deficiency anaemia secondary to blood loss (chronic)

190

1601

1.19

1.57

1.5

1.3

512.27

549.75

mg/l

0.49

183

1525

Conotruncal defects

160

0.43

1.56

1.0

3.9

430.86

436.50

mg/l

—

153

Alcohol abuse counselling and surveillance

145

1.68

1.56

1.2

435.37

511.14

mg/l

1.02

139

Benign neoplasm of bone and articular cartilage

114

914

1.26

1.56

1.3

455.76

532.71

mg/l

0.80

108

874

Enteropathic arthropathies

224

1.54

1.56

1.2

1.4

528.91

495.63

mg/l

0.20

214

Other congenital malformations, including avohilmo

190

1603

1.19

1.55

1.3

1.7

428.30

484.16

mg/l

1.66

184

1538

Valvular operations

119

1469

0.81

1.55

1.2

1.5

688.89

540.05

mg/l

1.27

114

1404

Mental and behavioural disorders due to cocaine

3.52

1.55

1.4

1.5

678.60

622.80

mg/l

—

Chronic hepatitis NAS

115

1.77

1.55

1.2

706.40

467.09

mg/l

0.34

107

Hernia of abdominal wall

630

5748

1.10

1.55

1.3

500.64

558.46

mg/l

2.45

609

5517

Angina pectoris

760

4628

1.09

1.53

1.3

602.16

582.28

mg/l

0.17

720

4416

Benign neoplasm: Transverse colon

138

1132

1.23

1.53

1.3

1.2

503.87

577.01

mg/l

1.61

130

1067

Malignant neoplasm of accessory sinuses

2.98

1.53

1.0

1.2

885.00

383.19

mg/l

—

Benign mammary dysplasia

173

1452

1.20

1.52

1.3

537.73

538.37

mg/l

0.00

166

1391

Molar incisor enamel hypoplasia

474

1.34

1.49

6.0

2.5

434.03

398.58

mg/l

0.10

460

Myocardial infarction, unclassifiable

160

1706

0.84

1.48

1.3

688.23

583.27

mg/l

0.29

154

1611

Hirsutism in women

203

1.55

1.47

1.2

1.4

423.10

400.23

mg/l

0.15

194

Benign lipomatous neoplasm

384

3425

1.12

1.47

1.3

562.56

544.42

mg/l

0.24

367

3284

Malignant neoplasm of skin, including Hilmo

713

4382

1.09

1.47

1.3

572.31

546.37

mg/l

0.44

682

4187

Benign neoplasm of mouth and pharynx

136

1121

1.22

1.46

1.2

1.3

561.66

552.02

mg/l

0.06

129

1066

Malignant neoplasm of rectosigmoid junction

151

0.46

1.45

1.3

1.2

418.86

526.53

mg/l

—

144

Barrett oesophagus

490

1.34

1.45

1.2

1.3

532.77

620.50

mg/l

0.77

462

Malignant neoplasm of oesophagus

227

0.52

1.44

1.0

1.3

477.25

542.02

mg/l

0.47

211

Pneumonia derived septicemia

329

1.41

1.42

1.5

1.8

1104.68

481.82

mg/l

2.42

312

Other mycoses, not elsewhere classified/unspecified, including avohilmo

165

1.60

1.42

1.5

1.3

558.00

475.14

mg/l

0.26

157

Malignant neoplasm of heart, mediastinum and pleura

111

1.74

1.41

1.9

1.3

582.74

520.50

mg/l

0.21

105

Other disorders of veins

571

5131

1.10

1.40

1.2

1.3

555.55

525.33

mg/l

0.42

552

4915

Systemic disorders of connective tissue in diseases classified elsewhere

2.27

1.40

1.3

1.6

345.78

508.20

mg/l

—

Congenital deformities of hip, including avohilmo

222

1.50

1.39

1.6

2.6

351.85

423.42

mg/l

0.67

214

HSIL lesion of the vulva

182

1.56

1.39

1.4

1.3

728.43

483.11

mg/l

0.42

171

Hypertrichosis

239

1.48

1.39

1.2

1.4

410.00

437.45

mg/l

0.20

226

Ectropion of eyelid

280

1.44

1.38

1.3

654.82

610.82

mg/l

0.17

263

Malignant neoplasm of other endocrine glands and related structures

3.09

1.38

1.8

1.2

681.00

420.94

mg/l

—

Primary open-angle glaucoma

356

3056

1.12

1.36

1.3

538.02

574.82

mg/l

0.74

341

2898

Contact with lifting and transmission devices, not elsewhere classified

167

1.58

1.36

1.4

1.3

542.92

532.53

mg/l

0.04

158

Lichen ruber planus, wide definition including periferal and oral lichen planus

292

2577

1.14

1.36

1.3

514.78

559.55

mg/l

0.93

280

2468

Malignant neoplasm of breast, HER2-negative

473

3367

0.90

1.36

1.2

1.3

553.06

510.64

mg/l

0.72

449

3219

Traumatic ischaemia of muscle

120

1.69

1.36

1.4

1.2

409.70

500.88

mg/l

0.67

115

Benign neoplasm: Skin of ear and external auricular canal

349

1.39

1.36

1.4

1.3

620.14

533.80

mg/l

0.35

326

Endometriosis diagnosis and infertility diagnosis occurring together

156

1314

1.19

1.35

1.4

1.2

435.24

451.24

mg/l

0.19

146

1263

Foreign body on external eye

201

1729

1.17

1.35

1.3

550.97

552.21

mg/l

0.01

190

1650

Chronic nephritic syndrome

358

1.38

1.35

1.4

1.3

611.78

550.20

mg/l

0.20

334

Nephrotic syndrome

299

1.42

1.35

1.5

1.9

691.55

481.22

mg/l

0.65

284

Lichen simplex chronicus and prurigo

637

1.28

1.34

1.5

1.2

627.73

538.01

mg/l

0.39

606

Single delivery by forceps and vacuum extractor

168

1182

0.84

1.33

1.3

399.81

448.01

mg/l

0.75

161

1136

Disorder of thyroid, unspecified

113

1.71

1.33

1.4

1.3

479.79

513.33

mg/l

0.14

106

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

218

2067

0.86

1.33

1.3

707.96

557.01

mg/l

0.63

209

1963

Acute nephritic syndrome

176

1.55

1.33

1.3

1.4

431.89

488.97

mg/l

0.43

168

Labour and delivery complicated by fetal stress [distress]

302

2218

0.88

1.33

1.3

397.17

411.56

mg/l

0.34

295

2120

Mucosal proctocolitis

174

1483

1.18

1.32

1.2

1.4

486.96

524.08

mg/l

0.59

169

1418

Malignant neoplasm of testis

129

1.65

1.31

1.1

1.2

852.81

517.85

mg/l

0.67

121

Supervision of high-risk pregnancy

295

1564

1.14

1.31

1.3

425.12

449.28

mg/l

0.34

283

1501

Other diseases of gallbladder

386

1.36

1.30

1.4

1.3

458.44

564.99

mg/l

1.99

370

Pre-eclampsia or eclampsia

301

2671

1.13

1.30

1.3

475.02

478.66

mg/l

0.03

292

2560

Other benign neoplasms of skin

489

4454

1.10

1.30

1.3

522.22

536.27

mg/l

0.24

465

4248

Malignant neoplasm of breast

475

3370

0.91

1.30

1.2

1.3

551.59

510.47

mg/l

0.69

451

3222

Other endophthalmitis

2.14

1.30

1.3

1.6

434.40

472.33

mg/l

—

Pollen allergy

292

2550

1.13

1.30

1.3

1.6

401.26

459.57

mg/l

1.59

280

2452

Other infections specific to the perinatal period

2.05

1.29

2.9

6.0

229.09

453.73

mg/l

1.05

Gestational [pregnancy-induced] hypertension

369

3308

1.12

1.29

1.3

443.30

452.08

mg/l

0.13

352

3179

Benign thyroid growths and nodules

420

3528

1.11

1.29

1.3

520.72

541.00

mg/l

0.37

408

3363

Pneumococcal septicemia

319

1.39

1.28

1.5

1.8

1097.92

498.27

mg/l

2.13

301

Idiopathic gout

107

875

1.23

1.27

1.3

766.56

588.02

mg/l

1.45

100

828

Sulfonylureas

297

2656

0.89

1.27

1.3

765.24

554.14

mg/l

1.22

280

2527

Thyrotoxicosis with diffuse goitre

184

1582

1.17

1.26

1.5

1.3

488.39

501.00

mg/l

0.17

173

1510

Enterobiasis, including avohilmo

253

1.44

1.25

1.8

2.2

386.00

411.41

mg/l

0.23

242

Other nonthrombocytopenic purpura

1.89

1.25

1.3

1.5

492.38

471.05

mg/l

0.10

Hypoplasia of dental enamel , including avohilmo

450

1.31

1.24

6.4

2.5

449.02

399.07

mg/l

0.14

438

Hypoplasia of dental enamel, prenatal

2.17

1.23

6.2

5.0

1098.80

384.56

mg/l

—

Malignant neoplasm of breast, including Hilmo

487

3417

0.91

1.23

1.2

1.3

549.82

509.60

mg/l

0.69

463

3267

Malignant neoplasm of breast, HER2-negative, including Hilmo

487

3417

0.91

1.23

1.2

1.3

549.82

509.60

mg/l

0.69

463

3267

Pre-eclampsia

281

2495

1.13

1.22

1.3

481.06

467.39

mg/l

0.13

273

2396

Burn and corrosion confined to eye and adnexa

221

1.46

1.22

1.2

1.4

2053.75

480.90

mg/l

0.46

210

Oesophageal obstruction

297

1.39

1.21

1.3

574.98

625.98

mg/l

0.15

280

Short Achilles tendon (acquired)

239

1.44

1.19

1.2

1.3

435.07

517.19

mg/l

0.88

226

Lumbosacral root disorders, not elsewhere classified

1.73

1.19

1.8

1.2

452.25

489.25

mg/l

0.17

Diseases caused by chlamydiae, including avohilmo

149

1.57

1.19

1.1

1.3

440.70

474.96

mg/l

0.13

142

Vasomotor rhinitis (mode)

776

1.23

1.17

1.3

434.70

540.89

mg/l

1.23

743

Postmenopausal bleeding

329

1540

1.12

1.17

1.4

1.3

487.09

572.94

mg/l

1.61

312

1485

Pedestrian injured in other and unspecified transport accidents

110

1.66

1.17

1.2

1.3

493.00

470.14

mg/l

0.11

104

Erythrasma

2.58

1.16

1.0

1.3

596.00

474.40

mg/l

—

Contact with other sharp object(s)

804

1.23

1.16

1.3

1.4

468.96

517.38

mg/l

0.83

765

L02BG Aromatase inhibitors

307

3378

0.90

1.16

1.3

570.65

544.93

mg/l

0.22

294

3231

Oesophagitis

509

1.28

1.15

1.4

1.3

509.66

606.59

mg/l

0.82

483

Paget disease

0.00

1.15

0.0

1.2

—

551.89

—

Degeneration of macula and posterior pole

577

4107

1.09

1.15

1.3

564.00

571.42

mg/l

0.13

553

3909

Other respiratory diseases principally affecting the interstitium

198

1727

1.15

1.3

684.52

586.57

mg/l

0.31

183

1639

Congenital deformities of hip

200

1.47

1.12

1.6

2.7

361.48

431.15

mg/l

0.56

193

Lichen planus, including avohilmo

242

2143

1.13

1.12

1.3

521.47

558.42

mg/l

0.65

232

2047

Other disorders of amniotic fluid and membranes

198

1670

1.15

1.12

1.2

1.3

396.27

432.13

mg/l

1.07

193

1609

Other conjunctival vascular disorders and cysts

209

1.45

1.12

1.2

1.3

607.60

541.23

mg/l

0.21

197

Lichen sclerosus et atrophicus

143

1221

1.18

1.11

1.4

1.3

564.25

537.23

mg/l

0.15

137

1167

Gout, strict definition

200

1751

1.15

1.11

1.3

699.11

571.59

mg/l

2.10

194

1660

Gestational diabetes (for exclusion)

556

3528

1.09

1.11

1.3

465.59

436.43

mg/l

0.50

542

3385

COPD, hospital admissions

463

4249

0.92

1.10

1.3

554.30

585.78

mg/l

0.57

435

4067

Other disorders of thyroid

128

1.58

1.10

1.6

1.2

516.15

500.20

mg/l

0.06

120

Psoriasis vulgaris

243

2159

1.13

1.08

1.2

1.3

503.05

530.00

mg/l

0.46

227

2064

Contact with heat and hot substances

595

1.25

1.08

1.3

1.6

502.00

520.70

mg/l

0.14

563

Pre-eclampsia or poor fetal growth

435

3968

1.09

1.07

1.3

457.05

465.34

mg/l

0.11

421

3810

Bacterial sepsis of newborn

1.84

1.06

4.7

6.8

496.83

442.13

mg/l

0.13

Digestive system disorders of fetus and newborn

2.42

1.06

3.0

4.7

330.60

416.32

mg/l

—

Malignant neoplasm of respiratory system and intrathoracic organs

193

1823

0.88

1.06

1.3

720.22

567.15

mg/l

0.55

186

1727

Idiopathic thrombocytopenic purpura

280

1.37

1.05

1.6

1.4

573.82

466.97

mg/l

0.61

267

Sleep terrors [night terrors]

2.35

1.05

1.4

2.9

433.80

315.32

mg/l

—

Dronedarone medication

276

0.65

1.04

1.1

1.3

638.06

594.91

mg/l

0.13

264

COPD, early/later onset

470

4279

0.92

1.03

1.3

563.68

586.98

mg/l

0.36

442

4095

IBD (strict) with PSC

108

0.46

1.02

1.0

1.6

418.20

434.33

mg/l

—

101

Neurofibromatosis, type 1

1.80

1.02

1.2

1.4

515.67

445.37

mg/l

0.25

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

226

1947

1.13

1.02

1.4

1.8

456.75

508.28

mg/l

1.51

216

1864

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

242

2161

1.12

1.01

1.4

1.3

509.22

522.81

mg/l

0.15

236

2066

ILD, hospital admissions

166

1447

1.15

1.01

1.3

683.94

568.82

mg/l

0.31

154

1371

Open wound of hip and thigh

327

1.32

0.98

1.3

1.5

639.13

494.08

mg/l

0.32

311

Maternal care for known or suspected abnormality of pelvic organs

368

2266

1.10

0.98

1.3

412.19

457.29

mg/l

1.17

362

2178

Congenital malformation syndromes predominantly affecting facial appearance

0.00

0.98

0.0

4.7

—

319.81

—

Congenital malformations of posterior segment of eye

1.84

0.98

1.6

3.7

387.00

451.80

mg/l

—

Malignant neoplasm of breast, HER-positive

354

2888

0.91

0.98

1.2

1.3

538.57

524.53

mg/l

0.17

336

2759

Inflammatory disease of cervix uteri

585

1.24

0.98

1.8

1.3

598.11

508.07

mg/l

0.36

558

Infective bursitis

241

1.38

0.97

1.3

693.55

585.69

mg/l

0.32

226

All dysplastic lesions of the cervix uteri, vagina or vulva

425

3818

1.09

0.96

1.3

503.18

458.40

mg/l

0.46

410

3670

Presence of cardiac and vascular implants and grafts

462

3676

0.92

0.96

1.3

565.18

589.07

mg/l

0.44

439

3510

481

4003

1.08

0.95

1.3

609.29

564.45

mg/l

0.43

461

3800

Duodenal ulcer

111

943

1.18

0.95

1.2

1.3

665.40

622.08

mg/l

0.27

101

893

Malignant neoplasm of testis, including Hilmo

150

1.48

0.94

1.1

1.2

829.05

529.87

mg/l

0.61

141

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

2.21

0.93

1.3

1.1

561.00

488.32

mg/l

—

Nontoxic goitre/thyroid nodule

359

3290

1.09

0.93

1.3

513.61

532.54

mg/l

0.34

347

3130

Actinomycosis

2.19

0.92

1.7

1.2

618.17

468.50

mg/l

—

Ankyloglossia

201

1.41

0.91

2.6

3.3

447.00

401.54

mg/l

0.18

196

Malignant neoplasm of breast, ER-positive, including Hilmo

357

2895

0.91

1.2

1.3

537.07

524.09

mg/l

0.16

339

2766

Polyp of the female genital tract

390

2027

1.09

0.90

1.2

1.3

494.09

528.76

mg/l

0.53

377

1959

Other diseases caused by chlamydiae, including avohilmo

160

1.45

0.90

1.1

1.3

440.70

479.44

mg/l

0.15

153

Mesothelioma, including Hilmo

105

0.47

0.89

1.2

1.3

1103.00

527.99

mg/l

—

100

Interstitial lung disease

166

1463

1.14

0.89

1.3

683.94

567.40

mg/l

0.32

154

1386

Interstitial lung disease endpoints

166

1463

1.14

0.89

1.3

683.94

567.40

mg/l

0.32

154

1386

Congenital malformation of biliary tract

2.06

0.88

1.2

4.9

241.17

454.93

mg/l

—

Other interstitial pulmonary diseases

166

1465

1.14

0.87

1.3

683.94

567.42

mg/l

0.32

154

1387

Seborrhoeic keratosis

303

2765

1.10

0.87

1.3

628.25

563.36

mg/l

0.44

293

2638

Ventral hernia

290

2641

1.10

0.87

1.4

1.3

513.21

538.41

mg/l

0.42

280

2523

Aortic aneurysm

210

2293

0.90

0.86

1.4

1.3

519.16

578.08

mg/l

1.51

203

2178

Eustachian salpingitis and obstruction

110

946

1.17

0.84

1.2

1.4

475.96

482.06

mg/l

0.05

102

912

Evidence of alcohol involvement determined by blood alcohol level

129

1.49

0.84

1.2

465.95

471.37

mg/l

0.04

123

Obstructed labour due to maternal pelvic abnormality

184

1640

1.13

0.84

1.3

542.01

518.21

mg/l

0.17

175

1571

ILD, hospital admissions 1, main diag only

148

1301

1.14

0.84

1.3

706.17

574.29

mg/l

0.33

139

1234

Malignant neoplasm of skin

652

4147

1.07

0.84

1.3

595.86

550.09

mg/l

0.81

622

3957

LSIL lesion of the cervix uteri, vagina or vulva

200

1793

1.12

0.83

1.3

462.65

463.81

mg/l

0.01

192

1722

Wide developmental disorders

424

1.25

0.83

1.5

2.9

370.96

425.78

mg/l

0.59

408

Peripheral artery disease

435

3695

0.93

0.82

1.3

715.30

588.82

mg/l

0.80

418

3517

Birth asphyxia

1.76

0.81

2.8

5.7

1083.50

370.98

mg/l

—

Microtia (small ears)

0.00

0.81

0.0

2.5

—

288.67

—

Benign neoplasm: Descending colon

710

1.19

0.80

1.2

1.3

629.48

593.66

mg/l

0.16

672

Skin changes due to chronic exposure to nonionizing radiation

446

3759

1.08

0.80

1.3

622.88

566.95

mg/l

0.53

426

3564

Erectile dysfunction, exclusion

0.00

0.79

0.0

1.2

—

547.77

—

Fetus and newborn affected by complications of placenta, cord and membranes

0.00

0.79

0.0

4.2

—

352.37

—

Benign neoplasm: Skin, unspecified

417

0.76

0.78

1.3

552.63

513.46

mg/l

0.10

395

Seropositive rheumatoid arthritis, wide

314

2890

1.09

0.78

1.3

756.31

542.60

mg/l

0.83

301

2772

Exposure to uncontrolled fire, not in building or structure

2.25

0.77

1.2

2.0

509.60

445.74

mg/l

—

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

186

0.64

0.77

1.3

1.2

521.42

526.60

mg/l

0.02

175

Shigellosis

2.22

0.77

1.0

1.1

435.80

601.30

mg/l

—

Noninfective disorders of pinna

2.15

0.76

1.6

1.1

401.60

480.79

mg/l

—

Acquired atrophy of ovary and fallopian tube

2.13

0.75

1.2

1.1

557.40

501.42

mg/l

—

Polycystic ovarian syndrome, broad definition

161

1436

1.12

0.75

1.3

454.44

418.01

mg/l

0.20

153

1382

Malignant neoplasm of other and unspecified parts of biliary tract

135

0.59

0.74

1.1

1.3

581.25

520.76

mg/l

—

127

Malignant neoplasm of vulva, including Hilmo

125

1.46

0.73

1.6

1.2

1044.22

467.67

mg/l

0.70

119

Other menopausal disorders

354

1825

1.08

0.73

1.3

507.01

541.79

mg/l

0.38

340

1762

Malignant neoplasm of cervix uteri, including Hilmo

242

0.70

0.73

1.3

1.2

541.24

446.13

mg/l

0.35

229

Anomalies of dental arch relationship, including avohilmo

283

2352

1.09

0.73

2.1

1.5

454.98

471.51

mg/l

0.21

270

2253

Type 1 diabetes, wide definition, subgroup 2

107

0.56

0.73

1.0

1.9

545.83

459.65

mg/l

—

101

Cutis laxa senilis

1.60

0.73

1.2

500.58

491.01

mg/l

0.03

Other hammer toe(s) (acquired)

187

1533

1.11

0.72

1.3

623.65

532.75

mg/l

0.33

177

1454

Chronic tubulo-interstitial nephritis

326

1.26

0.72

1.3

477.66

511.90

mg/l

0.33

313

Malignant neoplasm of oesophagus, including Hilmo

310

0.74

0.72

1.0

1.2

520.09

558.23

mg/l

0.23

290

Complications of labour and delivery

901

4772

1.05

0.71

1.3

495.66

496.90

mg/l

0.02

866

4570

Haemangioma, any site

108

943

1.15

0.71

1.2

1.5

474.88

540.26

mg/l

0.85

103

903

Burn and corrosion of other internal organs

1.96

0.71

1.0

1.1

458.00

449.23

mg/l

—

Other congenital malformations of the digestive system

495

1.21

0.71

2.5

426.23

454.44

mg/l

0.22

479

Pedal cyclist injured in noncollision transport accidents

152

1357

1.12

0.71

1.3

1.5

554.65

534.03

mg/l

0.10

147

1295

Cardiac arrest

438

1.21

0.71

1.1

1.3

613.46

537.27

mg/l

0.52

407

Gonarthrosis, primary, with knee surgery

670

5494

0.95

0.70

1.3

585.51

582.39

mg/l

0.03

635

5258

Coxarthrosis, primary

759

5993

1.05

0.70

1.3

645.64

571.63

mg/l

0.99

716

5741

Vitiligo

118

1.46

0.70

1.5

427.47

456.69

mg/l

0.18

111

Use of levodopa decarbox-comt-inhibitor

283

1.28

0.70

1.6

1.3

495.03

619.80

mg/l

1.14

265

Ventricular septal defect, a heart condition

273

0.72

0.70

1.8

3.6

340.00

433.23

mg/l

1.22

266

Malignant neoplasm of cervix uteri

181

0.66

0.70

1.4

1.2

473.25

435.45

mg/l

0.12

172

Myocardial infarction

557

4122

0.94

0.69

1.3

579.49

580.46

mg/l

0.01

531

3936

Central nervous system disorder causing precocious puberty

1.89

0.69

2.0

4.4

961.40

266.93

mg/l

—

Congenital malformations of aortic and mitral valves

464

0.79

0.69

1.5

2.0

479.81

528.52

mg/l

0.69

443

Parapsoriasis

187

1.35

0.69

1.1

1.5

599.40

476.88

mg/l

0.56

177

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

235

2089

1.09

0.68

1.4

1.7

465.72

516.14

mg/l

1.45

224

1997

Idiopathic urticaria

231

1.31

0.68

1.3

1.5

435.30

459.79

mg/l

0.18

219

Coxarthrosis, primary, with hip surgery

502

4938

0.94

0.68

1.3

657.93

556.45

mg/l

1.26

477

4713

Benign neoplasm: Skin of other and unspecified parts of face

117

1032

1.14

0.68

1.2

1.3

502.29

570.11

mg/l

0.89

112

980

Malignant neoplasm of thymus, including Hilmo

1.66

0.67

1.0

1.2

387.29

455.09

mg/l

—

Artificial joint operation, meniscal resection

1302

8017

1.04

0.67

1.3

573.21

562.49

mg/l

0.15

1239

7692

Antenatal screening

270

1641

0.92

0.67

1.3

436.53

447.09

mg/l

0.14

257

1577

COPD-related respiratory insufficiency

120

1061

1.13

0.67

1.2

1.3

628.26

607.19

mg/l

0.11

110

1004

Ectopic pregnancy

225

2060

1.09

0.67

1.4

1.3

478.95

490.90

mg/l

0.11

216

1981

Medical treatment for female infertility

257

2761

0.92

0.66

1.3

446.62

426.96

mg/l

0.16

241

2664

Precocious puberty

1.61

0.66

1.4

3.3

603.00

329.45

mg/l

—

Other noninflammatory disorders of uterus, except cervix

254

1558

1.09

0.65

1.2

1.3

520.05

567.23

mg/l

0.58

243

1503

LSIL lesion of the cervix uteri

160

1443

1.11

0.65

1.2

1.3

468.27

455.96

mg/l

0.07

153

1387

Primary coxarthrosis, bilateral

324

3016

1.08

0.64

1.3

664.27

554.08

mg/l

0.97

304

2874

Injury of muscle and tendon at hip and thigh level

132

1178

1.12

0.64

1.3

608.31

558.20

mg/l

0.41

126

1124

Mental and behavioural disorders associated with the puerperium

112

1.44

0.64

1.3

1.4

339.06

388.48

mg/l

0.66

104

Arthropathy in ulcerative colitis

129

1.41

0.64

1.2

1.3

446.39

453.78

mg/l

0.04

122

Carcinoma in situ of vulva

1.51

0.64

1.3

463.38

433.46

mg/l

0.15

Maternal care related to the fetus and amniotic cavity and possible delivery problems

638

3550

1.05

0.64

1.3

503.18

479.99

mg/l

0.15

616

3405

Puerperal sepsis

156

1407

1.11

0.63

1.3

438.36

515.92

mg/l

1.85

148

1348

Other chronic obstructive pulmonary disease, including avohilmo

607

5244

0.95

0.63

1.3

581.46

579.85

mg/l

0.02

569

5015

Autism

288

1.26

0.62

1.1

2.6

334.67

419.77

mg/l

1.44

276

Other specified/unspecified spondylopathies

173

1.34

0.62

1.3

453.00

614.61

mg/l

1.57

166

Single ventricle heart

0.00

0.61

0.0

4.7

—

316.05

—

Childhood allergy (age < 16)

215

1626

1.09

0.61

1.7

1.8

400.88

418.11

mg/l

0.16

204

1558

Other/unspecified seropositive rheumatoid arthritis

307

2860

1.08

0.61

1.3

762.79

542.33

mg/l

0.85

295

2743

Thyroiditis, unspecified

139

1.38

0.61

1.5

565.16

491.48

mg/l

0.31

131

Anoxic brain damage

1.49

0.61

1.5

1.2

430.38

505.14

mg/l

0.44

Traumatic amputation of ankle and foot

0.00

0.61

0.0

1.2

—

567.67

—

AV-block

206

1612

1.09

0.60

1.2

1.4

522.73

539.17

mg/l

0.24

198

1540

Ulcerative colitis (strict definition, require KELA)

218

2006

1.09

0.60

1.2

1.3

505.39

517.37

mg/l

0.13

213

1918

Malignant neoplasm of bone and articular cartilage

1.46

0.60

1.5

1.3

367.93

500.63

mg/l

1.10

Malignant neoplasm of vulva

1.46

0.60

1.4

1.2

1048.79

481.24

mg/l

0.51

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

303

2826

1.07

0.59

1.3

764.05

543.96

mg/l

0.83

291

2709

Maxillary prognathism

1.53

0.59

1.0

2.3

305.25

359.25

mg/l

—

Single delivery by caesarean section

227

1406

0.92

0.59

1.5

1.3

455.05

467.60

mg/l

0.10

222

1352

D07AA Corticosteroids, weak (group I)

207

1899

1.09

0.59

1.5

1.7

486.08

485.57

mg/l

0.00

199

1818

Need for immunization against other single viral diseases

175

1.32

0.59

1.4

1.3

742.17

477.40

mg/l

0.62

167

Abnormal findings in secretions and smears from cervix uteri vagina vulva

729

5128

1.05

0.58

1.3

466.07

493.35

mg/l

0.42

703

4931

Actinomycosis, including avohilmo

1.74

0.58

1.7

1.1

618.17

472.11

mg/l

—

Actinic keratosis

425

3646

1.06

0.58

1.3

632.25

566.58

mg/l

0.61

406

3455

Other infective otitis externa

641

1.16

0.58

1.2

1.3

471.12

526.26

mg/l

0.47

605

Cystic kidney disease, including avohilmo

342

0.79

0.57

1.2

1.5

567.04

509.40

mg/l

0.28

327

Injury of muscle and tendon at lower leg level

182

1666

1.09

0.57

1.3

671.49

546.78

mg/l

0.40

175

1594

Complications of the puerperium, not elsewhere classified

466

1.19

0.57

1.3

518.02

448.50

mg/l

0.23

447

Adjustment and management of implanted device

176

1609

1.10

0.57

1.2

1.3

542.30

553.61

mg/l

0.12

171

1534

Retinoschisis and retinal cysts

212

1.28

0.56

1.1

1.4

526.78

563.08

mg/l

0.27

195

Mental and behavioural disorders of puerperium, not classified elsewhere

116

1.39

0.55

1.3

339.06

393.43

mg/l

0.74

108

Benign neoplasm: Peripheral nerves and autonomic nervous system

142

1.35

0.55

1.3

545.74

465.36

mg/l

0.62

132

Dislocation, sprain and strain of joints and ligaments of elbow

748

1.14

0.55

1.7

1.8

478.18

507.10

mg/l

0.22

719

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

212

1959

1.08

0.54

1.2

1.3

510.85

518.68

mg/l

0.08

207

1872

Juvenile cataract

1.56

0.53

1.2

1.7

1125.33

470.95

mg/l

—

Malignant neoplasm of head and neck, including Hilmo

103

919

1.12

0.53

1.3

1.2

651.34

547.62

mg/l

0.75

861

Disorder of pancreatic internal secretion, other and/or unspecified

1.53

0.53

1.3

1.2

625.10

481.77

mg/l

—

Basal cell carcinoma, including Hilmo

576

3718

1.05

0.53

1.3

596.17

554.75

mg/l

0.68

549

3543

All dysplastic lesions of the cervix uteri

365

3389

1.06

0.53

1.2

1.3

505.78

444.60

mg/l

0.58

351

3262

Pleural plaque

801

0.87

0.52

1.3

520.47

642.57

mg/l

1.27

747

Exclusion endpoint for clefts

223

1.26

0.52

1.4

3.3

341.61

474.82

mg/l

1.87

216

Maternal care for known or suspected malpresentation of fetus

232

1780

0.93

0.52

1.3

379.10

425.04

mg/l

2.23

226

1716

Obstructed labour due to malposition and malpresentation of fetus

278

2749

0.93

0.52

1.2

1.3

453.55

448.74

mg/l

0.05

268

2632

Malignant neoplasm, without specification of site

251

1.24

0.51

1.2

1.3

660.94

529.39

mg/l

0.41

238

Male infertility

444

1.18

0.51

1.6

1.4

1193.21

528.05

mg/l

0.48

425

Bronchiectasis

725

1.13

0.50

1.4

1.3

464.72

567.39

mg/l

1.56

688

Keratoconus

252

1.24

0.50

1.1

1.3

781.23

482.08

mg/l

0.52

241

Foreign body in ear

198

1.27

0.50

1.7

1.8

796.80

448.58

mg/l

0.77

190

In situ neoplasms

502

4789

1.05

0.49

1.3

526.30

526.68

mg/l

0.00

482

4559

209

1810

1.08

0.49

1.3

586.05

605.74

mg/l

0.19

196

1715

Serous carcinoma of ovary, including Hilmo

334

0.80

0.49

1.1

1.2

526.37

479.88

mg/l

0.26

315

Other disorders of iris and ciliary body

235

1.24

0.48

1.3

491.72

496.41

mg/l

0.03

222

Dermatopolymyositis, unspecified

1.51

0.48

1.1

377.57

458.98

mg/l

—

276

2524

0.94

0.48

1.3

589.50

587.53

mg/l

0.02

262

2384

Postpartum haemorrhage due to retained placenta

142

1550

0.91

0.48

1.3

525.50

445.02

mg/l

0.69

137

1495

Delivery, wide proxy

431

2171

1.05

0.48

1.3

528.16

469.43

mg/l

0.97

404

2077

Benign neoplasm: Connective and other soft tissue of head, face and neck

146

1.31

0.47

1.1

1.5

461.79

511.83

mg/l

0.27

140

Conduction disorders

375

2847

1.06

0.47

1.3

1.4

512.74

545.90

mg/l

0.76

362

2714

Femoral hernia

383

1.18

0.47

1.2

1.3

563.04

548.35

mg/l

0.04

358

Infections of breast associated with childbirth

411

1.17

0.47

1.3

378.29

458.80

mg/l

1.70

393

Laparoscopic left hemicolectomy

153

0.71

0.46

1.3

1.2

525.18

504.87

mg/l

0.11

146

Congenital malformations of heart and great arteries

169

1516

1.08

0.45

1.4

1.9

419.17

515.27

mg/l

4.31

160

1455

Colitis, primary sclerosing

141

0.70

0.45

1.1

1.6

332.10

428.61

mg/l

—

135

Cystic kidney disease

308

0.81

0.45

1.2

1.6

564.28

514.27

mg/l

0.21

294

Postpartum haemorrhage

330

2873

0.95

0.44

1.2

1.3

455.42

447.08

mg/l

0.10

319

2746

Retinal breaks without detachment

190

1769

1.08

0.44

1.3

491.08

560.16

mg/l

2.21

184

1685

Multiple delivery

967

0.90

0.44

1.3

471.39

491.64

mg/l

0.17

933

Haemangioma and lymphangioma, any site

111

1011

1.10

0.43

1.2

1.5

472.39

542.12

mg/l

0.97

106

967

Other specified transport accidents

1.44

0.43

1.5

1.4

310.38

471.48

mg/l

—

All-cause Heart Failure

667

4812

0.96

0.43

1.4

1.3

590.77

577.31

mg/l

0.12

645

4581

Inguinal or femoral hernia, bilateral

113

1031

1.10

0.42

1.2

1.3

643.11

548.57

mg/l

0.83

108

973

Calcific aortic valvular stenosis

264

2693

0.94

0.42

1.3

598.64

572.28

mg/l

0.35

255

2564

Calcific aortic valvular stenosis, operated

264

2693

0.94

0.42

1.3

598.64

572.28

mg/l

0.35

255

2564

Hypersensitivity pneumonitis due to organic dust

131

1.31

0.42

1.6

1.3

717.53

478.97

mg/l

0.32

124

Haemolytic disease of fetus and newborn

0.00

0.42

0.0

9.1

—

218.67

—

Pulmonary artery stenosis

0.00

0.42

0.0

7.2

—

239.88

—

Calcific aortic valvular stenosis, including rheumatic fever

265

2697

0.94

0.41

1.3

598.05

572.53

mg/l

0.34

256

2567

Alport

0.00

0.41

0.0

3.8

—

339.24

—

HSIL lesion of the cervix uteri, vagina or vulva

272

2571

1.06

0.41

1.2

1.3

536.84

455.72

mg/l

0.60

263

2474

Supernumerary ureter

0.00

0.41

0.0

4.3

—

285.76

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

593

3848

1.04

0.41

1.2

1.3

603.72

557.07

mg/l

0.74

566

3669

Folliculitis decalvans

0.00

0.41

0.0

1.1

—

732.41

—

Macular pucker

173

1611

1.08

0.41

1.3

565.83

579.55

mg/l

0.15

167

1529

Heart failure, strict

678

4880

0.96

0.41

1.4

1.3

588.55

579.01

mg/l

0.08

655

4646

Other chronic obstructive pulmonary disease

468

3995

0.96

0.41

1.3

564.59

589.90

mg/l

0.39

440

3821

Maternal care for other known or suspected fetal problems

340

2025

1.05

0.41

1.2

1.3

438.64

435.83

mg/l

0.03

329

1945

Personal history of allergy to drugs, medicaments and biological substances

123

1.31

0.41

1.1

1.2

373.00

444.27

mg/l

0.79

115

Noonan syndrome

0.00

0.41

0.0

5.5

—

278.94

—

Malignant neoplasm of thymus

1.49

0.41

1.0

1.3

423.40

455.41

mg/l

—

Other congenital malformations of eye

0.00

0.40

0.0

3.1

—

440.28

—

Typhoid and paratyphoid fevers

1.48

0.40

1.0

1.1

785.40

528.68

mg/l

—

Medullary cystic kidney disease, nephronophthisis

0.00

0.40

0.0

1.1

—

509.61

—

Multiple gestation

102

1118

0.91

0.40

1.5

1.3

505.61

439.17

mg/l

0.75

102

1078

Family history of malignant neoplasm

142

1314

1.08

0.40

1.2

1.3

488.13

492.18

mg/l

0.03

136

1256

Operations 2 for CAVS

264

2686

0.94

0.40

1.3

598.64

572.94

mg/l

0.34

255

2557

Calcific aortic valvular stenosis, diagnosis (helper)

264

2686

0.94

0.40

1.3

598.64

572.94

mg/l

0.34

255

2557

Follicular adenocarcinoma of thyroid gland, including Hilmo

104

0.67

0.40

1.1

1.2

594.00

435.65

mg/l

—

Postmenopausal atrophic vaginitis

310

1601

1.06

0.40

1.3

468.48

566.81

mg/l

2.20

301

1543

Inguinal hernia, bilateral

111

1017

1.09

0.39

1.2

1.3

647.52

545.38

mg/l

0.91

106

961

Use of rasagiline

242

1.20

0.39

1.4

1.3

473.83

596.81

mg/l

1.49

226

Primary gonarthrosis, bilateral

646

5220

1.04

0.39

1.3

560.43

578.18

mg/l

0.34

620

4990

Pseudopolyposis of colon

1.41

0.38

1.0

1.3

355.20

437.31

mg/l

—

Other congenital malformations of the digestive system, including avohilmo

585

1.12

0.38

2.3

2.4

419.08

485.67

mg/l

0.71

563

Twin gestation

1081

0.91

0.37

1.5

1.3

506.03

438.96

mg/l

0.73

1042

CR(E)ST syndrome

152

1.26

0.37

1.2

646.11

504.81

mg/l

0.60

143

Pleural plaque with presence of asbestos

567

0.88

0.37

1.2

1.3

547.02

621.43

mg/l

0.54

526

Contact with other hot fluids

318

1.17

0.37

1.2

1.7

414.06

499.59

mg/l

0.90

304

Oral lichen planus, including avohilmo , including avohilmo

763

1.10

0.37

1.3

1.2

480.38

530.47

mg/l

0.57

726

Colectomy operation

181

1699

1.07

0.36

1.2

1.3

542.99

579.29

mg/l

0.36

173

1612

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

108

995

1.09

0.35

1.2

1.3

439.24

457.19

mg/l

0.19

102

958

Deep bite

153

1254

1.07

0.35

2.1

1.8

412.43

494.51

mg/l

2.20

143

1206

Malignant neoplasm of larynx

125

0.72

0.35

1.4

1.2

762.89

581.97

mg/l

—

119

Unspecified lump in breast

186

1750

1.06

0.35

1.3

441.68

523.12

mg/l

2.38

180

1680

Inhalation and ingestion of other objects causing obstruction of respiratory tract

1.37

0.34

1.2

1.9

350.00

414.73

mg/l

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

118

1.28

0.34

1.5

1.3

448.47

517.77

mg/l

0.45

111

Left hemicolectomy

191

1.21

0.33

1.2

460.26

515.54

mg/l

0.44

178

Benign neoplasm: other/unspecified salivary gland

228

1.19

0.33

1.1

1.2

527.11

511.25

mg/l

0.06

217

Aphakia

109

1.29

0.33

1.4

1.3

468.50

557.56

mg/l

0.53

104

Other congenital malformations of tongue, mouth and pharynx

172

1.22

0.33

4.0

3.5

455.43

436.86

mg/l

0.05

167

Premature rupture of membranes

276

2060

0.95

0.33

1.3

450.34

438.63

mg/l

0.14

266

1975

Endometriosis of fallopian tube

1.36

0.32

2.9

1.5

613.50

514.62

mg/l

—

Inflammation of lacrimal passages (acute and unspecified)

154

0.78

0.32

2.9

1.3

514.83

500.66

mg/l

0.03

148

Use of cabergoline

110

1.28

0.32

2.2

1.4

403.57

430.26

mg/l

0.22

104

Basal cell carcinoma

542

3574

1.03

0.31

1.3

603.47

556.92

mg/l

0.74

515

3403

Major anomalies of jaw size

267

1.17

0.31

1.3

1.7

388.97

481.88

mg/l

1.84

252

Corneal degeneration

156

1.22

0.31

1.2

1.4

595.47

521.11

mg/l

0.22

148

Congenital malformations of eye, ear, face and neck

762

1.09

0.31

1.3

2.0

399.05

472.41

mg/l

2.03

727

Abrasion of teeth

463

4791

0.97

0.31

1.3

451.47

536.75

mg/l

4.98

432

4596

Maternal care for known or suspected fetal abnormality and damage

216

1737

1.05

0.31

1.3

438.61

430.68

mg/l

0.05

210

1671

Other acute skin changes due to ultraviolet radiation

305

1.15

0.31

1.8

1.3

438.11

533.69

mg/l

1.18

290

Sequelae of tuberculosis

0.73

0.31

2.1

1.2

347.71

527.60

mg/l

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

184

1.20

0.30

1.3

2.0

397.86

472.83

mg/l

0.87

175

Pectus excavatum, including avohilmo

1.31

0.30

1.3

1.6

306.14

379.67

mg/l

—

Other noninfective disorders of lymphatic vessels and lymph nodes

362

1.14

0.30

1.1

1.3

650.63

525.64

mg/l

0.42

347

Tooth eruption problems

205

1879

1.05

0.30

2.2

1.6

408.17

431.88

mg/l

0.32

195

1797

Polymorphous light eruption

1.32

0.30

1.5

1.3

361.00

435.39

mg/l

0.71

Other and unspecified nonscarring hair loss

1.32

0.30

1.6

1.2

406.73

400.58

mg/l

0.02

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

879

1.08

0.30

1.3

585.96

450.26

mg/l

0.69

846

Androgenic alopecia

1.30

0.30

3.8

1.3

534.00

416.17

mg/l

0.34

Bicuspidal aortic valve syndrome

387

0.88

0.29

1.5

1.6

497.09

538.32

mg/l

0.51

370

Carbimazole or st.post thyroidectomy, condition for graves disease

262

2510

1.04

0.28

1.4

1.3

531.89

522.09

mg/l

0.08

252

2404

Abnormal spermatozoa

123

1154

1.07

0.28

1.2

1.3

670.20

585.85

mg/l

0.45

117

1097

Malignant neoplasm of anus and anal canal, including Hilmo

116

0.77

0.27

1.1

1.2

458.56

505.63

mg/l

—

108

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

119

0.75

0.27

1.2

1.3

379.00

424.58

mg/l

—

114

Intrahepatic Cholestasis of Pregnancy (ICP)

826

1.08

0.27

1.1

1.3

418.70

435.50

mg/l

0.17

798

Coronary atherosclerosis

840

5173

1.02

0.27

1.3

579.73

580.58

mg/l

0.01

796

4944

Rheumatic valve diseases

150

0.80

0.27

1.3

370.92

482.41

mg/l

1.36

145

Inguinal of femoral hernia, unilateral

243

1.16

0.27

1.1

1.2

572.00

497.84

mg/l

0.15

229

Inguinal hernia, unilateral

243

1.16

0.27

1.1

1.2

572.00

497.84

mg/l

0.15

229

Femoral hernia, unilateral

243

1.16

0.27

1.1

1.2

572.00

497.84

mg/l

0.15

229

Unstable angina pectoris

423

3217

1.03

0.26

1.3

686.33

589.18

mg/l

0.63

402

3066

Delivery

526

2691

1.03

0.26

1.3

562.81

488.86

mg/l

0.91

495

2577

Small cell lung cancer

192

0.83

0.25

1.2

569.06

554.91

mg/l

0.05

181

Small cell lung cancer, including Hilmo

192

0.83

0.25

1.2

569.06

554.91

mg/l

0.05

181

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

273

2545

1.04

0.25

1.3

701.43

544.26

mg/l

2.79

263

2413

Primary biliary cholangitis (PBC)

181

0.83

0.25

1.1

1.3

468.20

524.56

mg/l

0.27

170

Thyrotoxicosis with toxic multinodular goitre

581

0.91

0.25

1.3

614.34

544.11

mg/l

0.48

552

Postpartum hemorraghe, parous women as controls

330

2857

0.96

0.25

1.2

1.3

455.42

443.40

mg/l

0.16

319

2743

Psoriatic arthropathies, ICD10

124

1170

1.06

0.25

1.2

1.3

491.93

542.92

mg/l

0.75

118

1117

Other specific arthropathies, wide

198

1.17

0.25

1.4

1.2

764.09

486.74

mg/l

0.53

189

Small cell lung cancer, helper endpoint

191

0.84

0.24

1.2

569.06

533.31

mg/l

0.15

178

Hypertension, Pulmonary Arterial

1.17

0.24

2.0

1.2

504.89

427.72

mg/l

—

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

126

0.79

0.24

1.1

1.2

589.00

486.69

mg/l

—

121

Malignant neoplasm of renal pelvis, including Hilmo

0.73

0.24

1.0

1.2

633.50

513.25

mg/l

—

Benign neoplasm: Duodenum

246

1.14

0.24

1.6

1.3

513.11

550.16

mg/l

0.29

231

Benign neoplasm: Skin of eyelid, including canthus

169

1612

1.05

0.23

1.2

1.3

529.14

555.64

mg/l

0.32

162

1530

COPD

497

4144

0.97

0.23

1.3

559.59

590.04

mg/l

0.52

468

3966

Aggressive periodontitis

222

0.85

0.23

1.3

786.05

512.70

mg/l

0.47

213

Adhesive middle ear disease

143

1.19

0.23

1.0

1.4

511.06

426.07

mg/l

0.55

137

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

108

1018

1.06

0.23

1.2

1.3

439.24

473.55

mg/l

0.41

102

974

Major coronary heart disease event excluding revascularizations

770

4971

1.02

0.23

1.3

590.49

579.98

mg/l

0.10

734

4746

Olecranon bursitis

534

1.09

0.23

1.3

522.83

595.27

mg/l

1.01

504

Pleural effusion

151

1440

1.05

0.22

1.4

1.3

596.08

592.19

mg/l

0.02

144

1365

Birth injury to scalp

0.00

0.22

0.0

3.9

—

297.80

—

Digeorge syndrome

0.00

0.22

0.0

8.9

—

235.09

—

Vibratory urticaria

0.00

0.22

0.0

1.2

—

619.50

—

Pregnancy, childbirth and the puerperium

360

1822

1.03

0.21

1.3

504.49

466.47

mg/l

0.47

339

1740

Juvenile dermatomyositis

0.00

0.21

0.0

2.9

—

326.73

—

Explosion and rupture of other specified pressurized devices

0.00

0.21

0.0

1.1

—

536.70

—

Staphylococcal scalded skin syndrome

0.00

0.21

0.0

2.2

—

247.00

—

Lichen striatus

0.00

0.21

0.0

1.2

—

453.36

—

Malignant neoplasm of pyriform sinus, including Hilmo

0.00

0.21

0.0

1.6

—

565.60

—

Ascorbic acid deficiency

0.00

0.21

0.0

2.7

—

283.33

—

Induced delusional disorder

0.00

0.21

0.0

1.3

—

379.58

—

Disorders of copper metabolism

0.00

0.21

0.0

4.0

—

324.08

—

Congenital glaucoma

0.00

0.21

0.0

1.2

—

358.92

—

Transepidermal elimination disorders

0.00

0.21

0.0

1.1

—

340.83

—

Rifle, shotgun and larger firearm discharge

0.00

0.21

0.0

1.0

—

568.17

—

Intentional self-harm by jumping or lying before moving object

0.00

0.21

0.0

1.2

—

464.00

—

Other psoriatic arthropathies

120

1139

1.06

0.21

1.2

1.3

487.64

544.47

mg/l

0.84

114

1086

Thyrotoxicosis from ectopic thyroid tissue

0.00

0.21

0.0

1.2

—

403.46

—

Hirsprung

0.00

0.21

0.0

4.5

—

630.85

—

Other recurrent vertebral subluxation

0.00

0.21

0.0

1.2

—

393.69

—

Polydactyly

0.00

0.21

0.0

5.5

—

285.69

—

Cicatricial pemphigoid

0.00

0.21

0.0

1.3

—

391.23

—

Disorders of sexual preference

0.00

0.21

0.0

1.2

—

569.38

—

Postpartum hemorraghe, all women as controls

330

3315

0.97

0.21

1.2

1.3

455.42

435.16

mg/l

0.30

319

3185

Benign neoplasm: Vulva

192

1.15

0.21

1.0

1.3

445.82

498.94

mg/l

0.61

182

Traction detachment of retina

1.26

0.20

1.4

1.3

566.10

464.92

mg/l

—

Inguinal hernia

787

5128

1.02

0.20

1.3

1.4

624.75

570.31

mg/l

0.52

754

4919

Mandibular retrognathia

757

0.93

0.20

2.2

1.7

367.91

473.80

mg/l

3.72

728

Iodine-deficiency-related goitre

0.00

0.20

0.0

1.1

—

328.07

—

Secondary lactase deficiency

0.00

0.20

0.0

1.3

—

553.86

—

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

108

1.21

0.20

1.8

2.9

389.23

410.08

mg/l

0.10

103

COPD related to multimorbidity

417

3615

0.97

0.20

1.3

572.49

587.24

mg/l

0.19

391

3452

Gastrointestinal stromal tumor and sarcoma

115

0.78

0.20

1.0

1.3

983.67

497.20

mg/l

—

107

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

271

0.88

0.20

1.1

1.2

557.50

474.25

mg/l

0.43

256

Orthopaedic devices associated with adverse incidents

176

0.85

0.20

1.3

1.2

434.80

570.15

mg/l

1.45

165

Amputation of ankle bones

174

1.15

0.20

1.5

1.3

534.50

509.36

mg/l

0.14

166

Rheumatic fever incl heart disease

218

0.87

0.19

1.3

401.00

490.86

mg/l

0.71

207

Malignant neoplasm of gallbladder, including Hilmo

1.18

0.19

1.0

1.2

438.17

463.22

mg/l

—

Chronic suppurative otitis media, including avohilmo

829

0.94

0.19

1.4

1.8

807.45

535.34

mg/l

0.43

789

Respiratory and cardiovascular disorders specific to the perinatal period

292

1.11

0.19

5.2

3.8

675.75

394.08

mg/l

0.79

287

Hyphaema and other vascular disorders of iris and ciliary body

165

1.16

0.19

1.2

1.3

496.84

482.54

mg/l

0.09

156

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

842

1.06

0.18

1.1

1.3

418.70

454.42

mg/l

0.40

807

Graves disease, strict definition

122

1165

1.05

0.18

1.4

1.3

467.07

486.67

mg/l

0.22

115

1122

Other congenital malformations of tongue, mouth and pharynx, including avohilmo

222

1.12

0.18

3.5

3.2

434.00

413.48

mg/l

0.07

217

Other malignant neoplasms of skin (=non-melanoma skin cancer)

554

3683

1.02

0.17

1.2

1.3

611.43

555.28

mg/l

0.90

527

3510

Arthropathic psoriasis

132

1265

1.04

0.17

1.2

1.3

500.25

553.79

mg/l

0.77

126

1206

Congenital malformations of breast

176

1.14

0.17

1.1

1.3

340.75

442.12

mg/l

1.96

168

Chronic suppurative otitis media

691

0.94

0.17

1.5

1.6

541.80

526.40

mg/l

0.06

654

Birth trauma

0.74

0.17

1.0

2.7

321.20

395.15

mg/l

—

Benign neoplasm of urinary organs

436

1.08

0.17

1.2

1.3

460.30

561.01

mg/l

1.62

411

Malignant neoplasm of other and unspecified female genital organs

152

0.85

0.17

1.0

1.2

507.38

482.81

mg/l

0.06

144

Other specified/unspecified nutritional deficiencies

1.13

0.16

1.0

1.3

515.50

476.06

mg/l

—

Other congenital malformations of female genitalia

1.20

0.16

1.4

1.5

322.55

356.62

mg/l

0.30

Acute appendicitis, with complications

220

2135

1.03

0.16

1.4

1.3

598.15

540.86

mg/l

0.68

210

2039

Carcinoma in situ of cervix uteri

123

1281

0.96

0.16

1.2

1.3

402.39

449.30

mg/l

0.92

118

1229

Trichomoniasis

0.79

0.16

1.2

512.00

498.54

mg/l

—

Inflammation of lacrimal passages (chronic)

119

0.84

0.15

1.7

1.3

563.50

503.81

mg/l

—

112

Benign neoplasm of other and unspecified female genital organs

429

1.07

0.15

1.1

1.3

446.63

525.03

mg/l

0.99

412

Ulcerative ileocolitis

410

0.93

0.15

1.1

1.3

489.71

517.23

mg/l

0.12

389

malignant neoplasm of male genital organs, including Hilmo

327

1918

1.02

0.15

1.3

657.61

584.62

mg/l

0.82

314

1832

Trichomoniasis, including avohilmo

0.77

0.14

1.1

541.71

485.23

mg/l

—

Arterial embolism and thrombosis of lower extremity artery

285

0.91

0.14

1.3

431.65

608.43

mg/l

1.65

265

Carcinoma in situ of other and unspecified genital organs

208

1.11

0.14

1.2

1.3

407.39

511.13

mg/l

1.19

196

Undescended testis, unilateral

0.83

0.14

2.6

4.2

307.13

416.63

mg/l

—

Sequelae of tuberculosis, including avohilmo

0.81

0.13

2.1

1.2

348.25

524.08

mg/l

—

Non-ischemic cardiomyopathy

365

2836

1.02

0.13

1.5

1.3

521.30

564.97

mg/l

1.06

355

2691

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

153

1483

1.03

0.13

1.2

1.3

485.58

553.42

mg/l

1.54

143

1414

Primary Sclerosing Cholangitis, IBD and UDCA required

209

1.10

0.13

1.1

2.0

371.13

449.42

mg/l

1.02

200

Autism spe

297

1.08

0.12

1.2

2.4

343.34

436.48

mg/l

1.28

286

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

210

1.10

0.12

1.3

1.2

478.13

534.03

mg/l

0.28

198

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

944

1.04

0.12

1.2

1.3

517.16

564.71

mg/l

0.49

898

Other diseases caused by chlamydiae

116

0.86

0.12

1.3

354.80

485.03

mg/l

—

111

Pneumothorax

679

1.05

0.12

1.2

1.3

693.38

603.05

mg/l

0.17

644

Congenital malformations of anterior segment of eye

1.17

0.11

1.2

2.0

420.10

437.74

mg/l

—

Mandibular prognathia

163

1.11

0.11

1.4

2.5

436.11

460.38

mg/l

0.11

156

Heart failure and bmi 25plus

364

2466

0.98

0.10

1.3

565.54

609.34

mg/l

0.79

349

2344

Seropositive rheumatoid arthritis, strict definition

166

1620

1.03

0.10

1.2

1.3

906.24

548.90

mg/l

0.71

158

1541

Chronic respiratory disease originating in the perinatal period

1.17

0.10

3.8

5.8

445.80

369.07

mg/l

—

Venous complications and haemorrhoids in the puerperium

125

1.12

0.10

1.5

1.3

500.00

438.03

mg/l

0.25

119

Carcinoma in situ of skin of lower limb, including hip

183

1.10

0.10

1.2

1.3

559.75

544.50

mg/l

0.06

171

Fatigue fracture of vertebra

1.14

0.10

1.2

2.9

552.80

432.86

mg/l

—

Congenital malformations of great veins

1.08

0.09

1.2

5.4

379.00

324.59

mg/l

—

290

0.93

0.09

1.8

4.1

401.18

400.09

mg/l

0.00

285

Crossbite

837

0.97

0.09

3.5

2.1

431.43

455.79

mg/l

0.09

807

malignant neoplasm of male genital organs

318

1883

1.02

0.09

1.3

654.36

585.64

mg/l

0.73

305

1799

Congenital malformations of genital organs

118

1140

1.03

0.09

1.5

1.8

415.69

455.15

mg/l

0.49

109

1101

Carcinoma in situ of rectum

116

1.12

0.09

1.7

1.2

620.08

510.80

mg/l

0.29

110

Varicose veins

766

5726

1.01

0.09

1.3

609.54

553.63

mg/l

0.46

734

5484

Cardiovascular disorders originating in the perinatal period

1.13

0.09

1.8

5.9

1082.17

447.55

mg/l

—

Glaucoma, exfoliation

867

0.97

0.08

1.3

1.2

522.35

621.89

mg/l

0.76

820

Cardiomyopathy

185

1884

0.98

0.08

1.4

591.81

541.27

mg/l

0.84

180

1803

Other benign neoplasm of uterus: Cervix uteri

1.08

0.08

1.1

1.2

499.43

400.17

mg/l

—

Leiomyoma of uterus

843

4689

1.01

0.07

1.3

542.02

509.38

mg/l

0.44

812

4501

Benign neoplasm: Tongue

266

0.94

0.07

1.3

594.32

509.74

mg/l

0.35

251

Pure hyperglyceridaemia

215

1.07

0.07

1.4

572.57

550.13

mg/l

0.12

205

Malignant neoplasm of eye and adnexa

1.08

0.07

2.1

1.3

543.38

473.04

mg/l

—

Abnormal findings on diagnostic imaging of breast

143

0.91

0.07

1.5

1.2

428.00

493.89

mg/l

0.56

136

Slow fetal growth and fetal malnutrition

0.86

0.07

1.0

6.2

294.29

427.72

mg/l

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

271

2289

1.01

0.07

1.3

528.11

579.01

mg/l

1.14

253

2181

Malignant neoplasm of gum, including Hilmo

0.85

0.07

1.3

1.2

780.43

482.80

mg/l

—

Mixed hyperlipidaemia

353

1.05

0.07

1.4

1.2

569.38

612.22

mg/l

0.25

329

Non-rheumatic valve diseases

598

4227

1.01

0.07

1.4

562.26

561.00

mg/l

0.02

578

4045

Other nonscarring hair loss

118

1.10

0.07

1.5

1.2

397.69

404.98

mg/l

0.03

111

Operations for atrial fibrillation

122

0.90

0.07

1.0

1.2

530.73

513.68

mg/l

0.06

117

Benign neoplasm: Appendix

1.04

0.07

1.7

1.2

403.22

513.30

mg/l

—

Fetus and newborn affected by maternal complications of pregnancy

0.86

0.07

2.3

6.0

261.75

397.52

mg/l

—

Autoimmune hepatitis

1.13

0.07

1.6

1.9

491.00

452.27

mg/l

—

Leiomyosarcoma, including Hilmo

0.86

0.07

1.0

1.3

531.25

496.61

mg/l

—

Malignant neoplasm of larynx, including Hilmo

152

0.92

0.06

1.7

1.2

938.79

553.18

mg/l

1.43

142

Congenital malformations of ovaries, fallopian tubes and broad ligaments

622

1.03

0.06

1.3

453.75

465.26

mg/l

0.07

599

Valvular heart disease excluding rheumatic fever

603

4272

1.01

0.05

1.4

568.59

559.53

mg/l

0.15

583

4090

Benign leiomyoma with endometriosis

166

1635

1.02

0.05

1.3

485.70

518.99

mg/l

0.46

155

1574

Other and unspecified haemorrhagic conditions

131

0.91

0.05

1.1

1.4

567.00

452.30

mg/l

0.25

125

Colorectal neuroendocrine tumor and carcinoma

141

0.92

0.05

1.3

434.54

446.30

mg/l

0.06

133

HSIL lesion of the cervix uteri

241

2383

1.01

0.05

1.2

1.3

512.56

452.36

mg/l

0.39

232

2296

Migraine without aura, drug-induced

120

1.09

0.05

1.4

1.3

762.92

450.33

mg/l

0.78

115

Malignant neoplasm of head and neck

773

1.02

0.04

1.3

1.2

613.53

527.39

mg/l

0.53

721

Other disorders originating in the perinatal period

140

1.07

0.04

3.3

4.5

319.87

353.14

mg/l

0.19

140

Myocardial infarction, without ST-elevation

425

3806

1.01

0.04

1.3

669.85

580.59

mg/l

0.57

399

3639

Poor fetal growth

159

1570

1.01

0.04

1.2

1.3

457.12

425.49

mg/l

0.25

153

1509

Melanoma in situ of other and unspecified parts of face

101

1.09

0.04

1.3

490.82

492.88

mg/l

0.01

Embedded and impacted teeth

382

3121

0.99

0.04

1.6

1.4

444.75

457.51

mg/l

0.16

366

2994

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

210

1.05

0.03

1.2

1.3

557.59

504.21

mg/l

0.15

199

826

1.02

0.03

1.3

712.85

599.55

mg/l

0.27

786

Other and unspecified disease of Bartholin gland

260

0.96

0.03

1.2

1.3

695.56

506.45

mg/l

0.32

251

Malignant neoplasm of prostate, including Hilmo

308

1805

1.01

0.03

1.3

640.96

588.58

mg/l

0.52

295

1727

Maternal care for known or suspected disproportion

471

0.98

0.03

1.3

534.72

446.36

mg/l

0.32

453

Primary biliary cholangitis, wide definition

191

1.05

0.03

1.2

1.6

505.05

510.77

mg/l

0.02

180

Diseases caused by chlamydiae

108

0.92

0.03

1.3

354.80

473.53

mg/l

—

103

HSIL lesion of the vagina

148

0.94

0.02

1.4

1.3

1093.29

467.15

mg/l

0.56

139

Pyogenic granuloma

162

1.05

0.02

1.2

1.4

489.71

449.64

mg/l

0.12

154

Embedded teeth, including avohilmo

116

1148

1.01

0.02

1.6

1.5

459.87

453.22

mg/l

0.05

109

1097

Other assisted single delivery

192

1.04

0.02

1.2

1.4

333.50

438.52

mg/l

2.29

187

Long labour

328

2766

1.00

0.02

1.2

1.3

468.51

447.81

mg/l

0.21

319

2645

Malignant neoplasm of bladder, including Hilmo

104

1016

1.01

0.02

1.3

1.2

654.31

559.04

mg/l

0.52

957

Dislocation of lens

107

0.93

0.02

1.5

1.3

764.10

615.92

mg/l

—

102

Carcinoma in situ of skin, other sites/unspecified

117

0.94

0.01

1.5

1.3

566.64

501.40

mg/l

0.19

112

Lung cancer and mesothelioma

174

1484

0.99

0.01

1.2

1.3

750.49

538.39

mg/l

0.76

167

1424

Allergic contact dermatitis due to drugs in contact with skin

213

1.03

0.01

1.2

1.3

608.77

483.70

mg/l

0.59

200

Malignant neoplasm of breast, ER-negative, including Hilmo

236

2216

1.00

0.01

1.3

555.08

504.15

mg/l

0.57

226

2111

Malignant neoplasm of breast, HER-negative

215

2073

1.00

0.01

1.3

565.81

506.99

mg/l

0.62

205

1972

Heart failure,strict

634

4430

1.00

0.01

1.4

1.3

548.25

579.15

mg/l

0.77

613

4222

Impacted teeth

278

2393

1.00

0.01

1.6

1.4

435.16

443.10

mg/l

0.08

266

2294

Pacemaker

374

3483

1.00

0.01

1.3

523.00

574.63

mg/l

1.81

356

3320

Family history of other conditions

154

1.04

0.00

1.1

1.5

557.75

436.72

mg/l

0.37

148

Later onset COPD, excluding more controls

186

1412

1.00

0.00

1.2

1.3

530.87

536.88

mg/l

0.06

175

1344

COPD, hospital admission 2, with asthma infections

336

2885

1.00

0.00

1.3

521.92

581.75

mg/l

1.72

314

2750

Other specified congenital malformation syndromes affecting multiple systems

184

1.03

0.00

1.1

3.8

312.26

442.49

mg/l

1.97

177

Malignant neoplasm of prostate

298

1767

1.00

0.00

1.3

637.51

589.62

mg/l

0.45

285

1690

Cholangitis (primary sclerosing, PSC)

579

1.00

0.00

1.2

1.5

465.60

556.06

mg/l

1.49

556

Benign neoplasm: Skin of lip

106

1.04

0.00

1.3

1.2

568.18

483.79

mg/l

0.19

101

Malignant neoplasm of other and ill-defined sites, including Hilmo

114

0.96

0.00

3.7

1.3

364.82

522.49

mg/l

1.35

108

Localized scleroderma [morphea]

134

0.97

0.00

1.5

1.3

489.00

506.31

mg/l

0.08

125

Benign neoplasm: Kidney

332

0.99

0.00

1.2

1.3

435.58

542.64

mg/l

1.98

318

Supervision of normal pregnancy

279

1589

1.00

0.00

1.3

405.65

446.86

mg/l

1.12

269

1527

319

1.02

0.00

2.2

3.9

378.59

406.64

mg/l

0.13

314

Hypotension due to drugs

103

0.97

0.00

1.4

1.2

468.50

516.36

mg/l

—

Polycystic kidney disease

236

1.02

0.00

1.2

1.6

589.58

500.04

mg/l

0.42

225

Other disorders of breast and lactation associated with childbirth

177

1.02

0.00

1.2

1.3

365.78

392.35

mg/l

0.28

170

Benign neoplasm of thyroid gland

324

0.99

0.00

1.2

1.4

516.47

521.06

mg/l

0.03

310

Abscess of external ear

118

1.02

0.00

1.3

1.6

773.42

437.12

mg/l

0.59

111

Ankylosing hyperostosis [Forestier]

109

1.01

0.00

1.1

1.3

497.00

512.50

mg/l

0.07

104

Benign neoplasm: Vagina

129

1.01

0.00

1.2

492.31

449.39

mg/l

0.13

119

Single spontaneous delivery

508

2683

1.00

0.00

1.2

1.3

553.17

489.49

mg/l

0.74

478

2569

Maxillary retrognathism

191

0.99

0.00

1.2

2.5

463.32

456.79

mg/l

0.02

182

Cardiomyopathy, other and unspecified

777

1.00

0.00

1.4

1.3

636.01

555.64

mg/l

0.74

747

Other and unspecified acute skin changes due to ultraviolet radiation

205

0.98

0.00

2.0

1.2

483.30

506.15

mg/l

0.13

193

Malignant neoplasm of pyriform sinus

0.00

0.0

1.6

—

422.20

—

Leiomyosarcoma

0.87

0.00

1.0

1.3

561.00

508.33

mg/l

—

Brucellosis, including avohilmo

0.00

0.0

1.2

—

308.33

—

Selective deficiency of immunoglobulin M [IgM]

0.00

0.0

3.6

—

411.00

—

Carcinoma in situ of bronchus and lung

0.00

0.0

1.0

—

369.71

—

Benign neoplasm: Pluriglandular involvement

0.00

0.0

1.2

—

383.00

—

Rifle, shotgun and larger firearm discharge, undetermined intent

0.00

0.0

1.0

—

714.40

—

Disorders of tyrosine metabolism

0.00

-0.00

0.0

1.1

—

369.75

—

Plague, including avohilmo, including avohilmo

0.00

-0.00

0.0

1.2

—

337.60

—

Secondary sideroblastic anaemia due to drugs and toxins

0.00

-0.00

0.0

1.2

—

499.67

—

Lipid storage disorder, other/unspecified

0.00

-0.00

0.0

1.3

—

512.00

—

Disorders of conjunctiva in diseases classified elsewhere

0.00

-0.00

0.0

1.4

—

411.80

—

Hereditary erythropoietic porphyria

0.00

-0.00

0.0

1.2

—

292.80

—

Pelvic region

0.00

-0.00

0.0

1.0

—

758.00

—

Rabies, including avohilmo

0.00

-0.00

0.0

1.2

—

703.20

—

Trachoma

0.00

-0.00

0.0

1.2

—

531.60

—

Hereditary factor IX deficiency

0.00

-0.00

0.0

4.6

—

410.00

—

Legal intervention

0.00

-0.00

0.0

1.0

—

698.17

—

Benign neoplasm: Scapula and long bones of upper limb

0.94

-0.00

1.2

1.3

465.11

463.76

mg/l

—

Brucellosis

0.00

-0.00

0.0

1.2

—

307.60

—

Histoplasmosis, including avohilmo

0.00

-0.00

0.0

1.0

—

390.75

—

Disorders of fructose metabolism

0.00

-0.00

0.0

1.3

—

455.50

—

Crushing injuries involving multiple body regions

0.00

-0.00

0.0

1.3

—

416.17

—

Fibrothorax

0.00

-0.00

0.0

1.0

—

664.57

—

Carcinoma in situ of respiratory system, other/unspecified

0.00

-0.00

0.0

1.4

—

828.40

—

Toxic effect of soaps and detergents

0.00

-0.00

0.0

1.2

—

399.40

—

Congenital aortic valve stenosis

0.98

-0.00

1.2

4.0

466.60

474.14

mg/l

—

Histoplasmosis

0.00

-0.00

0.0

1.0

—

390.75

—

Nanophthalmos, microphthalmos and macrophthalmos

0.00

-0.00

0.0

6.4

—

246.43

—

Ascariasis

0.00

-0.00

0.0

1.3

—

373.67

—

Carcinoma in situ of other/unspecified male genital organs

0.00

-0.00

0.0

1.2

—

688.60

—

Iliac crest spur

0.00

-0.00

0.0

1.4

—

385.29

—

Cardiovascular devices associated with adverse incidents

0.00

-0.00

0.0

1.1

—

428.25

—

Drowning and submersion in swimming-pool or bath

0.00

-0.00

0.0

1.4

—

877.14

—

Benign neoplasm: Parathyroid gland

0.92

-0.00

1.2

1.3

444.33

546.04

mg/l

—

Myelofibrosis

0.00

-0.00

0.0

1.0

—

392.20

—

Malignant neoplasm of parotid gland, including Hilmo

0.97

-0.00

1.2

1.3

432.22

446.76

mg/l

—

Trachoma, including avohilmo

0.00

-0.00

0.0

1.2

—

512.33

—

Other birth injuries

0.00

-0.00

0.0

1.0

—

281.43

—

Androgen resistance syndrome

0.00

-0.00

0.0

3.4

—

491.44

—

Exposure to vibration

0.00

-0.00

0.0

1.0

—

556.60

—

Obstetric and gynaecological devices associated with adverse incidents

0.00

-0.00

0.0

1.3

—

650.17

—

Malignant neoplasm of floor of mouth, including Hilmo

0.92

-0.00

1.0

1.2

489.29

479.63

mg/l

—

Benign neoplasm: Mesothelial tissue of other sites/unspecified

0.00

-0.00

0.0

1.2

—

289.33

—

Legal intervention and operations of war

0.00

-0.00

0.0

1.1

—

576.33

—

Chondrolysis

0.00

-0.00

0.0

1.0

—

401.00

—

Malignant neoplasm of trachea, including Hilmo

0.00

-0.00

0.0

1.1

—

633.14

—

Miliaria rubra

0.00

-0.00

0.0

1.5

—

594.13

—

Immunodeficiency with increased immunoglobulin M [IgM]

0.00

-0.00

0.0

1.3

—

392.83

—

Acquired keratosis follicularis

0.00

-0.00

0.0

1.1

—

302.00

—

Ischaemic infarction of muscle

0.00

-0.00

0.0

1.2

—

600.00

—

Cleft palate

0.92

-0.00

1.0

2.0

487.44

387.34

mg/l

—

Other injuries of spine and trunk, level unspecified

0.96

-0.00

1.1

1.5

845.25

475.14

mg/l

—

Cholera

0.00

-0.00

0.0

1.2

—

575.33

—

Short stature starting before birth

0.92

-0.00

2.5

5.8

333.33

358.18

mg/l

—

Rabies

0.00

-0.00

0.0

1.2

—

703.20

—

Crushing injury of thorax and traumatic amputation of part of thorax

0.00

-0.00

0.0

1.2

—

793.20

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Protein [Mass/volume] in Cerebral spinal fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS